CN1550549A - α-淀粉酶突变体 - Google Patents
α-淀粉酶突变体 Download PDFInfo
- Publication number
- CN1550549A CN1550549A CNA2004100617366A CN200410061736A CN1550549A CN 1550549 A CN1550549 A CN 1550549A CN A2004100617366 A CNA2004100617366 A CN A2004100617366A CN 200410061736 A CN200410061736 A CN 200410061736A CN 1550549 A CN1550549 A CN 1550549A
- Authority
- CN
- China
- Prior art keywords
- gly
- asn
- asp
- seq
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000637 alpha-Amylases Proteins 0.000 title claims abstract description 77
- 102000004139 alpha-Amylases Human genes 0.000 title claims abstract description 76
- 229940024171 alpha-amylase Drugs 0.000 title claims abstract description 76
- 230000000694 effects Effects 0.000 claims abstract description 92
- 229910052717 sulfur Inorganic materials 0.000 claims description 258
- 229910052720 vanadium Inorganic materials 0.000 claims description 243
- 229910052727 yttrium Inorganic materials 0.000 claims description 224
- 229910052799 carbon Inorganic materials 0.000 claims description 223
- 229910052698 phosphorus Inorganic materials 0.000 claims description 209
- 238000009738 saturating Methods 0.000 claims description 78
- 230000008859 change Effects 0.000 claims description 46
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 44
- 229910052757 nitrogen Inorganic materials 0.000 claims description 34
- 230000008034 disappearance Effects 0.000 claims description 26
- 229910052721 tungsten Inorganic materials 0.000 claims description 23
- 229910052740 iodine Inorganic materials 0.000 claims description 13
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 290
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 272
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 227
- 101150039403 ams gene Proteins 0.000 description 158
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 151
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 149
- 102000039446 nucleic acids Human genes 0.000 description 89
- 108020004707 nucleic acids Proteins 0.000 description 89
- 150000007523 nucleic acids Chemical class 0.000 description 89
- 238000000034 method Methods 0.000 description 83
- 102000004190 Enzymes Human genes 0.000 description 75
- 108090000790 Enzymes Proteins 0.000 description 75
- 229940088598 enzyme Drugs 0.000 description 75
- 239000002585 base Substances 0.000 description 60
- 239000000203 mixture Substances 0.000 description 60
- 229940024606 amino acid Drugs 0.000 description 56
- 235000001014 amino acid Nutrition 0.000 description 56
- 150000001413 amino acids Chemical class 0.000 description 56
- 239000000243 solution Substances 0.000 description 41
- 231100000219 mutagenic Toxicity 0.000 description 40
- 230000003505 mutagenic effect Effects 0.000 description 40
- 108090000623 proteins and genes Proteins 0.000 description 38
- 241000194108 Bacillus licheniformis Species 0.000 description 37
- 210000004027 cell Anatomy 0.000 description 34
- 239000013612 plasmid Substances 0.000 description 34
- 238000003752 polymerase chain reaction Methods 0.000 description 33
- 108020004414 DNA Proteins 0.000 description 31
- 238000013016 damping Methods 0.000 description 30
- 239000012530 fluid Substances 0.000 description 30
- 239000012634 fragment Substances 0.000 description 30
- 238000011534 incubation Methods 0.000 description 30
- 102220369447 c.1352G>A Human genes 0.000 description 28
- 102220023258 rs387907548 Human genes 0.000 description 25
- 241000894006 Bacteria Species 0.000 description 24
- 239000004382 Amylase Substances 0.000 description 22
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 22
- 108091028043 Nucleic acid sequence Proteins 0.000 description 22
- 108091034117 Oligonucleotide Proteins 0.000 description 22
- 125000000539 amino acid group Chemical group 0.000 description 22
- 238000001514 detection method Methods 0.000 description 21
- 241000193830 Bacillus <bacterium> Species 0.000 description 20
- 102220369445 c.668T>C Human genes 0.000 description 19
- 238000004760 accelerator mass spectrometry Methods 0.000 description 18
- 239000000523 sample Substances 0.000 description 16
- 102000013142 Amylases Human genes 0.000 description 15
- 108010065511 Amylases Proteins 0.000 description 15
- 235000019418 amylase Nutrition 0.000 description 15
- 239000012528 membrane Substances 0.000 description 15
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 14
- 239000011575 calcium Substances 0.000 description 14
- 239000003599 detergent Substances 0.000 description 14
- 229920002472 Starch Polymers 0.000 description 12
- 102220369446 c.1274G>A Human genes 0.000 description 12
- 239000002773 nucleotide Substances 0.000 description 12
- 125000003729 nucleotide group Chemical group 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 102220023257 rs387907546 Human genes 0.000 description 12
- 239000008107 starch Substances 0.000 description 12
- 108091008146 restriction endonucleases Proteins 0.000 description 11
- 235000019698 starch Nutrition 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 238000009826 distribution Methods 0.000 description 10
- 238000000329 molecular dynamics simulation Methods 0.000 description 10
- 102000035195 Peptidases Human genes 0.000 description 9
- 108091005804 Peptidases Proteins 0.000 description 9
- 238000013467 fragmentation Methods 0.000 description 9
- 238000006062 fragmentation reaction Methods 0.000 description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 238000009396 hybridization Methods 0.000 description 8
- 230000000977 initiatory effect Effects 0.000 description 8
- 230000000968 intestinal effect Effects 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- -1 amidine phosphate Chemical class 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 102220023256 rs387907547 Human genes 0.000 description 7
- 240000006439 Aspergillus oryzae Species 0.000 description 6
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 6
- 108090001060 Lipase Proteins 0.000 description 6
- 102000004882 Lipase Human genes 0.000 description 6
- 239000004367 Lipase Substances 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 229920002301 cellulose acetate Polymers 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 6
- 230000002478 diastatic effect Effects 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 235000019421 lipase Nutrition 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 229920001220 nitrocellulos Polymers 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 108010059892 Cellulase Proteins 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 5
- 108020005038 Terminator Codon Proteins 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 108010028144 alpha-Glucosidases Proteins 0.000 description 5
- 229940106157 cellulase Drugs 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 230000002538 fungal effect Effects 0.000 description 5
- 230000008676 import Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- 102000013415 peroxidase activity proteins Human genes 0.000 description 5
- 238000002708 random mutagenesis Methods 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000228245 Aspergillus niger Species 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 108020005091 Replication Origin Proteins 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 230000003625 amylolytic effect Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000001976 enzyme digestion Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000012900 molecular simulation Methods 0.000 description 4
- 239000001205 polyphosphate Substances 0.000 description 4
- 235000011176 polyphosphates Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000228212 Aspergillus Species 0.000 description 3
- 101100316860 Autographa californica nuclear polyhedrosis virus DA18 gene Proteins 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- 101150000715 DA18 gene Proteins 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 101001062854 Rattus norvegicus Fatty acid-binding protein 5 Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 102000047612 human CCN2 Human genes 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 102220004457 rs11567847 Human genes 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 241000193752 Bacillus circulans Species 0.000 description 2
- 241000193749 Bacillus coagulans Species 0.000 description 2
- 241000193422 Bacillus lentus Species 0.000 description 2
- 101100055551 Bacillus licheniformis amyS gene Proteins 0.000 description 2
- 241000193388 Bacillus thuringiensis Species 0.000 description 2
- 241000193764 Brevibacillus brevis Species 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 101100216056 Lactobacillus amylovorus amyL gene Proteins 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241000194109 Paenibacillus lautus Species 0.000 description 2
- 102000001746 Pancreatic alpha-Amylases Human genes 0.000 description 2
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 229940054340 bacillus coagulans Drugs 0.000 description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 101150055766 cat gene Proteins 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000037029 cross reaction Effects 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 229940111205 diastase Drugs 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 229940049547 paraxin Drugs 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- RVLOMLVNNBWRSR-KNIFDHDWSA-N (2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O RVLOMLVNNBWRSR-KNIFDHDWSA-N 0.000 description 1
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 102220554160 APC membrane recruitment protein 1_V56A_mutation Human genes 0.000 description 1
- 102220511128 APC membrane recruitment protein 1_V56I_mutation Human genes 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- YNOCMHZSWJMGBB-GCJQMDKQSA-N Ala-Thr-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O YNOCMHZSWJMGBB-GCJQMDKQSA-N 0.000 description 1
- KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 description 1
- 241000534414 Anotopterus nikparini Species 0.000 description 1
- PHHRSPBBQUFULD-UWVGGRQHSA-N Arg-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N PHHRSPBBQUFULD-UWVGGRQHSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000035101 Aspartic proteases Human genes 0.000 description 1
- 108091005502 Aspartic proteases Proteins 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 101000924385 Aspergillus niger Acid alpha-amylase Proteins 0.000 description 1
- 101000757144 Aspergillus niger Glucoamylase Proteins 0.000 description 1
- 101900318521 Aspergillus oryzae Triosephosphate isomerase Proteins 0.000 description 1
- 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 101100342470 Dictyostelium discoideum pkbA gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 101100385973 Escherichia coli (strain K12) cycA gene Proteins 0.000 description 1
- 101100001650 Geobacillus stearothermophilus amyM gene Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 125000000534 N(2)-L-lysino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C([H])([H])C(C([H])([H])N([H])[H])([H])[H] 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 241000590028 Pseudoalteromonas haloplanktis Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Chemical group OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 102220548687 Tectonin beta-propeller repeat-containing protein 1_T66P_mutation Human genes 0.000 description 1
- IBIDRSSEHFLGSD-YUMQZZPRSA-N Val-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-YUMQZZPRSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 108010048241 acetamidase Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010045649 agarase Proteins 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 101150069003 amdS gene Proteins 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 101150039703 amyL gene Proteins 0.000 description 1
- 101150008194 argB gene Proteins 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 102220427352 c.206A>C Human genes 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000011545 carbonate/bicarbonate buffer Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 108010005400 cutinase Proteins 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 101150005799 dagA gene Proteins 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 101150039489 lysZ gene Proteins 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 101150095344 niaD gene Proteins 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108091006091 regulatory enzymes Proteins 0.000 description 1
- 102220253319 rs1307934269 Human genes 0.000 description 1
- 102200148528 rs587776998 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- WUWHFEHKUQVYLF-UHFFFAOYSA-M sodium;2-aminoacetate Chemical compound [Na+].NCC([O-])=O WUWHFEHKUQVYLF-UHFFFAOYSA-M 0.000 description 1
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000000547 structure data Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 101150052264 xylA gene Proteins 0.000 description 1
- 101150110790 xylB gene Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38609—Protease or amylase in solid compositions only
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38636—Preparations containing enzymes, e.g. protease or amylase containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
Abstract
本发明涉及亲本类透阿米尔α-淀粉酶的变体,它相对所述亲本α淀粉酶,至少以下性能之一发生改变:i)在pH8到10.5的pH稳定性提高;和/或ii)在pH8到10.5对Ca2+的稳定性提高,和/或iii)在10℃到60℃的温度范围,特异活性增强。
Description
本申请是题为“α-淀粉酶突变体”的中国专利申请98810871.2的分案申请。该母案申请是国际申请PCT/DK98/00471,其公开号为WO99/23211。
技术领域
本发明涉及亲本类透阿米尔(Termamyl-like)α-淀粉酶的变体(突变体),其在中温和/或高pH下的活性更高。
背景技术
α-淀粉酶(α-1,4-葡聚糖-4-葡聚糖水解酶,EC3.2.1.1)构成这样一组酶,它们催化淀粉和其他线性及分枝1,4-葡萄糖苷寡-糖和多糖的水解。
有大量专利和科学文献涉及这类工业上非常重要的酶。从例如WO90/11352,WO95/10603,WO95/26397,WO96/23873和WO96/23874可以知道许多α-淀粉酶,比如类透阿米尔α-淀粉酶变体。
在更近期的涉及α-淀粉酶的公开文献中,WO96/23874提供了一种类透阿米尔α-淀粉酶的三维,X-射线晶体结构数据,该酶含有解淀粉芽孢杆菌α-淀粉酶(BANTM)的300个氨基端氨基酸残基以及含有所述氨基酸序列的地衣形芽孢杆菌α-淀粉酶的羧基端301-483位氨基酸(后者以透阿米尔TM的商品名出售),因此该酶与工业上很重要的芽孢杆菌α-淀粉酶(其在本文中包含在术语“类透阿米尔α-淀粉酶”中,该术语特别包括地衣形芽孢杆菌,解淀粉芽孢杆菌(BANTM)和嗜热脂肪芽孢杆菌(BSGTM)α-淀粉酶)有密切的关系。WO96/23874还描述了在分析亲本类透阿米尔α-淀粉酶之结构的基础上,设计相对亲本改变了性质的亲本类透阿米尔α-淀粉酶之变体的方法。
发明简述
本发明涉及新的类透阿米尔α-淀粉酶的α-淀粉分解酶变体(突变体),该变体在高pH和中温的洗涤能力(相对亲本α-淀粉酶)提高。
在本发明文中术语“中温”意指10℃到60℃,优选20℃到50℃,特别是30℃到40℃。
术语“高pH”意指目前用于洗涤的碱性pH,更具体说是大约pH8到10.5。
在本发明文中,“低温α-淀粉酶”意指一种在0-30℃的温度范围内具有相对最佳活性的α-淀粉酶。
在本发明文中,“中温α-淀粉酶”意指一种在30℃-60℃的温度范围内具有最佳活性的α-淀粉酶。比如,SP690和SP722α-淀粉酶分别是“中温α-淀粉酶”。
在本发明文中,“高温α-淀粉酶”意指一种在60℃-110℃的温度范围内具有最佳活性的α-淀粉酶。比如,透阿米尔是一种“高温α-淀粉酶”。
本发明的变体可以实现这些特性的改变:
类透阿米尔α-淀粉酶在pH8到10.5的稳定性;和/或在pH8到10.5对Ca2+的稳定性;和/或在10℃-60℃,优选20℃-50℃,特别是30℃-40℃的特异活性。
应当注意的是,相对最适温度通常取决于所用的特定pH。换句话说,在例如pH8确定的相对最适温度可能与例如pH10确定的相对最适温度非常不同。
温度对酶活性的影响
活性部位及其周围的动力学取决于温度和氨基酸组成,并且对一种酶的相对最适温度有重要意义。通过比较中温和高温α-淀粉酶的动力学,可以确定出高温α-淀粉酶在中等温度下的功能关键区域。图2显示了SP722α-淀粉酶(SEQ ID NO:2)和地衣形芽孢杆菌α-淀粉酶(以Termanyl购自Novo Nodisk)(SEQ ID NO:4)。
图中显示,在中温范围(30-60℃),SP722绝对活性的相对最适温度比同源的地衣形芽孢杆菌α-淀粉酶高,后者在60-100℃左右具有最佳活性。这些分布图主要取决于活性部位残基及其周围的温度稳定性和动力学。另外,活性分布图取决于所用pH和活性部位残基的pKa。
本发明更具体地涉及:
1.一种亲本类透阿米尔α-淀粉酶的变体,该变体具有α-淀粉酶活性,所述变体包含1或多个突变,其对应于下列SEQ ID NO:2所示氨基酸序列中的突变:
T141,K142,F143,D144,F145,P146,G147,R148,G149,Q174,R181,G182,D183,G184,K185,A186,W189,S193,N195,H107,K108,G109,D166,W167,D168,Q169,S170,R171,Q172,F173,F267,W268,K269,N270,D271,L272,G273,A274,L275,K311,E346,K385,G456,N457,K458,P459,G460,T461,V462,T463。
2.项1的变体,所述变体有1或多个下列取代或缺失:
T141A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
K142A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
F143A, D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
D144A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F145A, D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
P146A, D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
G147A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
R148A, D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G149A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
R181*,A,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G182*,A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
D183*,A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G184*,A,R,D,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
K185A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
A186D, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
W189A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
S193A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,T,W,Y,V;
N195A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
H107A, D,R,N,C,E,Q,G,I,L,K,M,F,P,S,T,W,Y,V;
K108A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
G109A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
D166A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
W167A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
D168A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
Q169A, D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
S170A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,T,W,Y,V;
R171A, D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
Q172A, D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F173A, D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
Q174*,A,D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F267A, D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
W268A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
K269A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
N270A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
D271A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
L272A, D,R,N,C,E,Q,G,H,I,K,M,F,P,S,T,W,Y,V;
G273A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
A274D, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
L275A,D,R,N,C,E,Q,G,H,I,K,M,F,P,S,T,W,Y,V;
K311A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
E346A,D,R,N,C,Q,G,H,I,K,L,M,F,P,S,T,W,Y,V;
K385A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
G456A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
N457A,D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K458A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
P459A,D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
G460A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
T461A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
V462A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y;
T463A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V.
3.项2的变体,其中所述变体有1或多个下列取代或缺失:
K142R;S193P;N195F;K269R,Q;N270Y,R,D;K311R;E346Q;K385R;K458R;P459T;T461P;Q174*;R181Q,N,S;G182T,S,N;D183*;G184*;K185A,R,D,C,E,Q,G,H,I,L,M,N,F,P,S,T,W,Y,V;A186T,S,N,I,V,R;W189T,S,N,Q.
4.项1-3的变体,其中所述变体在D183+G184位点缺失,还有1或多个下列取代或缺失:K142R;S193P;N195F;K269R,Q;N270Y,R,D;K311R;E346Q;K385R;K458R;P459T;T461P;Q174*;R181Q,N,S;G182T,S,N;D183*;G184*;K185A,R,D,C,E,Q,G,H,I,L,M,N,F,P,S,T,W,Y,V;A186T,S,N,I,V,R;W189T,S,N,Q。
5.项1-4任何一项的变体,其中相对亲本α-淀粉酶所述变体至少下列性能之一发生改变:
i)在pH8到10.5的pH稳定性提高;和/或
ii)在pH8到10.5的Ca2+稳定性提高,和/或
iii)在温度为10到60℃,优选20-50℃,特别是30-40℃特异活性增强。
6.项1-5任何一项的变体,在pH8到10.5稳定性提高,具有1或多个对应下列位点(使用SEQ ID NO:2的编号)的位点的突变:T141,K142,F143,D144,F145,P146,G147,R148,G149,R181,A186,S193,N195,K269,N270,K311,K458,P459,T461。
7.项6的变体,该变体具有1或多个下列取代:
T141A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
K142A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
F143A,D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
D144A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F145A,D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
P146A,D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
G147A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
R148A,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G149A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
K181A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
A186D,R,N,C,E,Q,G,H,I,L,P,K,M,F,S,T,W,Y,V;
S193A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,T,W,Y,V;
N195A,D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K269A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
N270A,D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K311A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
K458A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
P459A,D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
T461A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V.
8.项7的变体,该变体具有1或多个下列取代:K142R,R181S,A186T,S193P,N195F,K269R,N270Y,K311R,K458R,P459T和T461P。
9.项1-5的变体,在pH8到10.5对Ca2+的稳定性提高,具有1或多个对应下列位点(使用SEQ ID NO:2的编号)的突变:R181,G182,D183,G184,K185,A186,W189,N195,N270,E346,K385,K458,P459。
10.项9的变体,该变体具有1或多个下列取代或缺失:
R181*,A,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G182*,A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
D183*,A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G184*,A,R,D,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
K185A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
A186D, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
W189A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
N195A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
N270A, R,D,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
E346A, R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K385A, R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
K458A, R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
P459A, R,D,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V.
11.项10的变体,其中所述变体具有1或多个下列取代或缺失:
R181Q,N;G182T,S,N;D183*;G184*;K185A,R,D,C,E,Q,G H,I,L,M,N,F,P,S,T,W,Y,V;A186T,S,N,I,V;W189T,S,N,Q;N195F;N270R,D;E346Q;K385R;K458R;P459T。
12.项1-11的变体,其中所述亲本类透阿米尔α-淀粉酶选自:
具有SEQ ID NO:1所示序列的芽孢杆菌菌株NCIB12512α-淀粉酶;
具有SEQ ID NO:5所示序列的解淀粉芽孢杆菌α-淀粉酶;
具有SEQ ID NO:4所示序列的地衣形芽孢杆菌α-淀粉酶。
13.项1-5的变体,在10-60℃,优选20-50℃,特别是30-40℃的温度范围内特异活性提高,在1或多个下列位点(使用SEQ ID NO:2的编号)具有突变:H107,K108,G109,D166,W167,D168,Q169,S170,R171,Q172,F173,Q174,D183,G184,N195,F267,W268,K269,N270,D271,L272,G273,A274,L275,G456,N457,K458,P459,G460,T461,V462,T463。
14.项13的变体,该变体含有1或多个下列取代:
H107A, D,R,N,C,E,Q,G,I,L,K,M,F,P,S,T,W,Y,V;
K108A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
G109A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
D166A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
W167A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
D168A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
Q169A, D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
S170A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,T,W,Y,V;
R171A, D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
Q172A, D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F173A, D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
Q174*,A,D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
D183*,A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
G184*,A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
N195A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F267A, D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
W268A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
K269A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
N270A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
D271A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
L272A, D,R,N,C,E,Q,G,H,I,K,M,F,P,S,T,W,Y,V;
G273A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
A274D, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
L275A, D,R,N,C,E,Q,G,H,I,K,M,F,P,S,T,W,Y,V;
G456A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
N457A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K458A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
P459A, D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
G460A,D,R,N,C,E,Q,H,L,L,K,M,F,P,S,T,W,Y,V;
T461A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
V462A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y;
T463A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V.
15.项14的变体,其中所述变体含有1或多个下列取代或缺失:
Q174*,D183*,G184*,N195F,K269S。
16.项13-15的变体,其中所述亲本类透阿米尔α-淀粉酶是具有SEQID NO:4所示序列的地衣形芽孢杆菌α-淀粉酶。
17.一种DNA构建体,它含有编码项1-16任何一项所述α-淀粉酶变体的DNA序列。
18.一种携带项17所述DNA构建体的重组表达载体。
19.一种用项17所述DNA构建体或项18所述载体进行转化的细胞。
20.项19的细胞,它是一种微生物细胞。
21.项20的细胞,它是细菌或真菌。
22.项21的细胞,它是革兰氏阳性细菌,比如枯草芽孢杆菌,地衣形芽孢杆菌,迟缓芽孢杆菌,短芽孢杆菌,嗜热脂肪芽孢杆菌,嗜碱芽孢杆菌,解淀粉芽孢杆菌,凝结芽孢杆菌,环状芽孢杆菌,灿烂芽孢杆菌,或苏云金芽孢杆菌。
23.项1-16任何一项所述α-淀粉酶变体用于洗涤和/或清洗餐具的用途。
24.含有项1-16任何一项所述α-淀粉酶变体的洗涤剂添加剂,任选该添加剂是非dusting颗粒,稳定化的液体或被保护的酶。
25.项24的洗涤剂添加剂,它含有0.02-200mg酶蛋白/g添加剂。
26.项24或25的洗涤剂添加剂,它还含有另一种酶,比如蛋白酶,脂酶,过氧化物酶,另一种淀粉水解酶和/或纤维素酶。
27.一种包含项1-16任何一项所述α-淀粉酶变体的洗涤剂组合物。
28.项27的洗涤剂组合物,它另外包含另一种酶,比如蛋白酶,脂酶,过氧化物酶,另一种淀粉水解酶和/或纤维素酶。
29.一种手洗或自动餐具洗涤剂组合物,该组合物包含项1-16任何一项所述的α-淀粉酶变体。
30.项29的清洗餐具的洗涤剂组合物,该组合物另外包含另一种酶,比如蛋白酶,脂酶,过氧化物酶,另一种淀粉水解酶和/或纤维素酶。
31.一种手洗或自动的衣物洗涤组合物,该组合物包含项1-16任何一项所述的α-淀粉酶变体。
32.项31的衣物洗涤组合物,该组合物另外包含另一种酶,比如蛋白酶,脂酶,过氧化物酶,淀粉水解酶和/或纤维素酶。
33.制备α-淀粉酶的方法,该α-淀粉酶具有
1)改变了的pH最佳值,和/或
2)改变了的温度最佳值,和/或
3)稳定性提高,
所述方法包括以下步骤:
i)将两个或多个pH,温度和/或稳定性曲线迥异的α-淀粉酶的3D结构之分子动力学进行比较,从而确定(a)α-淀粉酶突变的目标位点和/或区域;
ii)在所确定的位点和/或区域进行1或多个氨基酸的取代,添加和/或缺失。
34.项33的方法,其中将一种中温α-淀粉酶与一种高温α-淀粉酶进行比较。
35.项33的方法,其中将一种低温α-淀粉酶与一种中温或高温α-淀粉酶进行比较。
36.项33-35的方法,其中所述α-淀粉酶至少70%,优选80%,达到90%,比如达到95%,尤其是95%同源。
37.项36的方法,其中所比较的α-淀粉酶是类透阿米尔α-淀粉酶。
38.项28的方法,其中所比较的α-淀粉酶是SEQ ID NO:1到SEQ IDNO:8所示的任何一个α-淀粉酶。
本发明更进一步涉及编码本发明所述变体的DNA构建体;制备本发明所述变体的方法;以及本发明所述变体单独地或与其他酶结合,在各种工业产品或方法中的用途,例如,用在洗涤剂中或用于淀粉液化。
本发明最后一个方面涉及生产α-淀粉酶的方法,该酶的最适pH,和/或最适温度发生改变,和/或稳定性提高。
命名法则
在本说明书和项书中,使用了氨基酸残基的常规单字母和三字母编码。为了便于参考,采用以下命名法则来描述本发明的α-淀粉酶变体:
原氨基酸:位点:取代氨基酸
根据这一命名原则,例如在第30位丙氨酸到天冬酰胺的取代应表示为:
Ala30Asn或A30N
在同一位点的丙氨酸缺失表示为:
Ala30*或A30*
添加的氨基酸残基,比如赖氨酸插入表示为:
Ala30 AlaLys或A30AK
连续的氨基酸残基片段,比如30-33位氨基酸残基缺失表示为(30-33)*或Δ(A30-N33)。
当特定α-淀粉酶与其他α-淀粉酶相比含有一个“缺失”,并且在该位点做了一个插入,这种情况表示为(对于36位插入了一个天冬氨酸):
36Asp或36D
多重突变用加号隔开,即:
Ala30Asp+Glu34Ser或A30N+E34S
代表在30和34位分别将丙氨酸和谷氨酸取代为天冬氨酸和丝氨酸。
当在一个给定位点可以插入1或多个可选择的氨基酸残基时,将其表示为:
A30N,E或
A30N或A30E
另外,当本文中确定了一个适合进行修饰的位置而没有建议具体的修饰方式,应当理解为可以用任何氨基酸残基来取代该位点的氨基酸残基。因此,例如,如果提及30位的丙氨酸修饰,但没有具体化,应当理解可以将该丙氨酸缺失或用任何其他氨基酸来取代它,即下列之一的氨基酸:R,N,D,A,C,Q,E,G,H,I,L,K,M,F,P,S,T,W,Y,V。
附图说明
图1是6个亲本类透阿米尔α-淀粉酶的氨基酸序列对比。最左端的数字代表下列各氨基酸序列:
1:SEQ ID NO:2
2:Kaoamyl
3:SEQ ID NO:1
4:SEQ ID NO:5
5:SEQ ID NO:4
6:SEQ ID NO:3
图2显示SP722(SEQ ID NO:2)(pH9)和地衣形芽孢杆菌α-淀粉酶(SEQID NO:4)(pH7.3)的温度活性关系图。
图3显示SP690(SEQ ID NO:1),SP722(SEQ ID NO:2),地衣形芽孢杆菌α-淀粉酶(SEQ ID NO:4)在pH10的温度分布图。
图4是5个α-淀粉酶的氨基酸序列对比。最左端的数字代表下列各氨基酸序列:
1:amyp-小鼠
2:amyp-大鼠
3:amyp-猪 猪胰腺α-淀粉酶(PPA)
4:amyp-人
5:amy-altha A.haloplanctis α-淀粉酶(AHA)
发明详述
类透阿米尔α-淀粉酶
众所周知,芽孢杆菌亚种所产生的许多α-淀粉酶在氨基酸水平上同源性极高。例如,发现包含SEQ ID NO:4所示氨基酸序列的地衣形芽孢杆菌α-淀粉酶(商品名为透阿米尔TM)与包含SEQ ID NO:5所示氨基酸序列的解淀粉芽孢杆菌α-淀粉酶大约89%同源,与包含SEQ ID NO:3所示氨基酸序列的嗜热脂肪芽孢杆菌α-淀粉酶大约79%同源。其他的同源α-淀粉酶包括来源于芽孢杆菌菌株NCIB12289,NCIB12512,NCIB12513或DSM9375的α-淀粉酶(这些在WO95/26397中都有详细的描述)以及Tsukamoto等描述过的α-淀粉酶(生物化学和生物物理研究通讯,151(1988),25-31页,参见SEQID NO:6)。
其他同源α-淀粉酶包括EP0252666中描述的地衣形芽孢杆菌(ATCC27811)产生的α-淀粉酶,以及WO91/00353和WO94/18314中鉴定到的α-淀粉酶。在产品OptithermTM和TakathermTM(Solvay有售),MaxamylTM(Gist-brocades/Genencor有售),Spezym AATM和Spezym Delta AATM(Genencor有售)以及KeistaseTM(Daiwa有售)中含有其他一些商品类透阿米尔地衣形芽孢杆菌α-淀粉酶。
由于发现这些α-淀粉酶之间有极大的同源性,可以认为它们属于同类α-淀粉酶,即“类透阿米尔α-淀粉酶”类。
因此,在本文中,术语“类透阿米尔α-淀粉酶”意指这类α-淀粉酶,它在氨基酸水平上与透阿米尔TM(即具有文中SEQ ID NO:4所示氨基酸序列的地衣形芽孢杆菌α-淀粉酶)有极大的同源性。换句话说,以下所有具有SEQ ID NO:1,2,3,4,5,6,7或8所示氨基酸序列,或者WO95/26397中的SEQ ID NO:1所示氨基酸序列(与此处SEQ ID NO:7所示氨基酸序列相同)之α-淀粉酶或者WO95/26397中的SEQ ID NO:2所示氨基酸序列(与此处SEQ ID NO:8所示氨基酸序列相同)或者Tsukamoto等文中(1988,该氨基酸序列在文中见SEQ ID NO:6)之α-淀粉酶都被认为是“类透阿米尔α-淀粉酶”。其他的类透阿米尔α-淀粉酶是这样一些α-淀粉酶:i)与SEQ ID NO:1-8所示氨基酸序列中的至少一个有至少60%,比如至少70%(例如至少75%),或至少80%(例如至少85%),至少90%或至少95%同源,和/或ii)与至少一个所述α-淀粉酶的抗体有免疫交叉反应,和/或iii)由这样一种DNA序列编码,这些序列能与编码以上特定α-淀粉酶的DNA序列进行杂交,根据本申请的SEQ ID NO:9,10,11或12(这些编码序列分别编码此处SEQID NO:1,2,3,4和5所示的氨基酸序列),WO95/26397中的SEQ ID NO:4(文中SEQ ID NO:13显示了该DNA序列和终止密码子TAA,并编码文中SEQ ID NO:8所示的氨基酸序列)以及WO95/26397中的SEQ ID NO:5(文中SEQ ID NO:14所示)很容易得到这些序列。
对于特性i),可以借助任何常规算法来确定“同源性”,优选利用GCG程序包7.3版本(1993年6月)中的GAP程序,该程序中GAP罚分采用缺省值,即GAP生成罚分为3.0,GAP延伸罚分为0.1(Genetic computergroup(1991)GCG程序包程序手册,版本7,575 Science Drive,Madison,Wisconsin,USA53711)。
可以利用透阿米尔(SEQ ID NO:4)和类透阿米尔α-淀粉酶之间的结构对比来鉴定其他类透阿米尔α-淀粉酶中的等同/相应位点。获得所述结构对比的一个方法是利用GCG程序包中的Pile Up程序,该程序中GAP罚分采用缺省值,即GAP生成罚分为3.0,GAP延伸罚分为0.1。其他结构对比方法包括疏水簇分析(Gaboriaud等,(1987),FEBS快报224,149-155页)和反相成丝技术(reverse threading)(Huber T,Torda,AE,蛋白质科学,7卷,1期:142-149(1998))。
可以利用抗相关类透阿米尔α-淀粉酶的至少一个表位,或者与之反应的抗体来检测α-淀粉酶的特性ii),即免疫交叉反应性。可以通过本领域的已知方法,例如Hudson等(实用免疫学,第3版(1989),Blackwell ScientificPublications)描述的方法来制备单克隆或多克隆抗体。可以利用本领域已知的检测方法(这类例子有Western印迹或者Hudson等(1989)描述的径向免疫扩散法)来确定免疫交叉反应性。就这方面而言,发现具有SEQ ID NO:1,2,3,4,5,6,7或8所示氨基酸序列的α-淀粉酶之间分别有免疫交叉反应。
可以在所研究的α-淀粉酶的全长或部分核苷酸或氨基酸序列的基础上适当地制备到用于根据特性iii)来鉴定类透阿米尔α-淀粉酶的寡核苷酸探针。
检测杂交的适宜条件包括在5×SSC中预浸泡,于~40℃在含有20%甲酰胺,5×Denhardt′s溶液,50mM磷酸钠(pH6.8)以及50mg超声变性小牛胸腺DNA的溶液中预杂交1小时,然后于~40℃在补充有100mMATP的同一溶液中杂交18小时,随之将滤膜洗3次,每次在2×SSC,0.2%SDS中于40℃(低严格性),优选50℃(中等严格性),更优选65℃(高严格性),还要优选的是~75℃(极高严格性)洗30分钟。有关杂交方法的其他细节可见Sambrook等,分子克隆:实验手册,第2版,Cold Spring Harbor,1989.
在本文中,“来源于”不仅是指由所研究的微生物菌株产生或能产生的α-淀粉酶,也指分离自该菌株的DNA序列所编码的,并在用所述DNA序列转化的宿主微生物中产生的α-淀粉酶。最后,该术语意指这样的α-淀粉酶,它由合成的和/或cDNA来源的DNA序列编码并且具备所述α-淀粉酶的鉴定特征。该术语还用来表示亲本α-淀粉酶可以是天然存在的α-淀粉酶的变异体,即由天然存在的α-淀粉酶的1或多个氨基酸残基经过修饰(插入,取代,缺失)所产生的变体。
亲本杂交α-淀粉酶
亲本α-淀粉酶(即主链α-淀粉酶)可以是一种杂交α-淀粉酶,即包含组合在一起的来源于至少两个α-淀粉酶的部分氨基酸序列。
亲本杂交α-淀粉酶可以是这样的酶,在氨基酸同源性和/或免疫杂交反应性和/或DNA杂交(如上所述)的基础上可以确定它属于类透阿米尔α-淀粉酶家族。在这种情况中,杂交α-淀粉酶通常包含类透阿米尔α-淀粉酶的至少一部分和1或多个其他α-淀粉酶的1个或多个部分,后者选自微生物(细菌或真菌)和/或哺乳动物来源的类透阿米尔α-淀粉酶或非类透阿米尔α-淀粉酶。
因此,亲本杂交α-淀粉酶可以包括来源于至少两个类透阿米尔α-淀粉酶,或者来源于至少一个类透阿米尔α-淀粉酶和至少一个非类透阿米尔细菌α-淀粉酶,或者来源于至少一个类透阿米尔和至少一个真菌α-淀粉酶的部分氨基酸序列的组合。来源于部分氨基酸序列的类透阿米尔α-淀粉酶可以是,例如文中提到的那些特定类透阿米尔α-淀粉酶中的任何一个。
例如,亲本α-淀粉酶可以包括来源于地衣形芽孢杆菌菌株的α-淀粉酶的羧基端部分和来源于解淀粉芽孢杆菌菌株或嗜热脂肪芽孢杆菌菌株的α-淀粉酶的氨基端部分。例如,亲本α-淀粉酶可以包括地衣形芽孢杆菌α-淀粉酶的羧基端部分的至少430个氨基酸残基,还可以,例如,包括a)与具有SEQ ID NO:5所示氨基酸序列的解淀粉芽孢杆菌α-淀粉酶的37个氨基端氨基酸残基相对应的氨基酸片段和与具有SEQ ID NO:4所示氨基酸序列的地衣形芽孢杆菌α-淀粉酶的445个羧基端氨基酸残基相对应的氨基酸片段,或者杂交类透阿米尔α-淀粉酶与透阿米尔序列(即SEQ ID NO:4所示的地衣形芽孢杆菌α-淀粉酶)相同,除了氨基端的35个氨基酸残基被BAN(成熟蛋白质)(即SEQ ID NO:5所示的解淀粉芽孢杆菌α-淀粉酶)的氨基端33个残基(成熟蛋白质)取代;或者包括b)与具有SEQ ID NO:3所示氨基酸序列的嗜热脂肪芽孢杆菌α-淀粉酶的68个氨基端氨基酸残基相对应的氨基酸片段和与具有SEQ ID NO:4所示氨基酸序列的地衣形芽孢杆菌α-淀粉酶的415个羧基端氨基酸残基相对应的氨基酸片段。
另一合适的亲本杂交α-淀粉酶是先前在WO96/23874(Novo Nordisk申请)中描述的酶,该酶由BAN(解淀粉芽孢杆菌α-淀粉酶)的氨基端(成熟蛋白质的1-300位氨基酸)和透阿米尔的羧基端(成熟蛋白质的301-483位氨基酸)构成。通过将上述杂交α-淀粉酶(BAN:1-300/透阿米尔:301-483)的1或多个以下位点取代使其活性提高:Q360,F290和N102。尤其有意义的取代是1或多个以下取代:Q360E,D;F290A,C,D,E,G,H,I,K,L,M,N,P,Q,R,S,T;N102D,E。
SEQ ID NO:2所示SP722α-淀粉酶中的相应位点是S365,Y295,N106中的1或多个。在SEQ ID NO:2所示α-淀粉酶中尤其有意义的相应取代是S365D,E;Y295A,C,D,E,G,H,I,K,L,M,N,P,Q,R,S,T;以及N106D,E中的1或多个。
SEQ ID NO:1所示SP690α-淀粉酶中的相应位点是S365,Y295,N106中的1或多个。尤其有意义的相应取代是S365D,E;Y295A,C,D,E,G,H,I,K,L,M,N,P,Q,R,S,T;以及N106D,E中的1或多个。
上面提到的非类透阿米尔α-淀粉酶可以,例如,是(与类透阿米尔α-淀粉酶不同的)真菌α-淀粉酶,哺乳动物或植物α-淀粉酶或者细菌α-淀粉酶。这类α-淀粉酶的具体例子包括米曲霉TAKAα-淀粉酶,黑曲霉酸α-淀粉酶,枯草芽孢杆菌α-淀粉酶,猪胰腺α-淀粉酶和大麦α-淀粉酶。所有这些α-淀粉酶的结构与文中所述的典型类透阿米尔α-淀粉酶的结构显著不同。
上面提到的真菌α-淀粉酶,即来源于黑曲霉和米曲霉,在氨基酸水平上同源性极高,通常认为属于同族α-淀粉酶。来源于米曲霉的真菌α-淀粉酶以商品名FungamylTM销售。
另外,如果类透阿米尔α-淀粉酶的特定变体(本发明的变体)是指-以常规方式-特定类透阿米尔α-淀粉酶的氨基酸序列中的特异氨基酸残基发生的修饰(例如缺失或取代),那么应将其理解为涵盖了在等同位点(由各氨基酸序列之间的最可能氨基酸对比所确定的)进行修饰的另一个类透阿米尔α-淀粉酶的变体。
在本发明的一个优选实施方案中,α-淀粉酶主链来源于地衣形芽孢杆菌(与亲本类透阿米尔α-淀粉酶一样),例如前面提到过的,比如具有SEQ IDNO:4所示氨基酸序列的地衣形芽孢杆菌α-淀粉酶。
本发明变体的改变特性
以下讨论存在于本发明的变体中的突变与可能由该突变导致的预期性状变化(相对亲本类透阿米尔α-淀粉酶的这些性状)之间的关系。
在pH8-10.5的稳定性提高
在本发明文中,对于实现在高pH下稳定性提高有重要意义的突变(包括氨基酸取代)包括与SP722α-淀粉酶(具有SEQ ID NO:2所示氨基酸序列)中的1或多个下列位点所发生的突变相对应的突变:T141,K142,F143,D144,F145,P146,G147,R148,G149,R181,A186,S193,N195,K269,N270,K311,K458,P459,T461。
本发明的变体具有1或多个下列取代(使用SEQ ID NO:2的编号):
T141A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
K142A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
F143A,D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
D144A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F145A,D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
P146A,D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
G147A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
R148A,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G149A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
K181A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
A186D,R,N,C,E,Q,G,H,I,L,P,K,M,F,S,T,W,Y,V;
S193A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,T,W,Y,V;
N195A,D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K269A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
N270A,D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K311A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
K458A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
P459A,D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
T461A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V.
优选的高pH稳定性变体包括SP722α-淀粉酶(具有SEQ ID NO:2所示氨基酸序列)中的1或多个下列取代:
K142R,R181S,A186T,S193P,N195F,K269R,N270Y,K311R,K458R,P459T和T461P。
在具体实施方案中,用具有SEQ ID NO:1所示序列的芽孢杆菌菌株NCIB12512α-淀粉酶,或者具有SEQ ID NO:3所示序列的嗜热脂肪芽孢杆菌α-淀粉酶,或者具有SEQ ID NO:4所示序列的地衣形芽孢杆菌α-淀粉酶,或者具有SEQ ID NO:5所示序列的解淀粉芽孢杆菌α-淀粉酶作为主链,即亲本类透阿米尔α-淀粉酶来进行这些突变。
从图1的对比结果可以看到,嗜热脂肪芽孢杆菌α-淀粉酶在与SP722中的N270对应的位点已有一个酪氨酸。另外,芽孢杆菌菌株NCIB12512α-淀粉酶,嗜热脂肪芽孢杆菌α-淀粉酶,地衣形芽孢杆菌α-淀粉酶和解淀粉芽孢杆菌α-淀粉酶在与SP722中的K458对应的位点早已有精氨酸。另外,地衣形芽孢杆菌α-淀粉酶在与SP722中的T461对应的位点已有一个脯氨酸。因此,所述取代与这些α-淀粉酶无关。
可以利用实施例2中提及的分子动力学模拟,通过在所发现的区域进行取代来构建在高pH下稳定性提高的α-淀粉酶变体。模拟描述了那些在高pH(即pH8-10.5)比在中等pH有更高柔性或可变性的区域。
利用任何与类透阿米尔α-淀粉酶(BA2,在Novo Nodisk提出的WO96/23874的附录1中公开了该酶的3D结构)同源(定义如下)的细菌α-淀粉酶的结构,即有可能建立这些α-淀粉酶结构的模型并可以对它进行分子动力学模拟。用GCG程序包7.3版(1993年6月)中的UWGCG GAP程序测量到所述细菌α-淀粉酶的同源性可以为至少60%,优选70%以上,更优选80%以上,最优选90%以上同源于前面提及的类透阿米尔α-淀粉酶(BA2),测量采用缺省值作为GAP罚分(Genetic computer group(1991)GCG程序包程序手册,版本7,575 Science Drive,Madison,Wisconsin,USA53711)。将不利的残基取代为其他残基是可行的。
在pH8-10.5的Ca2+ 稳定性提高
Ca2+稳定性提高意味着酶在Ca2+耗尽的情况下,稳定性已有提高。在本发明文中,对于获得在高pH下Ca2+稳定性提高有重要意义的突变(包括氨基酸取代)包括与SP722α-淀粉酶(具有SEQ ID NO:2所示氨基酸序列)中的下列位点相对应的1或多个位点突变或缺失:R181,G182,D183,G184,K185,A186,W189,N195,N270,E346,K385,K458,P459。
本发明的变体具有1或多个下列取代或缺失:
R181*,A,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G182*,A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
D183*,A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G184*,A,R,D,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
K185A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
A186D, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
W189A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
N195A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
N270A, R,D,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
E346A, R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K385A, R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
K458A, R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
P459A, R,D,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V.
优选的是具有1或多个下列取代或缺失的变体:
R181Q,N;G182T,S,N;D183*;G184*;
K185A,R,D,C,E,Q,G,H,I,L,M,N,F,P,S,T,W,Y,V;A186T,S,N,I,V;
W189T,S,N,Q;N195F,N270R,D;E346Q;K385R;K458R;P459T.
在具体实施方案中,用具有SEQ ID NO:1所示序列的芽孢杆菌菌株NCIB12512α-淀粉酶,或者具有SEQ ID NO:5所示序列的解淀粉芽孢杆菌α-淀粉酶,或者具有SEQ ID NO:4所示序列的地衣形芽孢杆菌α-淀粉酶作为进行这些突变的主链。
从图1的对比结果可看到,地衣形芽孢杆菌α-淀粉酶没有与SP722中的D183和G184对应的位点。因此,所述缺失与该α-淀粉酶无关。
在一个优选实施方案中,变体是这样的芽孢杆菌菌株NCIB12512α-淀粉酶,它在D183和G184缺失,并有下列取代之一:R181Q,N和/或G182T,S,N和/或D183*;G184*和/或K185A,R,D,C,E,Q,G,H,I,L,M,N,F,P,S,T,W,Y,V和/或A186T,S,N,I,V和/或W189T,S,N,Q和/或N195F和/或N270R,D和/或E346Q和/或K385R和/或K458R和/或P459T。
在中温的特异活性增强
本发明另外一个方面,对于获得在10-60℃,优选20-50℃,尤其是30-40℃特异活性增强的变体来说,重要的突变包括与SP722α-淀粉酶(具有SEQID NO:2所示氨基酸序列)中的1或多个下列位点相对应的突变:
H107,K108,G109,D166,W167,D168,Q169,S170,R171,Q172,
F173,Q174,D183,G184,N195,F267,W268,K269,N270,D271,
L272,G273,A274,L275,G456,N457,K458,P459,G460,T461,
V462,T463.
本发明的变体具有1或多个下列取代:
H107A, D,R,N,C,E,Q,G,I,L,K,M,F,P,S,T,W,Y,V;
K108A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
G109A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
D166A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
W167A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
D168A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
Q169A, D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
S170A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,T,W,Y,V;
R171A, D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
Q172A, D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F173A, D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
Q174*,A,D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
D183*,A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
G184*,A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
N195A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F267A, D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
W268A, D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
K269A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
N270A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
D271A, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
L272A, D,R,N,C,E,Q,G,H,I,K,M,F,P,S,T,W,Y,V;
G273A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
A274D, R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
L275A, D,R,N,C,E,Q,G,H,I,K,M,F,P,S,T,W,Y,V;
G456A, D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
N457A, D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K458A, D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
P459A,D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
G460A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
T461A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
V462A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y;
T463A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V.
优选的变体具有1或多个下列取代或缺失:Q174*,D183*,G184*,K269S。
在具体实施方案中,用具有SEQ ID NO:4所示序列的地衣形芽孢杆菌α-淀粉酶作为进行这些突变的主链。
本发明变体的通用突变:在中温特异活性增强
特别有意义的氨基酸取代是那些能提高酶活性部位周围的可变性的取代。这可以通过那些能破坏活性部位附近(即优选与构成活性部位的任何残基在10A或8A或6A或4A之内)的稳定性相互作用的改变来实现。
这类例子是那些能降低侧链尺寸的突变,比如
Ala到Gly
Val到Ala或Gly
Ile或Leu到Val,Ala或Gly
Thr到Ser
我们希望,通过导入空腔或者通过能填塞突变造成的空间的结构重排,这些突变导致活性部位区域的柔性提高。
可以优选本发明的变体还包含1或多个除上面概括过的以外的修饰。因此,将被修饰的α-淀粉酶变体某部分存在的1或多个脯氨酸取代为非脯氨酸残基可能是有益的,所述非脯氨酸可以是任何可能的,天然非脯氨酸残基,优选是Ala,Gly,Ser,Thr,Val或Leu。
类似地,可以优选将亲本α-淀粉酶被修饰的那些氨基酸残基中存在的1或多个Cys残基取代为非半胱氨酸残基,比如Ser,Ala,Thr,Gly,Val或Leu。
另外,可以将本发明的变体进行修饰一作为唯一的修饰或者结合上面概括的任何修饰-以便将与SEQ ID NO:4中的185-209位氨基酸片段所对应的氨基酸片段中存在的1或多个Asp和/或Glu分别取代为Asn或Gln。同样有意义的是在类透阿米尔α-淀粉酶中,将与SEQ ID NO:4中的185-209位氨基酸片段所对应的氨基酸片段中存在的1或多个Lys残基取代为Arg。
应当明白,本发明涵盖了含有两个或多个上述修饰的变体。
另外,向此处描述的任何变体导入点突变可能是有益的。
活性部位周围可变性提高的α-淀粉酶变体
可以通过替换靠近底物部位的1或多个位点的1或多个氨基酸残基来提高本发明α-淀粉酶变体的可变性。这些位点是(使用SP722α-淀粉酶(SEQID NO:2)的编号):V56,K108,D168,Q169,Q172,L201,K269,L272,L275,K446,P459。
因此,本发明的一个方面涉及在1或多个上述位点发生突变的变体。
优选的取代是下列中的1或多个:
V56A,G,S,T;
K108A,D,E,Q,G,H,I,L,M,N,S,T,V;
D168A,G,I,V,N,S,T;
Q169A,D,G,H,I,L,M,N,S,T,V;
Q172A,D,G,H,I,L,M,N,S,T,V;
L201A,G,I,V,S,T;
K269A,D,E,Q,G,H,I,L,M,N,S,T,V;
L272A,G,I,V,S,T;
L275A,G,I,V,S,T;
Y295A,D,E,Q,G,H,I,L,M,N,F,S,T,V;
K446A,D,E,Q,G,H,I,L,M,N,S,T,V;
P459A,G,I,L,S,T,V.
在本发明的具体实施方案中,用具有SEQ ID NO:1所示序列的芽孢杆菌菌株NCIB12512α-淀粉酶,或者具有SEQ ID NO:3所示序列的嗜热脂肪芽孢杆菌α-淀粉酶,或者具有SEQ ID NO:4所示序列的地衣形芽孢杆菌α-淀粉酶,或者具有SEQ ID NO:5所示序列的解淀粉芽孢杆菌α-淀粉酶作为进行这些突变的主链。
从图1的对比可以看到,地衣形芽孢杆菌α-淀粉酶和解淀粉芽孢杆菌α-淀粉酶在与SP722中的K269相对应的位点有一个Glu。另外,嗜热脂肪芽孢杆菌α-淀粉酶在与SP722中的K269相对应的位点有一个Ser。因此,所述取代与这些α-淀粉酶无关。
另外,从图1的对比可以看到,解淀粉芽孢杆菌α-淀粉酶在与SP722中的L272相对应的位点有一个Ala,嗜热脂肪芽孢杆菌α-淀粉酶在与SP722中的L272相对应的位点有一个Ile。因此,所述取代与这些α-淀粉酶无关。
从图1的对比可以看到,芽孢杆菌菌株12512α-淀粉酶在与SP722中的L275相对应的位点有一个Ile。因此所述取代与该α-淀粉酶无关。
从图1的对比可以看到,解淀粉芽孢杆菌α-淀粉酶在与SP722中的Y295相对应的位点有一个Phe。另外,嗜热脂肪芽孢杆菌α-淀粉酶在与SP722中的Y295相对应的位点有一个Asn。因此,所述取代与这些α-淀粉酶无关。
从图1的对比可以看到,地衣形芽孢杆菌α-淀粉酶和解淀粉芽孢杆菌α-淀粉酶在与SP722中的K446相对应的位点有一个Asn。另外,嗜热脂肪芽孢杆菌α-淀粉酶在与SP722中的K446相对应的位点有一个His。因此,所述取代与这些α-淀粉酶无关。
从图1的对比可以看到,地衣形芽孢杆菌α-淀粉酶,解淀粉芽孢杆菌α-淀粉酶以及嗜热脂肪芽孢杆菌α-淀粉酶在与SP722中的P459相对应的位点有一个Ser。另外,芽孢杆菌菌株12512α-淀粉酶在与SP722中的P459相对应的位点有一个Thr。因此,所述取代与这些α-淀粉酶无关。
在中温有较高活性的酶的稳定化
本发明另一个实施方案涉及提高低温α-淀粉酶(例如河豚毒素交替单胞菌(Feller等,(1994),欧洲生物化学杂志222:441-447))和中温α-淀粉酶(例如SP722和SP690)的稳定性,这些酶具有中温活性,即通常称为嗜冷酶和嗜温酶。对于这一特定酶类,稳定性应理解为热稳定性或在钙耗竭条件下的稳定性。
通常,在中温显示高活性的酶在那些对酶有抑制作用的条件(比如温度或钙耗竭)下也会有严重问题。
从而,本发明的目的是提供在中温显示所需高活性,同时在轻微抑制条件下不丧失活性的酶。
应当优选稳定化变体于中温测定的活性是初始活性的100%或以上与50%之间,更优选在100%或以上与70%之间,最优选在100%或以上与85%之间,所述初始活性是酶在稳定化前在该特定温度的活性,并且得到的酶应能在抑制条件下比野生型的酶忍受更长时间的温育。
可以考虑的酶包括例如细菌或真菌来源的α-淀粉酶。
一例这类低温α-淀粉酶是分离自河豚毒素交替单胞菌(Feller等,(1994),欧洲生物化学杂志222:441-447)的酶。已得到了该α-淀粉酶的晶体结构(Aghajari等,(1998),蛋白质科学7:564-572)。
河豚毒素交替单胞菌α-淀粉酶(图4所示对比结果的5)与猪胰腺α-淀粉酶(PPA)(图4所示对比结果的3)大约66%同源。PPA 3D结构是已知的,并且可从Brookhaven数据库中以1OSE或1DHK的名字获得。根据与其他更稳定的α-淀粉酶的同源性,可以使得来自河豚毒素交替单胞菌α-淀粉酶实现“低温高活性酶”的稳定化,并同时维持所需的中温高活性。
图4显示5个α-淀粉酶,包括AHA和PPAα-淀粉酶的多重序列对比。使河豚毒素交替单胞菌α-淀粉酶的稳定性提高的特异突变是:T66P,Q69P,R155P,Q177R,A205P,A232P,L243R,V295P,S315R。
制备α-淀粉酶变体的方法
几种将突变导入基因的方法是本领域已知的。简要讨论α-淀粉酶-编码DNA序列之后,将讨论在α-淀粉酶-编码序列中的特定位点产生突变的方法。
克隆编码α-淀粉酶的DNA序列
可以利用多种本领域的公知方法,从任何能产生目的α-淀粉酶的细胞或微生物中分离编码亲本α-淀粉酶的DNA序列。首先,应当利用得自能产生目的α-淀粉酶的有机体的染色体DNA或信使RNA来构建基因组DNA和/或cDNA文库。然后,如果α-淀粉酶的氨基酸序列是已知的,可以合成并合成并用同源的,标记的寡核苷酸来由从目的有机体制备的基因组文库鉴定α-淀粉酶-编码克隆。另外,可以使用标记的寡核苷酸探针(该探针含有与已知α-淀粉酶基因同源的序列)作为探针,采用低严谨性杂交和洗涤条件来鉴定α-淀粉酶-编码克隆。
另一种鉴定α-淀粉酶-编码克隆的方法包括将基因组DNA片段插入表达载体(比如质粒),用所得基因组DNA文库转化α-淀粉酶阴性的细菌,以及随后将转化细菌铺到含有α-淀粉酶底物的琼脂上,从而能鉴定表达α-淀粉酶的克隆。
可选择地,可以通过已确立的标准方法来合成制备编码酶的DNA序列,例如S.L.Beaucage和M.H.Caruthers(1981)描述的磷酸脒方法或Matthes等(1984)描述的方法。在磷酸脒方法中,在例如自动DNA合成仪中合成寡核苷酸,将其纯化,退火,连接和克隆到合适的载体中。
最后,DNA序列可以是基因组和合成来源混合的,合成和cDNA来源混合的,或者基因组和cDNA来源混合的,其是依照标准技术,将合成的,基因组或cDNA来源的片段连接在一起而制备的(在合适时,对应完整DNA序列各部分的片段)。还可以如US4683202或R.K.Saiki等(1988)描述的,使用特异引物通过聚合酶链反应(PCR)来制备DNA序列。
表达α-淀粉酶变体
根据本发明,可以利用表达载体将通过上述方法,或者通过本领域已知的任何替代方法制备的编码变体的DNA序列表达为酶的形式,载体通常包括调控序列,该序列编码启动子,操纵子,核糖体结合位点,翻译起始信号以及任选地,阻遏子基因或各种激活子基因。
携带编码本发明所述α-淀粉酶变体之DNA序列的重组表达载体可以是任何能方便地进行重组DNA操作的载体,且载体的选择通常取决于它将要导入的宿主细胞。因此,载体可以是自主复制的载体,即以染色体外个体存在的载体,其复制独立于染色体的复制,例如质粒,噬菌体或染色体外元件,微小染色体或人工染色体。可选择地,载体可以是这样的,当被导入宿主细胞时,它会整合到宿主基因组中,并与所整合到其中的染色体一起复制。
在所述载体中,DNA序列应当可操纵地连接到合适的启动子序列。该启动子可以是任何在所选宿主细胞中显示转录活性的DNA序列,并可以来源于编码宿主细胞的同源或异源蛋白质的基因。适于引导编码本发明所述α-淀粉酶变体的DNA序列的转录的合适的启动子序列是在所选宿主细胞中显示转录活性的序列,并可以来源于编码宿主细胞的同源或异源蛋白质的基因。适于引导编码本发明所述α-淀粉酶变体的DNA序列进行转录(特别是在细菌宿主中)的启动子的例子是大肠杆菌lac操纵子的启动子,天蓝色链霉菌琼脂糖酶基因dagA的启动子,地衣形芽孢杆菌α-淀粉酶(amyL)的启动子,嗜热脂肪芽孢杆菌产麦芽淀粉酶基因(amyM)的启动子,解淀粉芽孢杆菌α-淀粉酶(amyQ)的启动子,枯草芽孢杆菌xylA和xylB基因等的启动子。在真菌宿主中进行转录时,有用的启动子的例子是来源于这样一些基因的启动子,所述基因编码米曲霉TAKA淀粉酶,米赫氏根霉天冬氨酸蛋白酶,黑曲霉中性α-淀粉酶,黑曲霉酸稳定α-淀粉酶,黑曲霉葡糖淀粉酶,米赫氏根霉脂酶,米曲霉碱性蛋白酶,米曲霉丙糖磷酸异构酶或构巢曲霉乙酰胺酶。
本发明的表达载体还可以包含合适的转录终止子以及,在真核细胞中时的多腺苷酸化序列,它们与编码发明所述α-淀粉酶变体的DNA序列可操纵地连接在一起。终止和多腺苷酸化序列可以适当地来自与启动子相同的来源。
载体还可以包含能使载体在目的宿主细胞中进行复制的DNA序列。这类序列的例子是质粒pUC19,pACYC177,pUB110,pE194,pAMB1和pIJ702的复制原点。
载体还可以包含选择标记,例如一个其产物能补偿宿主细胞缺陷的基因,比如来自枯草芽孢杆菌或地衣形芽孢杆菌的dal基因;或者赋予抗生素抗性(比如氨苄青霉素,卡那霉素,氯霉素或四环素抗性)的基因。另外,载体可以包含曲霉选择标记,比如amdS,argB,niaD和sC,产生潮霉素抗性的标记,或者可以通过共转化(例如WO91/17243中描述的)来实现选择。
胞内表达在某些方面可能是有益的,例如用某种细菌作为宿主细胞时,但通常优选表达是胞外的。总之,此处提及的芽孢杆菌α-淀粉酶包含一个允许被表达的蛋白酶分泌到培养基中的前导区。如果需要,可以方便地通过取代编码该前区的DNA序列来将该前区替换为不同的前导区或信号序列。
用于分别将编码α-淀粉酶变体,启动子,终止子和其他元件的本发明所述DNA构建体连接在一起,并将其插入合适的包含复制所用的必要信息之载体的步骤是本领域技术人员所熟知的(参考,例如,Sambrook等,分子克隆:实验指南,第2版,Cold Spring Harbor,1989)。
本发明的细胞,它包含如上所述的本发明DNA构建体或表达载体,可以有效地作为重组制备本发明α-淀粉酶变体的宿主细胞。可以用本发明编码变体的DNA构建体,方便地通过将该构建体(以1或多拷贝)整合到宿主染色体中来转化所述细胞。通常认为整合是有益的,因为这样DNA序列更可能稳定地保持在细胞中。可以依照常规方法,例如通过同源或异源重组将DNA构建体整合到宿主染色体中。可选择地,可以根据宿主细胞的不同类型用上面描述过的表达载体来转化细胞。
本发明的细胞可以是更高等的生物,比如哺乳动物或昆虫的细胞,但优选是微生物细胞,比如细菌或真菌(包括酵母)细胞。
合适的细菌的例子是革兰氏阳性细菌,比如枯草芽孢杆菌,地衣形芽孢杆菌,迟缓芽孢杆菌,短芽孢杆菌,嗜热脂肪芽孢杆菌,嗜碱芽孢杆菌,解淀粉芽孢杆菌,凝结芽孢杆菌,环状芽孢杆菌,灿烂芽孢杆菌,巨大芽孢杆菌,苏云金芽孢杆菌,或者浅青紫链霉菌或鼠灰链霉菌,或者是革兰氏阴性细菌,比如大肠杆菌。可以通过例如原生质体转化或利用竞争细胞以已知方式来实现细菌的转化。
可以有利地从酵母属或裂殖酵母属中选择酵母微生物,例如酿酒酵母。丝状真菌最好是属于曲霉属的种,例如米曲霉或黑曲霉。可以通过一个包括原生质体形成和转化,以及随后以已知方式再生细胞壁的方法来转化真菌细胞。在EP238023中描述了转化曲霉宿主细胞的适用步骤。
再一方面,本发明涉及制备发明所述α-淀粉酶变体的方法,该方法包括在有助于变体生产的条件下培养以上描述的宿主细胞,以及从细胞和/或培养基中回收变体。
用于培养细胞的培养基可以是任何适合目的宿主细胞生长以及本发明所述α-淀粉酶变体进行表达的常规培养基。可以从供应商那里获得合适的培养基或者可以根据公开的配方(例如,美国典型培养物保藏中心的目录中所描述的)来制备。
可以通过公知方法从培养基中方便地回收宿主细胞所分泌的α-淀粉酶变体,这些方法包括通过离心或过滤从培养基中分离细胞,以及借助盐(比如硫酸铵)来沉淀培养基中的蛋白类成分,然后利用层析操作,比如离子交换层析,亲合层析等。
工业应用
本发明的α-淀粉酶变体具备适合多种工业应用的有价值的特性。具体来说,本发明的酶变体可以作为洗涤,餐具清洗和硬金属表面清洁的洗涤剂组合物的成分。
许多变体在由淀粉生产甜味剂和乙醇,和/或纺织品退浆时尤其有用。在例如US3912590和欧洲专利公开号252730和63909中描述了在包括淀粉液化和/或糖化步骤的常规淀粉转化过程中使用的条件。
洗涤剂组合物
如上所述,可以适当地将本发明的变体加入洗涤剂组合物中。涉及洗涤剂组合物相关成分的进一步的细节,在这类洗涤剂组合物中配制变体的合适方法以及洗涤剂组合物的有关类型,可以参考例如,WO96/23874和WO97/07202。
包含本发明变体的洗涤剂组合物可以另外含有1或多种其他酶,比如脂酶,角质酶,蛋白酶,纤维素酶,过氧化物酶或漆酶,和/或另一种α淀粉酶。
可以将本发明的α-淀粉酶变体以常规使用的浓度加入洗涤剂中。目前考虑可以将本发明的变体以相当于每升使用常规剂量水平洗涤剂的洗涤/餐具清洗液中含0.00001-1mgα-淀粉酶的用量加入。
本发明还涉及提供具有1)改变了的最适pH,和/或2)改变了的最适温度,和/或3)稳定性提高的α-淀粉酶的方法,该方法包括以下步骤:
i)通过将两个或多个实质不同的pH,温度和/或稳定性曲线的α-淀粉酶3D结构的分子动力学进行比较,确定(a)进行α-淀粉酶突变的目的位点和/或区域,ii)在所确定的位点和/或区域取代,添加和/或缺失1或多个氨基酸。
在本发明的实施方案中,将一个中温α-淀粉酶与一个高温α-淀粉酶进行比较。在另一个实施方案中,将低温α-淀粉酶与中温或高温α-淀粉酶进行比较。
进行比较的α-淀粉酶应当优选相互之间至少70%,优选80%,到90%,比如达到95%,特别是95%同源。
进行比较的α-淀粉酶可以是上面定义的类透阿米尔α-淀粉酶。在具体实施方案中,进行比较的α-淀粉酶是SEQ ID NO:1到SEQ ID NO:8所示的α淀粉酶。
在另一个实施方案中,所比较的目的α-淀粉酶的稳定性曲线是Ca2+依赖曲线。
材料和方法
酶
SP722(SEQ ID NO:2,Novo Nodisk有售)
透阿米尔TM(SEQ ID NO:4,Novo Nodisk有售)
SP690(SEQ ID NO:1,Novo Nodisk有售)
枯草芽孢杆菌SHA273:见WO95/10603
质粒
pJE1包含编码SP722α-淀粉酶变体的基因(SEQ ID NO:2),即该基因缺失了成熟蛋白质中氨基酸D183-G184所对应的6个核苷酸。JE1基因的转录由amyL启动子引导。该质粒还包含复制原点和来自质粒pUB110(Gryczan,TJ等,(1978),细菌杂志134:318-329)的cat-基因,后者赋予对卡那霉素的抗性。
方法
构建文库载体pDorK101
可以用大肠杆菌/芽孢杆菌穿梭载体pDorK101(以下有描述)在大肠杆菌中导入突变,而不表达α-淀粉酶,然后以在芽孢杆菌中α-淀粉酶具有活性的方式进行修饰。如下构建载体:在SEQ ID NO:2:SP722的5’编码区中的PstI位点,用一个含有大肠杆菌复制原点的1.2kb片段通过基因打断使pJE1中的JE1编码基因(缺失D183-G184的SP722)失活。所述片段是从pUC19(GenBank入册编号#:X02514)经PCR扩增到的,扩增使用正向引物:5’-gacctgcagtcaggcaacta-3’和反向引物:5’-tagagtcgacctgcaggcat-3’。用PstI于37℃将PCR扩增产物和pJE1载体消化2小时。于室温连接pJE1载体片段和PCR片段1小时,并通过电转化转化到大肠杆菌中。所得载体命名为pDorK101。
滤膜筛选检测
可以用该检测方法,依靠筛选温度设置来筛选较之亲本酶在高pH的稳定性提高的类透阿米尔α-淀粉酶变体,以及较之亲本酶在高pH和中温的稳定性提高的类透阿米尔α-淀粉酶变体。
高pH滤膜检测
将芽孢杆菌文库铺在含有10μg/ml卡那霉素的TY琼脂板上的醋酸纤维素(OE67,Schleicher&Schuell,Dassel,Germany)和硝酸纤维素滤膜(Protran-Ba85,Schleicher&Schuell,Dassel,Germany)夹心上,于37℃保持至少21小时。将醋酸纤维素层放在TY琼脂板上。
铺板之后,但要在保温之前用针将每个滤膜夹心特异地标记一下,以便能够确定阳性变体在滤膜上的位置,并将结合了变体的硝酸纤维素滤膜转移到盛有甘氨酸-NaOH缓冲液(pH8.6-10.6)的容器中,于室温(可以在10-60℃变化)温育15分钟。将带有菌落的醋酸纤维素滤膜于室温保存在TY平板上待用。温育后,在含有1%琼脂糖,0.2%淀粉的甘氨酸-氢氧化钠缓冲液(pH8.6-10.6)的平板上检测残存的活性。用与滤膜夹心相同的方式标记带有硝酸纤维素滤膜的检测平板,并于室温培养2小时。移去滤膜后,用10%Lugol溶液将检测平板染色。降解淀粉的变体检测为深蓝色背景上的白色斑点,然后在保存平板上鉴定。在与第一次筛选相同的条件下将阳性变体重筛两次。
低钙滤膜检测
将芽孢杆菌文库铺在含有关抗生素(例如卡那霉素或氯霉素)的TY琼脂板上的醋酸纤维素(OE67,Schleicher&Schuell,Dassel,Germany)和硝酸纤维素膜(Protran-Ba85,Schleicher&Schuell,Dassel,Germany)夹心上,于37℃保持至少21小时。将醋酸纤维素层放在TY琼脂板上。
铺板之后,但要在培养之前用针将每个滤膜夹心特异地标记一下,以便能够将阳性变体固定在滤膜上,将结合了变体的硝酸纤维素滤膜转移到盛有碳盐酸-碳酸氢盐缓冲液(pH8.5-10)和不同浓度(0.001mM-100mM)EDTA的容器中,将膜于室温温育1小时。将带有菌落的醋酸纤维素滤膜于室温保存在TY平板上待用。温育后,在含有1%琼脂糖,0.2%淀粉的碳酸盐-碳酸氢盐缓冲液(pH8.5-10)的平板上检测残存活性。以与滤膜夹心相同的方式标记带有硝酸纤维素滤膜的检测平板,并于室温培养2小时。移去滤膜后,用10%Lugol溶液将检测平板染色。降解淀粉的变体检测为深蓝色背景上的白色斑点,然后在保存平板上鉴定。在与第一次筛选相同的条件下将阳性变体重筛两次。
获得目的区域的方法
有三个已知的细菌α-淀粉酶3D结构。两个是地衣形芽孢杆菌α-淀粉酶的,Brookhaven数据库1BPL(Machius等,(1995),分子生物学杂志246:545-559)和1VJS(Song等,(1996),用于糖类163工程的酶(生物技术进展,12卷)。这两个结构在两个钙离子和一个钠离子的结合位点周围所谓B-结构域的地方缺少一段重要的结构。因此我们使用了α-淀粉酶BA2(WO96/23874,它是BANTM(SEQ ID NO:5)和地衣形芽孢杆菌α-淀粉酶(SEQ ID NO:4)的杂交体)的3D结构。在该结构的基础上,建立了地衣形芽孢杆菌α-淀粉酶和SP722α-淀粉酶的模型。
α-淀粉酶变体的发酵和纯化
可以利用本领域公知的方法进行发酵和纯化。
稳定性测定
全部稳定性实验使用相同的设置进行。方法是:
在相应条件(1-4)下温育酶。于不同时刻取样品,例如0,5,10,15和30分钟后,将样品在检测缓冲液(0.1M 50mM Britton缓冲液pH7.3)中稀释25倍(所有取样稀释度相同),并采用Phadebas检测法(Pharmacia)在标准条件(pH7.3,37℃)下测量活性。
以温育前(0分钟)测量的活性作为对照(100%)。将下降的百分比作为温育时间的函数来计算活性。表中显示在温育例如30分钟后的残存活性。
特异活性测定
采用Phadebas检测法(Pharmacia)将特异活性确定为活性/mg酶。测定依照产品说明书进行(还可见以下“α-淀粉酶活性检测”)。
α-淀粉酶活性检测法
1.Phadebas检测法
通过一种采用Phadebas片剂作为底物的方法来测定α-淀粉酶的活性。Phadebas片剂(Phadebas Amylase Test,由Pharmacia Diagnostic提供)含有一种交联的不溶性兰色淀粉聚合物,该聚合物与牛血清白蛋白和缓冲物质混合在一起并做成片剂。
进行每次测量时,将一个药片悬浮于含有5ml 50mM Britton-Robinson缓冲液(50mM醋酸,50mM磷酸,50mM硼酸,0.1mM CaCl2,用NaOH调至所需pH)的试管中。于所需温度在水浴中进行实验。将待测α-淀粉酶在xml50mM Britton-Robinson缓冲液中进行稀释。将1ml该α-淀粉酶溶液加入5ml50mM Britton-Robinson缓冲液中。α-淀粉酶水解淀粉产生水溶性兰色碎片。在620nm比色测定到的所得兰色溶液的吸光度是α-淀粉酶活性的函数。
重要的是温育10或15分钟后测量的620nm吸光度应在0.2到2.0吸收单位内。在这样的吸光度范围内,活性和吸光度是线性关系(Lambert-Beer定律)。因此,必须调节酶的稀释度以便符合该法则。在特别设置的条件(温度,pH,反应时间,缓冲液条件)下,1mg给定α-淀粉酶将水解一定量的底物并产生兰色。在620nm测量兰色的强度。在给定条件下,所测得的吸光度与受测α-淀粉酶的特异活性直接成比例(活性/毫克纯α-淀粉酶蛋白质)。
2.替代方法
通过一种采用PNP-G7作为底物的方法来确定α-淀粉酶的活性。PNP-G7(邻-硝基苯-α,D-麦芽庚糖苷的缩写)是一种被封闭的寡糖,可以被内-淀粉酶切割。切割之后,试剂盒中包含的α-葡糖苷酶消化底物释放出游离的PNP分子,它呈现黄色,因此可以在λ=405nm(400-420nm)的可见光处比色测量。包含PNP-G7底物和α-葡糖苷酶的试剂盒由Boehringer-Mannheim(cat.No.1054635)制造。
将一瓶底物加入5ml缓冲液(BM1442309)来制备底物。将一瓶α-葡糖苷酶(BM1462309)加入45ml缓冲液(BM1442309)来制备α-葡糖苷酶。将5mlα-葡糖苷酶与0.5ml底物混匀制得工作溶液。
将20μl酶溶液转移到一个96孔微量滴定板上并于25℃温育来进行检测。加入200μl工作溶液(25℃)。将溶液混匀,预保温1分钟,并在3分钟内每15秒测量一次OD405nm处的吸光度。
在给定条件设置下,随时间变化的吸光度曲线的斜率与受测α-淀粉酶特异活性(活性/毫克酶)直接成比例。
使用DOPE程序进行随机诱变的一般方法
可以通过以下步骤进行随机诱变:
1.在亲本酶中选择目的修饰区域
2.在所选区域内决定突变位点和非突变位点
3.决定进行何种突变,例如相对要构建的变体的预期稳定性和/或性能
4.选择结构上可行的突变
5.相对步骤4来调整步骤3所选的残基
6.利用合适的预测算法来分析核苷酸分布状态
7.如果必要,根据遗传密码的可行性调节所需残基(例如,考虑遗传密码带来的限制(例如,为了避免导入终止密码子))(本领域技术人员应意识到某些密码子组合实际上不能用,需要进行调整)。
8.制备引物
9.利用引物进行随机诱变
10.通过筛选选择具有预期的改善特性的所得α-淀粉酶变体。
适用于步骤6的预测算法是本领域所公知的。Tomandl,D.等(计算机辅助的分子设计杂志,11(1997),29-38)描述了一种算法。以下描述另一种DOPE算法:
预测算法
“DOPE”程序是一种可用来以一定方式优化三联密码子的核苷酸组成的算法,从而,三联密码子能编码与所需氨基酸分布最相似的氨基酸分布。为了评价哪一个可能的分布状态与所需氨基酸分布最相似,需要一个评分公式。在“DOPE”程序中,发现以下函数是合适的:
其中Xi’是通过该程序计算得到的氨基酸和氨基酸组的数量,yi’是程序使用者定义的氨基酸和氨基酸组的希望量(例如,明确需要导入20个氨基酸或终止密码子中的哪一个,比如体现为一定的百分比(例如,90%Ala,3%Ile,7%Val)),wi’是由程序使用者定义的重要因素(例如,取决于将某个特定氨基酸残基插入所需位点的重要性)。N是21加上由程序使用者定义的氨基酸组的数量。用于该函数,规定00为1。
利用Monte-Carlo算法(Valleau,J.P.&Whittington,S.G(1977)描述过一个例子:A guide to Mont Carlo for statictical mechanics:1 highways.《统计力学,Part A:平衡技术》B.J.Berne编,New York:Plenum)来找出该函数的最大值。在每次迭代中进行以下步骤:
1.给每个碱基选择一个新的随机核苷酸组成,其中对于密码子所有三个位置的4种核苷酸G,A,T,C之一,目前和新组成之间的绝对差小于或等于d(参见以下d的定义)。
2.利用以上描述的函数s来比较新组成和目前组成的评分。如果新评分高于或等于目前组成的评分,保留新组成,将目前组成改为这个新的。如果新评分小,保留该组成的概率为exp(1000(新评分-目前评分))。
一个循环通常包括1000次上述迭代,其中的d由1线性降低至0。在一个优化过程中,进行100或更多次循环。最终得到产生最高评分的核苷酸组成。
实施例
实施例1
同源构建透阿米尔
TM
的实施例
地衣形芽孢杆菌α-淀粉酶与其他类透阿米尔α-淀粉酶的总的同源性很高,相似百分比极高。用Wisconsin大学Genetics Computer Group的程序GCG计算的透阿米尔TM与BSG(具有SEQ ID NO:3的嗜热脂肪芽孢杆菌α-淀粉酶)和BAN(具有SEQ ID NO:5的解淀粉芽孢杆菌α-淀粉酶)的相似率分别为89%和78%。与BANTM和BSG相比,TERM缺失残基G180和K181这两个残基。与BAN和透阿米尔TM相比,BSG在G371和I372之间缺失3个残基。另外与BANTM和透阿米尔TM相比,BSG在羧基端多出20个残基。与BSGTM相比,在氨基端,BANTM少2个残基,透阿米尔TM少1个残基。
在WO96/23974附录1所公开的结构的基础上,建立地衣形芽孢杆菌(透阿米尔TM)和解淀粉芽孢杆菌α-淀粉酶(BANTM)的结构模型。可以类似地建立其他类透阿米尔α-淀粉酶(例如文中公开的)的结构。
与用来描述当前结构的α-淀粉酶相比,透阿米尔TM的区别在于它在178-182位附近缺少两个残基。为了在模型结构中补偿这一点,用BIOSYM的HOMOLOGY程序来取代该结构(不仅是结构保守的区域)中等同位点处的残基,缺失位点除外。使透阿米尔TM(BANTM)中的G179(G177)和K180(K180)之间形成肽键。在模型中只发现有很少几个原子过于接近,这表明求解结构和模型结构之间结构关系密切(因此,后者是有效的)。
然后利用INSIGHT程序给这个非常粗略的透阿米尔TM结构在与求解结构相同的坐标处加上所述求解结构中的水(605)和离子(4个钙和1个钠)。这可以在只有很少的重叠下做到,换句话说,即吻合得很好。然后利用200步Steepest下降和600步共轭梯度(Conjugated gradient)对该模型结构进行最小化(参见Brook等,1983,计算化学杂志4:187-217)。然后对最小化了的结构进行分子动力学处理,加热5皮秒,随之平衡至多200皮秒但要在35皮秒以上。用Verlet算法进行动力学,利用偶联至水浴的Behrendsen(Behrendsen等,1984,化学物理学杂志81:3684-3690)保持300K的平衡温度。每皮秒去除旋转和翻译。
实施例2
提取鉴定pH稳定性提高和温度活性改变的α-淀粉酶变体的重要区域
的方法
对目的酶(此处是SP722和透阿米尔TM)的X-射线结构和/或建立的模型结构进行分子动力学模拟。利用CHARMM程序(得自分子模拟(MSI)程序或其他的合适程序,例如DISCOVER(来自MSI)做分子动力学模拟。在真空中进行分子动力学分析,更优选的是包含结晶水,或用包埋在水中(例如水球或水箱)的酶来进行。模拟进行300皮秒或更长时间,例如300-1200皮秒。提取结构中CA碳的各向同性波动,并在结构间进行比较。如果序列有缺失和/或插入,插入来自其他结构的各向同性波动从而使各向同性波动的差异为0。对各向同性波动的解释见CHARMM手册(可从MSI获得)。
可以利用标准电荷在可带电的氨基酸上进行分子动力学模拟。即令Asp和Glu带负电,Lys和Arg带正电。该条件类似大约7的中性pH。为了分析更高或更低pH,可以滴定分子以便使标准的可滴定残基的pKa(通常在pH2-10)发生改变,可滴定残基是Lys,Arg,Asp,Glu,Tyr和His,还有Ser,Thr和Cys也是可滴定的,但此处不考虑在内。此处将由pH导致的电荷改变描述为Asp和Glu在高pH带负电,Arg和Lys不带电。这是模拟10到11左右的pH,此时开始滴定Lys和Arg,因为这些残基正常pKa在9-11左右。
1.提取鉴定高pH稳定性之α-淀粉酶变体的重要区域的方法:
对于构建高pH稳定性的变体来说,重要的区域是那些在极端pH显示出最高可变性的区域,即有最高各向同性波动的区域。
通过进行两次分子动力学模拟来鉴定这种区域:i)一次高pH运行,这时将碱性氨基酸Lys和Arg看作是中性的(即非质子化的),酸性氨基酸Asp和Glu带(-1)电荷和ii)一次中性pH运行,碱性氨基酸Lys和Arg带有(+1)净电荷,酸性氨基酸带有(-1)电荷。
比较这两次运行,鉴定出在高pH比在中性pH分析下可变性更高的区域。
导入这样一些残基,这些残基能提高总的稳定性(例如氢键),使该区域更刚性(通过突变,比如用脯氨酸取代或替换甘氨酸残基),或者提高电荷或它们的相互作用均能够提高酶的高pH稳定性。
2.提取鉴定中温活性提高之α-淀粉酶变体的区域的方法:
对于构建中温活性提高之变体来说,重要的区域反映在SP722和透阿米尔各向同性波动的差值,即SP722减去透阿米尔CA的各向同性波动。选择各向同性波动中具有最高可变性的区域。预计这些区域和残基能提高酶在中温的活性。只有存在可变性正确的特定残基,才能表达α-淀粉酶的活性。如果残基的可变性太低,活性将下降或丧失。
实施例3
通过定域随机,预测的诱变来构建在中温Ca2+ 稳定性比亲本酶提高的 类透阿米尔α-淀粉酶变体
为了提高α-淀粉酶在低钙浓度下的稳定性,在预选区域进行随机诱变。
区域:残基:
SAI: R181-W189
利用DOPE软件(参见材料与方法)确定出SA1区中每个建议变化的峰值密码子,这些变化能减少终止密码子的数量(见表1)。计算密码子三个位置处的确切核苷酸分布状态以便给出氨基酸变化的建议数目。针对预测区域中的指定位点进行具体预测从而更可能得到所需残基,但仍允许其他可能性。
表1:
每个位点氨基酸残基的分布状态
R181:72%R,2%N,7%Q,4%H,4%K,11%S
G182:73%G,13%A,12%S,2%T
K185:95%K,5%R
A186:50%A,4%N,6%D,1%E,1%G,1%K,5%S,31%T
W187;100%W
D188:100%D
W189:92%W,8%S
将所得预测的寡核苷酸链作为有义链在表2中显示:野生型核苷酸和氨基酸序列以及每个预测位点的核苷酸分布状态。
表2
位点 181 182 185 186 187 188 189
氨基酸序列 Arg Gly Lys Ala Thr Asp Thr
野生型核苷酸序列 cga ggt aaa gct tgg gat tgg
正向引物(SEQ ID NO:15)
FSA:5’-caa aat cgt atc tac aaa ttc 123 456 a7g 8910 tgg gat t11g gaa gta gattcg gaa aat-3’
每个预测位点的核苷酸分布状态
1:35%A,65%C
2:83%G,17%A
3:63%G,37%T
4:86%G,14%A
5:85%G,15%C
6:50%T,50%C
7:95%A,5%G
8:58%G,37%A,5%T
9:86%C,13%A,1%G
10:83%T,17%G
11:92%G,8%C
反向引物(SEQ ID NO:6)
RSA:5’-gaa ttt gta gat acg att ttg-3’
随机诱变
利用表2中明显的峰值寡核苷酸(用一个常用术语称为FSA)和用于SA1区域的反向引物RSA以及跨越SacII和DraIII位点的SEQ ID NO:2:SP722特异引物,经重叠延伸法(Horton等,基因77(1989):61-68)来制备具有21个碱基对重叠的PCR-文库片段。质粒pJE1作为聚合酶链反应的模板。将PCR片段克隆到大肠杆菌/芽孢杆菌穿梭载体pDork101(见材料与方法)中,该载体能在大肠杆菌中进行诱变,在枯草芽孢杆菌中瞬时表达从而防止大肠杆菌中淀粉酶致死性的累积。将克隆的PCR片段导入大肠杆菌中后,从质粒中切下修饰过的pUC19片段,将启动子和突变了的透阿米尔基因物理地连接在一起,在芽孢杆菌中进行表达。
筛选
可以用前面“材料与方法”部分描述的低钙滤膜检测法来筛选文库。
实施例4
构建淀粉酶SEQ ID NO:1(SP690)的变体
将编码SEQ ID NO:1之淀粉酶的基因放入WO96/23873中描述的质粒pTVB106中。从该构建体中的amyL启动子开始在枯草芽孢杆菌中表达淀粉酶。
蛋白质的一个变体是Δ(T183-G184)+Y243F+Q391E+K444Q。WO96/23873中描述了该变体的构建过程。
经Sarkar和Sommer(1990,生物技术8:404-407)所描述的mega-引物法来构建Δ(T183-G184)+N195F。
利用基因特异引物B1(SEQ ID NO:17)和诱变引物101458(SEQ ID NO:19)经PCR来扩增一个接近645bp的DNA片段,该片段来自类pTVB106质粒(在编码SEQ ID NO:1之淀粉酶的基因中含有Δ(T183-G184)突变)。
从琼脂糖凝胶中纯化该645bp片段,并与引物Y2(SEQ ID NO:18)一起作为在同一模板上进行的第2次PCR中的mega-引物。
用限制酶BstEII和AflIII消化所得近1080bp的片段,纯化产生的约510bp的DNA片段,并将其与用相同酶消化过的类pTVB106质粒(在编码SEQ ID NO:1的淀粉酶的基因中含有Δ(T183-G184)突变)进行连接。用连接产物和氯霉素抗性转化子来转化感受态枯草芽孢杆菌SHA273(淀粉酶和蛋白酶低)细胞,并经DNA测序检测来证明质粒中正确的突变存在。
引物B1:(SEQ ID NO:17)
5’CGA TTG CTG ACG CTG TTA TTT GCG 3’
引物Y2:(SEQ ID NO:18)
5’CTT GTT CCC TTG TCA GAA CCA ATG 3’
引物101458:(SEQ ID NO:19)
5’GT CAT AGT TGC CGA AAT CTG TAT CGA CTT C 3’
以相似的方法构建变体:Δ(T183-G184)+K185R+A186T,除了所用诱变引物为101638外。
引物101638:(SEQ ID NO:20)
5’CC CAG TCC CAC GTA CGT CCC CTG AAT TTA TAT ATT TTG 3’
以相似的方法来构建变体:Δ(T183-G184)+A186T,Δ(T183-G184)+A186I,Δ(T183-G184)+A186S,Δ(T183-G184)+A186N,除了所用模板为类pTVB106质粒(携有变体Δ(T183-G184)+K185R+A186T),并用它作为克隆载体。
诱变寡核苷酸(Oligo 1)是:
5’CC CAG TCC CAG NTCTTT CCC CTG AAT TTA TAT ATT TTG3’(SEQ ID NO:21)
N代表用于合成诱变寡核苷酸(mutagenicoli-gonucleotide)的4种碱基:A,C,G和T的混合物。
测定转化子的序列来确定成熟淀粉酶中186位氨基酸的正确密码子。
如下构建变体:Δ(T183-G184)+K185R+A186T+N195F:
用引物X2和引物101458在类pTVB106质粒(携有突变Δ(T183-G184)+K185R+A186T)上进行PCR。将所得DNA片段与引物Y2一起作为在类pTVB106质粒(携有突变Δ(T183-G184)+N195F)上进行的PCR中的mega-引物。用限制性内切酶Acc65I和AflIII消化第2次PCR的产物,并将其克隆至用相同的酶消化过的类pTVB106质粒(Δ(T183-G184)+N195F)。
引物X2:(SEQ ID NO:22)
5’GCG TGG ACA AAG TTT GAT TTT CCT G 3’
如下构建变体:Δ(T183-G184)+K185R+A186T+N195F+Y243F+Q391E+K444Q:
用引物X2(SEQ ID NO:22)和引物10+K185R1458(SEQ ID NO:19)在类pTVB106质粒(携有突变Δ(T183-G184)+K185R+A186T)上做PCR。将所得DNA片段与引物Y2(SEQ ID NO:18)一起作为在类pTVB106质粒(携有突变Δ(T183-G184)+Y243F+Q391E+K444Q)上进行的PCR中的mega-引物。用限制性内切酶Acc65I和AflIII消化第2次PCR的产物,并将其克隆至用相同的酶消化过的类pTVB106质粒(Δ(T183-G184)+Y243F+Q391E+K444Q)。
实施例5
构建亲本SP722α-淀粉酶(SEQ ID NO:2)的定点α-淀粉酶变体
如下所述构建淀粉酶SEQ ID NO:2(SP722)的变体。
将编码SEQ ID NO:2之淀粉酶的基因转入WO96/23873中描述的质粒pTVB112中。从该构建体中的amyL启动子开始在枯草芽孢杆菌中表达淀粉酶。
经Sarkar和Sommer(1990,生物技术8:404-407)所描述的mega-引物法来构建Δ(D183-G184)+V56I。
利用基因特异引物DA03和诱变引物DA07经PCR来扩增一个接近820bp的DNA片段,该片段来自类pTVB112质粒(在编码SEQ ID NO:2之α-淀粉酶的基因中含有Δ(D183-G184)突变)。
从琼脂糖凝胶中纯化该820bp片段,并与引物DA01一起作为在同一模板上进行的第2次PCR中的mega-引物。
用限制酶NgoM I和Aat II消化所得近920bp的片段,纯化产生的约170bp的DNA片段,并将其与用相同酶消化过的类pTVB112质粒(在编码SEQ ID NO:2所示淀粉酶的基因中含有Δ(D183-G184)突变)进行连接。用连接产物来转化感受态枯草芽孢杆菌SHA273(淀粉酶和蛋白酶低)细胞,并经DNA测序检测氯霉素抗性转化子来证明质粒上含有正确的突变。
引物DA01:(SEQ ID NO:23)
5’CCTAATGATGGGAATCACTGG 3’
引物DA03:(SEQ ID NO:24)
5’GCATTGGATGCTTTTGAACAACCG 3’
引物DA07:(SEQ IDNO:25)
5’CGCAAAATGATATCGGGTATGGAGCC 3’
经Sarkar和Sommer(1990,生物技术8:404-407)描述的mega-引物法来构建变体:Δ(D183-G184)+K108L,Δ(D183-G184)+K108Q,Δ(D183-G184)+K108E,Δ(D183-G184)+K108V。
用引物DA03和诱变引物DA20在类pTVB112质粒(携有突变Δ(D183-G184))上做PCR。将所得DNA片段与引物DA01一起作为在类pTVB112质粒(携有突变Δ(D183-G184))上进行的PCR中的mega-引物。用限制性内切酶Aat II和Mlu I消化约920bp的第2次PCR的产物,并将其克隆至用相同的酶消化过的类pTVB112质粒(Δ(D183-G184))。
引物DA20(SEQ ID NO:26):
5’GTGATGAACCACSWAGGTGGAGCTGATGC 3’
S代表用于合成诱变寡核苷酸的2种碱基:C和G的混合物,W代表用于合成诱变寡核苷酸的2种碱基:A和T的混合物。
测定转化子的序列来确定成熟淀粉酶中108位氨基酸的正确密码子。
以相似的方法构建变体:Δ(D183-G184)+D168A,Δ(D183-G184)+D168I,Δ(D183-G184)+D168V,Δ(D183-G184)+D168T,除了所用诱变引物为DA14。
引物DA14(SEQ ID NO:27):
5’GATGGTGTATGGRYCAATCACGACAATTCC 3’
R代表用于合成诱变寡核苷酸的2种碱基:A和G的混合物,Y代表用于合成诱变寡核苷酸的2种碱基:C和T的混合物。
测定转化子的序列来确定成熟淀粉酶中168位氨基酸的正确密码子。
以相似的方法构建变体:Δ(D183-G184)+Q169N,除了所用诱变引物为DA15。
引物DA15(SEQ ID NO:28):
5’GGTGTATGGGATAACTCACGACAATTCC 3’
以相似的方法构建变体:Δ(D183-G184)+Q169L,除了所用诱变引物为DA16。
引物DA16(SEQ ID NO:29):
5’GGTGTATGGGATCTCTCACGACAATTCC 3’
以相似的方法构建变体:Δ(D183-G184)+Q172N,除了所用诱变引物为DA17。
引物DA17(SEQ ID NO:30):
5’GGGATCAATCACGAAATTTCCAAAATCGTATC 3’
以相似的方法构建变体:Δ(D183-G184)+Q172L,除了所用诱变引物为DA18。
引物DA18(SEQ ID NO:31):
5’GGGATCAATCACGACTCTTCCAAAATCGTATC 3’
以相似的方法构建变体:Δ(D183-G184)+L201I,除了所用诱变引物为DA06。
引物DA06(SEQ ID NO:32):
5’GGAAATTATGATTATATCATGTATGCAGATGTAG 3’
以相似的方法构建变体:Δ(D183-G184)+K269S,除了所用诱变引物为DA09。
引物DA09(SEQ ID NO:33):
5’GCTGAATTTTGGTCGAATGATTTAGGTGCC 3’
以相似的方法构建变体:Δ(D183-G184)+K269Q,除了所用诱变引物为DA11。
引物DA11(SEQ ID NO:34):
5’GCTGAATTTTGGTCGAATGATTTAGGTGCC 3’
以相似的方法构建变体:Δ(D183-G184)+N270Y,除了所用诱变引物为DA21。
引物DA21(SEQ ID NO:35):
5’GAATTTTGGAAGTACGATTTAGGTCGG 3’
以相似的方法构建变体:Δ(D183-G184)+L272A,Δ(D183-G184)+L272I,Δ(D183-G184)+L272V,Δ(D183-G184)+L272T,除了所用诱变引物为DA12。
引物DA12(SEQ ID NO:36):
5’GGAAAAACGATRYCGGTGCCTTGGAGAAC 3’
R代表用于合成诱变寡核苷酸的2种碱基:A和G的混合物,Y代表用于合成诱变寡核苷酸的2种碱基:C和T的混合物。
测定转化子的序列来确定成熟淀粉酶中272位氨基酸的正确密码子。
以相似的方法构建变体:Δ(D183-G184)+L275A,Δ(D183-G184)+L275I,Δ(D183-G184)+L275V,Δ(D183-G184)+L275T,除了所用诱变引物为DA13。
引物DA13(SEQ ID NO:37):
5’GATTTAGGTGCCTRYCAGAACTATTTA 3’
R代表用于合成诱变寡核苷酸的2种碱基:A和G的混合物,Y代表用于合成诱变寡核苷酸的2种碱基:C和T的混合物。
测定转化子的序列来确定成熟淀粉酶中275位氨基酸的正确密码子。
以相似的方法构建变体:Δ(D183-G184)+Y295E,除了所用诱变引物为DA08。
引物DA08(SEQ ID NO:38):
5’CCCCCTTCATGAGAATCTTTATAACG 3’
以Sarkar和Sommer(1990,生物技术8:404-407)描述的mega-引物法来构建变体Δ(D183-G184)+K446Q。
利用基因特异引物DA04(该引物在终止密码子下游214-231bp退火)和诱变引物DA10经PCR来扩增一个接近350bp的DNA片段,该片段来自类pTVB112质粒(在编码SEQ ID NO:2的淀粉酶的基因中含有Δ(D183-G184)突变)。
将所得DNA片段与引物DA05一起作为在类pTVB112质粒(携有突变Δ(D183-G184))上进行的PCR中的mega-引物。用限制性内切酶SnaB I和Not I消化约460bp的第2次PCR产物,并将其克隆至用相同的酶消化过的类pTVB106质粒(携有Δ(D183-G184)突变)。
引物DA04(SEQ ID NO:39):
5’GAATCCGAACCTCATTACACATTCG 3’
引物DA05(SEQ ID NO:40):
5’CGGATGGACTCGAGAAGGAAATACCACG 3’
引物DA10(SEQ ID NO:41):
5’CGTAGGGCAAAATCAGGCCGGTCAAGTTTGG 3’
以相似的方法构建变体:Δ(D183-G184)+K458R,除了所用诱变引物为DA22。
引物DA22(SEQ ID NO:42):
5’CATAACTGGAAATCGCCCGGGAACAGTTACG 3’
以相似的方法构建变体:Δ(D183-G184)+P459S和Δ(D183-G184)+P459T,除了所用诱变引物为DA19。
引物DA19(SEQ ID NO:43):
5’CTGGAAATAAAWCCGGAACAGTTACG 3’
W代表用于合成诱变寡核苷酸的2种碱基:A和T的混合物。
测定转化子的序列来确定成熟淀粉酶中495位氨基酸的正确密码子。
以相似的方法构建变体:Δ(D183-G184)+T461P,除了所用诱变引物为DA23。
引物DA23(SEQ ID NO:44):
5’GGAAATAAACCAGGACCCGTTACGATCAATGC 3’
以相似方法构建变体:Δ(D183-G184)+K142R,除了所用诱变引物为DA32。
引物DA32(SEQ ID NO:45):
5’GAGGCTTGGACTAGGTTTGATTTTCCAG 3’
以相似方法构建变体:Δ(D183-G184)+K269R,除了所用诱变引物为DA31。
引物DA31(SEQ ID NO:46):
5’GCTGAATTTTGGCGCAATGATTTAGGTGCC 3’
实施例6
构建亲本透阿米尔α-淀粉酶(SEQ ID NO:4)的定点α-淀粉酶变体
将编码透阿米尔α-淀粉酶的amyL基因转入WO96/10603(Novo Nordisk)中描述的质粒pDN1528中。通过WO97/41213或上面描述的“mega引物法”来构建分别携带所述亲本α-淀粉酶中N265R和N265D取代的变体。
诱变寡核苷酸是:
用于N265R取代的引物b11:
5’PCC AGC GCG CCT AGG TCA CGC TGC CAA TAT TCA G(SEQ IDNO:56)
用于N265D取代的引物b12:
5’PCC AGC GCG CCT AGG TCA TCC TGC CAA TAT TCA G(SEQ IDNO:57)
P代表磷酸根基团。
实施例7
确定具有SEQ ID NO:2所示氨基酸序列的亲本α-淀粉酶之变体在碱
性pH的pH稳定性
在这组分析中,利用了纯化的酶样品。用在100mM CAPS缓冲液(调至pH10.5)中的各变体溶液进行测量。将溶液在75℃温育。
温育20和30分钟后,用PNP-G7检测法(在“材料与方法”部分描述过)测量残存活性。用Britton Robinson缓冲液(pH7.3)测量样品中的残存活性。测量残存活性相对0分钟同一酶的相应对照溶液的下降值,所述对照溶液未在高pH和75℃温育。
在下表中将初始活性的百分比作为亲本酶(SEQ ID NO:2)和受测变体的一个函数。
| 变体 | 20分钟后的残存活性 | 30分钟后的残存活性 |
| Δ(D183-G184)+M323L | 56% | 44% |
| Δ(D183-G184)+M323L+R181S | 67% | 55% |
| Δ(D183-G184+M323L+A186T | 62% | 50% |
在另一组分析中,使用了培养物上清液。用溶在100mM CAPS缓冲液(调至pH10.5)中的各变体溶液进行测量。将溶液在80℃温育。
温育30分钟后,用Phadebas检测法(在上述“材料与方法”部分描述过)测量残存活性。用Britton Robinson缓冲液(pH7.3)测量样品中的残存活性。测量残存活性相对0分钟同一酶的相应对照溶液的下降值,所述对照溶液未在高pH和80℃温育。
在下表中将初始活性的百分比作为亲本酶(SEQ ID NO:2)和受测变体的一个函数。
| 变体 | 30分钟后的残存活性 |
| Δ(D183-G184) | 4% |
| Δ(D183-G184)+P459T | 25% |
| Δ(D183-G184)+K458R | 31% |
| Δ(D183-G184)+K311R | 10% |
实施例8
确定氨基酸序列如SEQ ID NO:1,SEQ ID NO:2和SEQ ID NO:4所
示的亲本α-淀粉酶之变体在碱性pH的钙稳定性
A:SEQ ID NO:1序列之变体的钙稳定性
用溶在100mM CAPS缓冲液(调至pH10.5)中的各变体溶液进行测量,并在(时间t=0时)向其中加入聚磷酸盐至终浓度为2400ppm。将溶液于50℃温育。
温育20和30分钟后,用PNP-G7检测法(上面描述过)测量残存活性。用Britton Robinson缓冲液(pH7.3)测量样品中的残存活性。测量残存活性相对0分钟时同一酶的相应对照溶液的下降值,所述对照溶液未在高pH和50℃温育。
在下表中将初始活性的百分比作为亲本酶(SEQ ID NO:1)和受测变体的一个函数。
| 变体 | 20分钟后的残存活性 | 30分钟后的残存活性 |
| Δ(T183-G184) | 32% | 19% |
| Δ(T183-G184)+A186T | 36% | 23% |
| Δ(T183-G184)+K185R+A186I | 45% | 29% |
| Δ(T183-G184)+A186I | 35% | 20% |
| Δ(T183-G184+N195F | 44% | n.d. |
n.d.=未测
B.SEQ ID NO:2序列之变体的钙稳定性
在这组分析中使用了纯化的酶样品。用溶在100mM CAPS缓冲液(调至pH10.5)中的各变体溶液进行测量,并在(时间t=0时)向其中加入聚磷酸盐至终浓度为2400ppm。将溶液于50℃温育。
温育20和30分钟后,用PNP-G7检测法(上面描述过)测量残存活性。用Britton Robinson缓冲液(pH7.3)测量样品中的残存活性。测量残存活性相对0分钟时同一酶的相应对照溶液的下降值,所述对照溶液未在高pH和50℃温育。
在下表中将初始活性的百分比作为亲本酶(SEQ ID NO:2)和受测变体的一个函数。
| 变体 | 20分钟后的残存活性 | 30分钟后的残存活性 |
| Δ(D183-G184)+M323L | 21% | 13% |
| Δ(D183-G184)+M323L+R181S | 32% | 19% |
| Δ(D183-G184)+M323L+A186T | 28% | 17% |
| Δ(D183-G184)+M323L+A186R | 30% | 18% |
| 变体 | 20分钟后的残存活性 | 30分钟后的残存活性 |
| Δ(D183-G184) | 30% | 20% |
| Δ(D183-G184)+N195F | 55% | 44% |
在这组分析中使用了培养物上清液。用溶在100mM CAPS缓冲液(调至pH10.5)中的各变体溶液进行测量,并在(时间t=0时)向其中加入聚磷酸盐至终浓度为2400ppm。将溶液于50℃温育。
温育30分钟后,用Phadebas检测法(上面描述过)测量残存活性。用Britton Robinson缓冲液(pH7.3)测量样品中的残存活性。测量残存活性相对0分钟时同一酶的相应对照溶液的下降值,所述对照溶液未在高pH和50℃温育。
在下表中将初始活性的百分比作为亲本酶(SEQ ID NO:2)和受测变体的一个函数。
| 变体 | 30分钟后的残存活性 |
| Δ(D183-G184) | 0% |
| Δ(D183-G184)+P459T | 19% |
| Δ(D183-G184)+K458R | 18% |
| Δ(D183-G184)+T461P | 13% |
| Δ(D183-G184)+E346Q+K385R | 4% |
C.SEQ ID NO:4中序列之变体的钙稳定性
用溶在100mM CAPS缓冲液(调至pH10.5)中的各变体溶液进行测量,并加入聚磷酸盐(在时间t=0)至终浓度为2400ppm。将溶液于60℃温育20分钟。
温育20分钟后,用PNP-G7检测法(上面描述过)测量残存活性。用Britton Robinson缓冲液(pH7.3)测量样品中的残存活性。测量残存活性相对0分钟时同一酶的相应对照溶液的下降值,所述对照溶液未在高pH和60℃温育。
在下表中将初始活性的百分比作为亲本酶(SEQ ID NO:4)和受测变体的一个函数。
| 变体 | 20分钟后的残存活性 |
| 透阿米尔(SEQ ID NO:4) | 17% |
| N265R | 28% |
| N265D | 25% |
实施例9
在中温测量氨基酸序列如SEQ ID NO:1所示之α-淀粉酶的活性
A:SEQ ID NO:1中序列的变体的α-淀粉酶活性
用溶在50mM Britton Robinson缓冲液(调节至pH7.3)中的各变体溶液,利用Phadebas检测法(上面描述过)进行测量。在37℃用50mM BrittonRobinson缓冲液(pH7.3),并在25℃用50mM CAPS缓冲液(pH10.5)测量样品中的活性。
下表显示亲本酶(SEQ ID NO:1)和受测变体的温度依赖活性和在25℃的活性相对37℃活性的百分比。
| 变体 | NU/mg 25℃ | NU/mg 37℃ | NU(25℃)/NU(37℃) |
| SP690 | 1440 | 35000 | 4.1% |
| Δ(T183-G184) | 2900 | 40000 | 7.3% |
| Δ(T183-G184)+K269S | 1860 | 12000 | 15.5% |
| Δ(Q174) | 3830 | 38000 | 7.9% |
用溶在50mM Britton Robinson缓冲液(调至pH7.3)中的各变体溶液,采用Phadebas检测法(上面描述过)进行另一项测量。于37℃和50℃用50mMBritton Robinson缓冲液(pH7.3)测量样品中的活性。
下表显示亲本酶(SEQ ID NO:1)和受测变体的温度依赖活性以及在37℃的活性相对50℃的活性的百分比。
| 变体 | NU/mg 37℃ | NU/mg 50℃ | NU(37℃)/NU(50℃) |
| SP690(SEQ ID NO:1) | 13090 | 21669 | 60% |
| K269Q | 7804 | 10063 | 78% |
B:SEQ ID NO:2中的序列的变体的α-淀粉酶活性
用溶在50mM Britton Robinson缓冲液(调至pH7.3)中的各变体溶液,采用Phadebas检测法(上面描述过)进行测量。于25℃和37℃用50mM BrittonRobinson缓冲液(pH7.3)测量样品中的酶活性。
下表显示亲本酶(SEQ ID NO:2)和受测变体的温度依赖活性以及在25℃活性相对37℃活性的百分比。
| 变体 | NU/mg25℃ | NU/mg37℃ | NU(25℃)/NU(37℃) |
| Δ(D183-G184)+M323L | 3049 | 10202 | 30% |
| Δ(D183-G184)+M323L+R181S | 18695 | 36436 | 51% |
C:SEQ ID NO:4中的序列的变体的α-淀粉酶活性
用溶在50mM Britton Robinson缓冲液(调至pH7.3)中的各变体溶液,采用Phadebas检测法(上述)测量。在37℃用50mM Britton Robinson缓冲液(pH7.3),并在60℃用50mM CAPS缓冲液(pH10.5)测量样品中的活性。
下表显示亲本酶(SEQ ID NO:4)和受测变体的温度依赖活性以及在37℃活性相对60℃活性的百分比。
| 变体 | NU/mg 37℃ | NU/mg 60℃ | NU(37℃)/NU(60℃) |
| 透阿米尔 | 7400 | 4350 | 170% |
| Q264S | 10000 | 4650 | 215% |
实施例10
构建亲本杂交体BAN:1-300/透阿米尔:301-483α-淀粉酶之变体
质粒pTVB191包含编码杂交体BAN:1-300/透阿米尔:301-483的基因以及可在枯草芽孢杆菌中使用的复制原点和赋予氯霉素抗性的cat基因。
采用mega-引物法(Sarkar和Sommer,1990),以质粒pTVB191为模板来构建变体BM4(F290E)。
用引物p1(SEQ ID NO:52)和诱变寡核苷酸bm4(SEQ ID NO:47)经聚合酶链反应(PCR)在标准条件下扩增一个444bp的片段。
从琼脂糖凝胶上纯化该片段,并与引物p2(SEQ ID NO:53)一起作为第2次PCR的“mega-引物”,产生一个531bp的片段。用限制内切酶HinD III和Tth111T消化该片段。将这样产生的389bp片段连接到用相同的两种酶切割过的质粒pTVB191中。将所得质粒转化至枯草芽孢杆菌SHA273中。通过在含有氯霉素和不溶性淀粉的平板上培养转化子来挑选出氯霉素抗性克隆。用碘蒸汽将平板染色后,选出形成晕圈的克隆,即分离到了表达活性α-淀粉酶的克隆。经DNA测序来证实所导入的突变。
以类似的方法构建变体BM5(F290K),BM6(F290A),BM8(Q360E)和BM11(N102D)。以下给出构建这些变体的细节。
变体:BM5(F290K)
诱变寡核苷酸:bm5(SEQ ID NO:48)
引物(第一次PCR):p1(SEQ ID NO:52)
所得片段的大小:444bp
引物(第二次PCR):p2(SEQ ID NO:53)
限制内切酶:HinD III,Tth111I
切割片段的大小:389bp
变体:BM6(F290A)
诱变寡核苷酸:bm6(SEQ ID NO:49)
引物(第一次PCR):p1(SEQ ID NO:52)
所得片段的大小:444bp
引物(第二次PCR):p2(SEQ ID NO:53)
限制内切酶:HinD III,Tth111I
切割片段的大小:389bp
变体:BM8(Q360E)
诱变寡核苷酸:bm8(SEQ ID NO:50)
引物(第一次PCR):p1(SEQ ID NO:52)
所得片段的大小:230bp
引物(第二次PCR):p2(SEQ ID NO:53)
限制内切酶:HinD III,Tth111I
切割片段的大小:389bp
变体:BM11(N102D)
诱变寡核苷酸:bm11(SEQ ID NO:51)
引物(第一次PCR):p3(SEQ ID NO:54)
所得片段的大小:577bp
引物(第二次PCR):p4(SEQ ID NO:55)
限制内切酶:HinD III,Pvu I
切割片段的大小:576bp
诱变寡核苷酸:
bm4(SEQ ID NO:47):F290E
引物5’GTG TTT GAC GTC CCG CTT CAT GAG AAT TTA CAG G
bm5(SEQ ID NO:48):F290K
引物5’GTG TTT GAC GTC CCG CTT CAT AAG AAT TTA CAG G
bm6(SEQ ID NO:49):F290A
引物5’GTG TTT GAC GTC CCG CTT CAT GCC AAT TTA CAG G
bm8(SEQ ID NO:50):Q360E
引物5’AGG GAA TCC GGA TAC CCT GAG GTT TTC TAC GG
bm11(SEQ ID NO:51):N102D
引物5’GAT GTG GTT TTG GAT CAT AAG GCC GGC GCT GAT G
其他引物
p1:5’CTG TTA TTA ATG CCG CCA AAC C(SEQ ID NO:52)
p2:5’G GAA AAG AAA TGT TTA CGG TTG CG(SEQ ID NO:53)
p3:5’G AAA TGA AGC GGA ACA TCA AAC ACG(SEQ ID NO:54)
p4:5’GTA TGA TTT AGG AGA ATT CC(SEQ ID NO:55)
实施例11
亲本杂交体BAN:1-300/透阿米尔:301-483α-淀粉酶变体在碱性pH下
的α-淀粉酶活性
用各酶的溶液,采用Phadebas检测法(上面描述过)进行测量。在50mMBritton Robinson缓冲液(用NaOH调至所需pH)中于30℃温育15分钟后,测量活性。
NU/mg酶
pH wt Q360E F290A F290K F290E N102D
8.0 5300 7800 8300 4200 6600 6200
9.0 1600 2700 3400 2100 1900 1900
参考文献
Klein,C.等,生物化学1992,31:8740-8746,
Mizuno,H.等,分子生物学杂志(1993)234:1282-1283,
Chang,C.等,分子生物学杂志(1993)229:235-238,
Larson,S.B.,分子生物学杂志(1994)235:1560-1584
Lawson,C.L.,分子生物学杂志(1994)236:590-600,
Qian,M.,等,分子生物学杂志(1993)231:785-799,
Brady,R.L.等,Acta Crystallogr.sect.B.47:527-535,
Swift,H.J.,等,Acta Crystallogr.sect.B.47:535-544,
A.Kadziola,博士论文:“大麦α-淀粉酶及采用X-射线晶体学研究的其与底物类似物抑制剂形成的复合体”,哥本哈根大学化学系1993MacGregor,E.A.,Food Hydrocolloids,1987,1卷,5-6,P.B.Diderichsen和L.Christiansen,来自嗜热脂肪芽孢杆菌的产麦芽糖的α-淀粉酶的克隆,FEMS微生物快报:56:53-60(1988)
Hudson等,实用免疫学,第3版(1989),Blackwell Scientific Publications,Sambrook等,分子克隆:实验指南,第2版,Cold Spring Harbor,1989S.L.Beaucage和M.H.Caruthers,四面体快报22,1981:1859-1869
Matthes等,EMBO杂志3,1984:801-805。
R.K.Saiki等,科学239,1988:487-491。
Morinaga等,1984,生物技术2:646-639
Nelson和Long,分析生物化学180,1989:147-151
Hunkapiller等,1984,自然310:105-111
R.Higuchi,B.Krummel和R.K.Saiki(1988)。DNA片段体外制备和特异突变的一般方法:蛋白质和DNA相互作用的研究。核酸研究16:7351-7367。
Dubnau等,1971,分子生物学杂志56:209-221。
Gryczan等,1978,细菌杂志134:318-329。
S.D.Erlich,1977,Proc.Natl.Acad.Sci.74:1680-1682。
Boel等,1990,生物化学29:6244-6249。
序列表
(1)一般资料:
(i)申请人:
(A)姓名:Novo Nordisk A/S
(B)街道:Novo Alle
(C)城市:DK-2880 Bagsvaerd
(E)国家:丹麦
(F)邮政编码(ZIP):DK-2880
(G)电话:+45 44 44 88 88
(H)传真:+45 44 49 32 56
(ii)发明题目:α-淀粉酶变体
(iii)序列数:46
(iv)计算机可读形式:
(A)介质类型:软盘
(B)计算机:IBM PC兼容机
(C)操作系统:PC-DOS/MS-DOS
(D)软件:Patent In Release#1.0,Version#1.25(EPO)
(2)SEQ ID NO:1的资料:
(i)序列特征:
(A)长度:485个氨基酸
(B)类型:氨基酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:肽
(xi)序列描述:SEQ ID NO:1:
His His Asn Gly Thr Asn Gly Thr Met Met Gln Tyr Phe Glu Trp Tyr
1 5 10 15
Leu Pro Asn Asp Gly Asn His Trp Asn Arg Leu Arg Asp Asp Ala Ala
20 25 30
Asn Leu Lys Ser Lys Gly Ile Thr Ala Val Trp Ile Pro Pro Ala Trp
35 40 45
Lys Gly Thr Ser Gln Asn Asp Val Gly Tyr Gly Ala Tyr Asp Leu Tyr
50 55 60
Asp Leu Gly Glu Phe Asn Gln Lys Gly Thr Val Arg Thr Lys Tyr Gly
65 70 75 80
Thr Arg Asn Gln Leu Gln Ala Ala Val Thr Ser Leu Lys Asn Asn Gly
85 90 95
Ile Gln Val Tyr Gly Asp Val Val Met Asn His Lys Gly Gly Ala Asp
100 105 110
Gly Thr Glu Ile Val Asn Ala Val Glu Val Asn Arg Ser Asn Arg Asn
115 120 125
Gln Glu Thr Ser Gly Glu Tyr Ala Ile Glu Ala Trp Thr Lys Phe Asp
130 135 l40
Phe Pro Gly Arg Gly Asn Asn His Ser Ser Phe Lys Trp Arg Trp Tyr
145 150 155 160
His Phe Asp Gly Thr Asp Trp Asp Gln Ser Arg Gln Leu Gln Asn Lys
165 170 175
Ile Tyr Lys Phe Arg Gly Thr Gly Lys Ala Trp Asp Trp Glu Val Asp
180 185 190
Thr Glu Asn Gly Asn Tyr Asp Tyr Leu Met Tyr Ala Asp Val Asp Met
195 200 205
Asp His pro Glu Val Ile His Glu Leu Arg Asn Trp Gly Val Trp Tyr
210 215 220
Thr Asn Thr Leu Asn Leu Asp Gly Phe Arg Ile Asp Ala Val Lys His
225 230 235 240
Ile Lys Tyr Ser Phe Thr Arg Asp Trp Leu Thr His Val Arg Asn Thr
245 250 255
Thr Gly Lys Pro Met Phe Ala Val Ala Glu Phe Trp Lys Asn Asp Leu
260 265 270
Gly Ala Ile Glu Asn Tyr Leu Asn Lys Thr Ser Trp Asn His Ser Val
275 280 285
Phe Asp Val Pro Leu His Tyr Asn Leu Tyr Asn Ala Ser Asn Ser Gly
290 295 300
Gly Tyr Tyr Asp Met Arg Asn Ile Leu Asn Gly Ser Val Val Gln Lys
305 310 315 320
His Pro Thr His Ala Val Thr Phe Val Asp Asn His Asp Ser Gln Pro
325 330 335
Gly Glu Ala Leu Glu Ser Phe Val Gln Gln Trp Phe Lys Pro Leu Ala
340 345 350
Tyr Ala Leu Val Leu Thr Arg Glu Gln Gly Tyr Pro Ser Val Phe Tyr
355 360 365
Gly Asp Tyr Tyr Gly Ile pro Thr His Gly Val Pro Ala Met Lys Ser
370 375 380
Lys Ile Asp Pro Leu Leu Gln Ala Arg Gln Thr Phe Ala Tyr Gly Thr
385 390 395 400
Gln His Asp Tyr Phe Asp His His Asp Ile Ile Gly Trp Thr Arg Glu
405 410 415
Gly Asn Ser Ser His pro Asn Ser Gly Leu Ala Thr Ile Met Ser Asp
420 425 430
Gly Pro Gly Gly Asn Lys Trp Met Tyr Val Gly Lys Asn Lys Ala Gly
435 440 445
Gln Val Trp Arg Asp Ile Thr Gly Asn Arg Thr Gly Thr Val Thr Ile
450 455 460
Asn Ala Asp Gly Trp Gly Asn Phe Ser Val Asn Gly Gly Ser Val Ser
465 470 475 480
Val Trp Val Lys Gln
485
(2)SEQ ID NO:2的资料:
(i)序列特征:
(A)长度:485个氨基酸
(B)类型:氨基酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:肽
(xi)序列描述: SEQ ID NO:2:
His His Asn Gly Thr Asn Gly Thr Met Met Gln Tyr Phe Glu Trp His
1 5 10 15
Leu Pro Asn Asp Gly Asn His Trp Asn Arg Leu Arg Asp Asp Ala Ser
20 25 30
Asn Leu Arg Asn Arg Gly Ile Thr Ala Ile Trp Ile Pro Pro Ala Trp
35 40 45
Lys Gly Thr Ser Gln Asn Asp Val Gly Tyr Gly Ala Tyr Asp Leu Tyr
50 55 60
Asp Leu Gly Glu Phe Asn Gln Lys Gly Thr Val Arg Thr Lys Tyr Gly
65 70 75 80
Thr Arg Ser Gln Leu Glu Ser Ala Ile His Ala Leu Lys Asn Asn Gly
85 90 95
Val Gln Val Tyr Gly Asp Val Val Met Asn His Lys Gly Gly Ala Asp
100 105 110
Ala Thr Glu Asn Val Leu Ala Val Glu Val Asn Pro Asn Asn Arg Asn
115 120 125
Gln Glu Ile Ser Gly Asp Tyr Thr Ile Glu Ala Trp Thr Lys Phe Asp
130 135 140
Phe Pro Gly Arg Gly Asn Thr Tyr Ser Asp Phe Lys Trp Arg Trp Tyr
145 150 155 160
His Phe Asp Gly Val Asp Trp Asp Gln Ser Arg Gln Phe Gln Asn Arg
165 170 175
Ile Tyr Lys Phe Arg Gly Asp Gly Lys Ala Trp Asp Trp Glu Val Asp
180 185 190
Ser Glu Asn Gly Asn Tyr Asp Tyr Leu Met Tyr Ala Asp Val Asp Met
195 200 205
Asp His Pro Glu Val Val Asn Glu Leu Arg Arg Trp Gly Glu Trp Tyr
210 215 220
Thr Asn Thr Leu Asn Leu Asp Gly Phe Arg Ile Asp Ala Val Lys His
225 230 235 240
Ile Lys Tyr Ser phe Thr Arg Asp Trp Leu Thr His ValArg Asn Ala
245 250 255
Thr Gly Lys Glu Met Phe Ala Val Ala Glu Phe Trp Lys Asn Asp Leu
260 265 270
Gly Ala Leu Glu Asn Tyr Leu Asn Lys Thr Asn Trp Asn His Ser Val
275 280 285
Phe Asp Val Pro Leu His Tyr Asn Leu Tyr Asn Ala Ser Asn Ser Gly
290 295 300
Gly Asn Tyr Asp Met Ala Lys Leu Leu Asn Gly Thr Val Val Gln Lys
305 310 315 320
His Pro Met His Ala Val Thr Phe Val Asp Asn His Asp Ser Gln Pro
325 330 335
Gly Glu Ser Leu Glu Ser Phe Val Gln Glu Trp Phe Lys Pro Leu Ala
340 345 350
Tyr Ala Leu Ile Leu Thr Arg Glu Gln Gly Tyr Pro Ser Val Phe Tyr
355 360 365
Gly Asp Tyr Tyr Gly Ile Pro Thr His Ser Val Pro Ala Met Lys Ala
370 375 380
Lys Ile Asp Pro Ile Leu Glu Ala Arg Gln Asn Phe Ala Tyr Gly Thr
385 390 395 400
Gln His Asp Tyr Phe Asp His His Asn Ile Ile Gly Trp Thr Arg Glu
405 410 415
Gly Asn Thr Thr His Pro Asn Ser Gly Leu Ala Thr Ile Met Ser Asp
420 425 430
Gly Pro Gly Gly Glu Lys Trp Met Tyr Val Gly Gln Asn Lys Ala Gly
435 440 445
Gln Val Trp His Asp Ile Thr Gly Asn Lys Pro Gly Thr Val Thr Ile
450 455 460
Asn Ala Asp Gly Trp Ala Asn Phe Ser Val Asn Gly Gly Ser Val Ser
465 470 475 480
Ile Trp Val Lys Arg
485
(2)SEQ ID NO:3的资料:
(i)序列特征:
(A)长度:514个氨基酸
(B)类型:氨基酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:肽
(xi)序列描述:SEQ ID NO:3:
Ala Ala Pro Phe Asn Gly Thr Met Met Gln Tyr Phe Glu Trp Tyr Leu
1 5 10 15
Pro Asp Asp Gly Thr Leu Trp Thr Lys Val Ala Asn Glu Ala Asn Asn
20 25 30
Leu Ser Ser Leu Gly Ile Thr Ala Leu Trp Leu Pro Pro Ala Tyr Lys
35 40 45
Gly Thr Ser Arg Ser Asp Val Gly Tyr Gly Val Tyr Asp Leu Tyr Asp
50 55 60
Leu Gly Glu Phe Asn Gln Lys Gly Ala Val Arg Thr Lys Tyr Gly Thr
65 70 75 80
Lys Ala Gln Tyr Leu Gln Ala Ile Gln Ala Ala His Ala Ala Gly Met
85 90 95
Gln Val Tyr Ala Asp Val Val Phe Asp His Lys Gly Gly Ala Asp Gly
100 105 110
Thr Glu Trp Val Asp Ala Val Glu Val Asn Pro Ser Asp Arg Asn Gln
115 120 125
Glu Ile Ser Gly Thr Tyr Gln Ile Gln Ala Trp Thr Lys Phe Asp Phe
130 135 140
Pro Gly Arg Gly Asn Thr Tyr Ser Ser Phe Lys Trp Arg Trp Tyr His
145 150 155 160
Phe Asp Gly Val Asp Trp Asp Glu Ser Arg LVs Leu Ser Arg Ile Tyr
165 170 175
Lys Phe Arg Gly Ile Gly Lys Ala Trp Asp Trp Glu Val Asp Thr Glu
180 185 190
Asn Gly Asn Tyr Asp Tyr Leu Met Tyr Ala Asp Leu Asp Met Asp His
195 200 205
Pro Glu Val Val Thr Glu Leu Lys Ser Trp Gly Lys Trp Tyr Val Asn
210 215 220
Thr Thr Asn Ile Asp Gly Phe Arg Leu Asp Ala Val Lys His Ile Lys
225 230 235 240
Phe Ser Phe Phe Pro Asp Trp Leu Ser Asp Val Arg Ser Gln Thr Gly
245 250 255
Lys Pro Leu Phe Thr Val Gly Glu Tyr Trp Ser Tyr Asp Ile Asn Lys
260 265 270
Leu His Asn Tyr Ile Met Lys Thr Asn Gly Thr Met Ser Leu Phe Asp
275 280 285
Ala Pro Leu His Asn Lys Phe Tyr Thr Ala Ser Lys Ser Gly Gly Thr
290 295 300
Phe Asp Met Arg Thr Leu Met Thr Asn Thr Leu Met Lys Asp Gln Pro
305 310 315 320
Thr Leu Ala Val Thr Phe Val Asp Asn His Asp Thr Glu Pro Gly Gln
325 330 335
Ala Leu Gln Ser Trp Val Asp Pro Trp Phe Lys Pro Leu Ala Tyr Ala
340 345 350
Phe Ile Leu Thr Arg Gln Glu Gly Tyr Pro Cys Val Phe Tyr Gly Asp
355 360 365
Tyr Tyr Gly Ile pro Gln Tyr Asn Ile Pro Ser Leu Lys Ser Lys Ile
370 375 380
Asp Pro Leu Leu Ile Ala Arg Arg Asp Tyr Ala Tyr Gly Thr Gln His
385 390 395 400
Asp Tyr Leu Asp His Ser Asp Ile Ile Gly Trp Thr Arg Glu Gly Val
405 410 415
Thr Glu Lys Pro Gly Ser Gly Leu Ala Ala Leu Ile Thr Asp Gly Pro
420 425 430
Gly Gly Ser Lys Trp Met Tyr Val Gly Lys Gln His Ala Gly Lys Val
435 440 445
Phe Tyr Asp Leu Thr Gly Asn Arg Ser Asp Thr Val Thr Ile Asn Ser
450 455 460
Asp Gly Trp Gly Glu Phe Lys Val Asn Gly Gly Ser Val Ser Val Trp
465 470 475 480
Val Pro Arg Lys Thr Thr Val Ser Thr Ile Ala Trp Ser Ile Thr Thr
485 490 495
Arg Pro Trp Thr Asp Glu Phe Val Arg Trp Thr Glu Pro Arg Leu Val
500 505 510
Ala Trp
(2)SEQ ID NO:4的资料:
(i)序列特征:
(A)长度:483个氨基酸
(B)类型:氨基酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:蛋白质
(xi)序列描述:SEQ ID NO:4:
Ala Asn Leu Asn Gly Thr Leu Met Gln Tyr Phe Glu Trp Tyr Met Pro
1 5 10 15
Asn Asp Gly Gln His Trp Arg Arg Leu Gln Asn Asp Ser Ala Tyr Leu
20 25 30
Ala Glu His Gly Ile Thr Ala Val Trp Ile Pro Pro Ala Tyr Lys Gly
35 40 45
Thr Ser Gln Ala Asp Val Gly Tyr Gly Ala Tyr Asp Leu Tyr Asp Leu
50 55 60
Gly Glu Phe His Gln Lys Gly Thr Val Arg Thr Lys Tyr Gly Thr Lys
65 70 75 80
Gly Glu Leu Gln Ser Ala Ile Lys Ser Leu His Ser Arg Asp Ile Asn
85 90 95
Val Tyr Gly Asp Val Val Ile Asn His Lys Gly Gly Ala Asp Ala Thr
100 105 110
Glu Asp Val Thr Ala Val Glu Val Asp Pro Ala Asp Arg Asn Arg Val
115 120 125
Ile Ser Gly Glu His Leu Ile Lys Ala Trp Thr His phe His Phe Pro
130 135 140
Gly Arg Gly Ser Thr Tyr Ser Asp Phe Lys Trp His Trp Tyr His Phe
145 150 155 160
Asp Gly Thr Asp Trp Asp Glu Ser Arg Lys Leu Asn Arg Ile Tyr Lys
165 170 175
Phe Gln Gly Lys Ala Trp Asp Trp Glu Val Ser Asn Glu Asn Gly Asn
180 185 190
Tyr Asp Tyr Leu Met Tyr Ala Asp Ile Asp Tyr Asp His Pro Asp Val
195 200 205
Ala Ala Glu Ile Lys Arg Trp Gly Thr Trp Tyr Ala Asn Glu Leu Gln
210 215 220
Leu Asp Gly Phe Arg Leu Asp Ala Val Lys His Ile Lys Phe Ser Phe
225 230 235 240
Leu Arg Asp Trp Val Asn His Val Arg Glu Lys Thr Gly Lys Glu Met
245 250 255
Phe Thr Val Ala Glu Tyr Trp Gln Asn Asp Leu Gly Ala Leu Glu Asn
260 265 270
Tyr Leu Asn Lys Thr Asn Phe Asn His Ser Val Phe Asp Val Pro Leu
275 280 285
His Tyr Gln Phe His Ala Ala Ser Thr Gln Gly Gly Gly Tyr Asp Met
290 295 300
Arg Lys Leu Leu Asn Gly Thr Val Val Ser Lys His Pro Leu Lys Ser
305 310 315 320
Val Thr Phe Val Asp Asn His Asp Thr Gln Pro Gly Gln Ser Leu Glu
325 330 335
Ser Thr Val Gln Thr Trp Phe Lys Pro Leu Ala Tyr Ala Phe Ile Leu
340 345 350
Thr Arg Glu Ser Gly Tyr Pro Gln Val Phe Tyr Gly Asp Met Tyr Gly
355 360 365
Thr Lys Gly Asp Ser Gln Arg Glu Ile Pro Ala Leu Lys His Lys Ile
370 375 380
Glu pro Ile Leu Lys Ala Arg Lys Gln Tyr Ala Tyr Gly Ala Gln His
385 390 395 400
Asp Tyr Phe Asp His His Asp Ile Val Gly Trp Thr Arg Glu Gly Asp
405 410 415
Ser Ser Val Ala Asn Ser Gly Leu Ala Ala Leu Ile Thr Asp Gly Pro
420 425 430
Gly Gly Ala Lys Arg Met Tyr Val Gly Arg Gln Asn Ala Gly Glu Thr
435 440 445
Trp His Asp Ile Thr Gly Asn Arg Ser Glu Pro Val Val Ile Asn Ser
450 455 460
Glu Gly Trp Gly Glu Phe His Val Asn Gly Gly Ser Val Ser Ile Tyr
465 470 475 480
Val Gln Arg
(2)SEQ ID NO:5的资料:
(i)序列特征:
(A)长度:480个氨基酸
(B)类型:氨基酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:蛋白质
(xi)序列描述:SEQ ID NO:5:
Val Asn Gly Thr Leu Met Gln Tyr Phe Glu Trp Tyr Thr Pro Asn Asp
1 5 10 15
Gly Gln His Trp Lys Arg Leu Gln Asn Asp Ala Glu His Leu Ser Asp
20 25 30
Ile Gly Ile Thr Ala Val Trp Ile Pro Pro Ala Tyr Lys Gly Leu Ser
35 40 45
Gln Ser Asp Asn Gly Tyr Gly Pro Tyr Asp Leu Tyr Asp Leu Gly Glu
50 55 60
Phe Gln Gln Lys Gly Thr Val Arg Thr Lys Tyr Gly Thr Lys Ser Glu
65 70 75 80
Leu Gln Asp Ala Ile Gly Ser Leu His Ser Arg Asn Val Gln Val Tyr
85 90 95
Gly Asp Val Val Leu Asn His Lys Ala Gly Ala Asp Ala Thr Glu Asp
100 105 110
Val Thr Ala Val Glu Val Asn Pro Ala Asn Arg Asn Gln Glu Thr Ser
115 120 125
Glu Glu Tyr Gln Ile Lys Ala Trp Thr Asp Phe Arg Phe Pro Gly Arg
130 135 140
Gly Asn Thr Tyr Ser Asp Phe Lys Trp His Trp Tyr His Phe Asp Gly
145 150 155 160
Ala Asp Trp Asp Glu Ser Arg Lys Ile Ser Arg Ile Phe Lys Phe Arg
165 170 175
Gly Glu Gly Lys Ala Trp Asp Trp Glu Val Ser Ser Glu Asn Gly Asn
180 185 190
Tyr Asp Tyr Leu Met Tyr Ala Asp Val Asp Tyr Asp His Pro Asp Val
195 200 205
Val Ala Glu Thr Lys Lys Trp Gly Ile Trp Tyr Ala Asn Glu Leu Ser
210 215 220
Leu Asp Gly Phe Arg Ile Asp Ala Ala Lys His Ile Lys Phe Ser Phe
225 230 235 240
Leu Arg Asp Trp Val Gln Ala Val Arg Gln Ala Thr Gly Lys Glu Met
245 250 255
Phe Thr Val Ala Glu Tyr Trp Gln Asn Asn Ala Gly Lys Leu Glu Asn
260 265 270
Tyr Leu Asn Lys Thr Ser Phe Asn Gln Ser Val Phe Asp Val Pro Leu
275 280 285
His Phe Asn Leu Gln Ala Ala Ser Ser Gln Gly Gly Gly Tyr Asp Met
290 295 300
Arg Arg Leu Leu Asp Gly Thr Val Val Ser Arg His Pro Glu Lys Ala
305 310 315 320
Val Thr Phe Val Glu Asn His Asp Thr Gln Pro Gly Gln Ser Leu Glu
325 330 335
Ser Thr Val Gln Thr Trp Phe Lys Pro Leu Ala Tyr Ala Phe Ile Leu
340 345 350
Thr Arg Glu Ser Gly Tyr Pro Gln Val Phe Tyr Gly Asp Met Tyr Gly
355 360 365
Thr Lys Gly Thr Ser Pro Lys Glu Ile Pro Ser Leu Lys Asp Asn Ile
370 375 380
Glu Pro Ile Leu Lys Ala Arg Lys Glu Tyr Ala Tyr Gly Pro Gln His
385 390 395 400
Asp Tyr Ile Asp His Pro Asp Val Ile Gly Trp Thr Arg Glu Gly Asp
405 410 415
Ser Ser Ala Ala Lys Ser Gly Leu Ala Ala Leu Ile Thr Asp Gly Pro
420 425 430
Gly Gly Ser Lys Arg Met Tyr Ala Gly Leu Lys Asn Ala Gly Glu Thr
435 440 445
Trp Tyr Asp Ile Thr Gly Asn Arg Ser Asp Thr Val Lys Ile Gly Ser
450 455 460
Asp Gly Trp Gly Glu Phe His Val Asn Asp Gly Ser Val Ser Ile Tyr
465 470 475 480
(2)SEQ ID NO:6的资料:
(i)序列特征:
(A)长度:485个氨基酸
(B)类型:氨基酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:肽
(xi)序列描述:SEQ ID NO:6:
His His Asn Gly Thr Asn Gly Thr Met Met Gln Tyr Phe Glu Trp Tyr
1 5 10 15
Leu Pro Asn Asp Gly Asn His Trp Asn Arg Leu Asn Ser Asp Ala Ser
20 25 30
Asn Leu Lys Ser Lys Gly Ile Thr Ala Val Trp Ile Pro Pro Ala Trp
35 40 45
Lys Gly Ala Ser Gln Asn Asp Val Gly Tyr Gly Ala Tyr Asp Leu Tyr
50 55 60
Asp Leu Gly Glu Phe Asn Gln Lys Gly Thr Val Arg Thr Lys Tyr Gly
65 70 75 80
Thr Arg Ser Gln Leu Gln Ala Ala Val Thr Ser Leu Lys Asn Asn Gly
85 90 95
Ile Gln Val Tyr Gly Asp Val Val Met Asn His Lys Gly Gly Ala Asp
100 105 110
Ala Thr Glu Met Val Arg Ala Val Glu Val Asn Pro Asn Asn Arg Asn
115 120 125
Gln Glu Val Thr Gly Glu Tyr Thr Ile Glu Ala Trp Thr Arg Phe Asp
130 135 140
Phe Pro Gly Arg Gly Asn Thr His Ser Ser Phe Lys Trp Arg Trp Tyr
145 150 155 160
His Phe Asp Gly Val Asp Trp Asp Gln Ser Arg Arg Leu Asn Asn Arg
165 170 175
Ile Tyr Lys Phe Arg Gly His Gly Lys Ala Trp Asp Trp Glu Val Asp
180 185 190
Thr Glu Asn Gly Asn Tyr Asp Tyr Leu Met Tyr Ala Asp Ile Asp Met
195 200 205
Asp His Pro Glu Val Val Asn Glu Leu Arg Asn Trp Gly Val Trp Tyr
210 215 220
Thr Asn Thr Leu Gly Leu Asp Gly Phe Arg Ile Asp Ala Val Lys His
225 230 235 240
Ile Lys Tyr Ser Phe Thr Arg Asp Trp Ile Asn His Val Arg Ser Ala
245 250 255
Thr Gly Lys Asn Met Phe Ala Val Ala Glu Phe Trp Lys Asn Asp Leu
260 265 270
Gly Ala Ile Glu Asn Tyr Leu Gln Lys Thr Asn Trp Asn His Ser Val
275 280 285
Phe Asp Val Pro Leu His Tyr Asn Leu Tyr Asn Ala Ser Lys Ser Gly
290 295 300
Gly Asn Tyr Asp Met Arg Asn Ile Phe Asn Gly Thr Val Val Gln Arg
305 310 315 320
His Pro Ser His Ala Val Thr Phe Val Asp Asn His Asp Ser Gln Pro
325 330 335
Glu Glu Ala Leu Glu Ser Phe Val Glu Glu Trp Phe Lys Pro Leu Ala
340 345 350
Tyr Ala Leu Thr Leu Thr Arg Glu Gln Gly Tyr Pro Ser Val Phe Tyr
355 360 365
Gly Asp Tyr Tyr Gly Ile Pro Thr His Gly Val Pro Ala Met Arg Ser
370 375 380
Lys Ile Asp Pro Ile Leu Glu Ala Arg Gln Lys Tyr Ala Tyr Gly Lys
385 390 395 400
Gln Asn Asp Tyr Leu Asp His His Asn Ile Ile Gly Trp Thr Arg Glu
405 410 415
Gly Asn Thr Ala His Pro Asn Ser Gly Leu Ala Thr Ile Met Ser Asp
420 425 430
Gly Ala Gly Gly Ser Lys Trp Met Phe Val Gly Arg Asn Lys Ala Gly
435 440 445
Gln Val Trp Ser Asp Ile Thr Gly Asn Arg Thr Gly Thr Val Thr Ile
450 455 460
Asn Ala Asp Gly Trp Gly Asn Phe Ser Val Asn Gly Gly Ser Val Ser
465 470 475 480
Ile Trp Val Asn Lys
485
(2)SEQ ID NO:7的资料:
(i)序列特征:
(A)长度:485个氨基酸
(B)类型:氨基酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:肽
(xi)序列描述:SEQ ID NO:7:
His His Asn Gly Thr Asn Gly Thr Met Met Gln Tyr Phe Glu Trp Tyr
1 5 10 15
Leu Pro Asn Asp Gly Asn His Trp Asn Arg Leu Arg Asp Asp Ala Ala
20 25 30
Asn Leu Lys Ser Lys Gly Ile Thr Ala Val Trp Ile Pro Pro Ala Trp
35 40 45
Lys Gly Thr Ser Gln Asn Asp Val Gly Tyr Gly Ala Tyr Asp Leu Tyr
50 55 60
Asp Leu Gly Glu Phe Asn Gln Lys Gly Thr Val Arg Thr Lys Tyr Gly
65 70 75 80
Thr Arg Asn Gln Leu Gln Ala Ala Val Thr Ser Leu Lys Asn Asn Gly
85 90 95
Ile Gln Val Tyr Gly Asp Val Val Met Asn His Lys Gly Gly Ala Asp
100 105 110
Gly Thr Glu Ile Val Asn Ala Val Glu Val Asn Arg Ser Asn Arg Asn
115 120 125
Gln Glu Thr Ser Gly Glu Tyr Ala Ile Glu Ala Trp Thr Lys Phe Asp
130 135 140
Phe Pro Gly Arg Gly Asn Asn His Ser Ser Phe Lys Trp Arg Trp Tyr
145 150 155 160
His Phe Asp Gly Thr Asp Trp Asp Gln Ser Arg Gln Leu Gln Asn Lys
165 170 175
Ile Tyr Lys Phe Arg Gly Thr Gly Lys Ala Trp Asp Trp Glu Val Asp
180 185 190
Thr Glu Asn Gly Asn Tyr Asp Tyr Leu Met Tyr Ala Asp Val Asp Met
195 200 205
Asp His Pro Glu Val Ile His Glu Leu Arg Asn Trp Gly Val Trp Tyr
210 215 220
Thr Asn Thr Leu Asn Leu Asp Gly Phe Arg Ile Asp Ala Val Lys His
225 230 235 240
Ile Lys Tyr Ser Phe Thr Arg Asp Trp Leu Thr His Val Arg Asn Thr
245 250 255
Thr Gly Lys Pro Met Phe Ala Val Ala Glu Phe Trp Lys Asn Asp Leu
260 265 270
Gly Ala Ile Glu Asn Tyr Leu Asn Lys Thr Ser Trp Asn His Ser Val
275 280 285
Phe Asp Val Pro Leu His Tyr Asn Leu Tyr Asn Ala Ser Asn Ser Gly
290 295 300
Gly Tyr Tyr Asp Met Arg Asn Ile Leu Asn Gly Ser Val Val Gln Lys
305 310 315 320
His Pro Thr His Ala Val Thr Phe Val Asp Asn His Asp Ser Gln Pro
325 330 335
Gly Glu Ala Leu Glu Ser Phe Val Gln Gln Trp Phe Lys Pro Leu Ala
340 345 350
Tyr Ala Leu Val Leu Thr Arg Glu Gln Gly Tyr Pro Ser Val Phe Tyr
355 360 365
Gly Asp Tyr Tyr Gly Ile Pro Thr His Gly Val Pro Ala Met Lys Ser
370 375 380
Lys Ile Asp Pro Leu Leu Gln Ala Arg Gln Thr Phe Ala Tyr Gly Thr
385 390 395 400
Gln His Asp Tyr Phe Asp His His Asp Ile Ile Gly Trp Thr Arg Glu
405 410 415
Gly Asn Ser Ser His Pro Asn Ser Gly Leu Ala Thr Ile Met Ser Asp
420 425 430
Gly Pro Gly Gly Asn Lys Trp Met Tyr Val Gly Lys Asn Lys Ala Gly
435 440 445
Gln Val Trp Arg Asp Ile Thr Gly Asn Arg Thr Gly Thr Val Thr Ile
450 455 460
Asn Ala Asp Gly Trp Gly Asn Phe Ser Val Asn Gly Gly Ser Val Ser
465 470 475 480
Val Trp Val Lys Gln
485
(2)SEQ ID NO:8的资料:
(i)序列特征:
(A)长度:485个氨基酸
(B)类型:氨基酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:肽
(xi)序列描述:SEQ ID NO:8:
His His Asn Gly Thr Asn Gly Thr Met Met Gln Tyr Phe Glu Trp His
1 5 10 15
Leu Pro Asn Asp Gly Asn His Trp Asn Arg Leu Arg Asp Asp Ala Ser
20 25 30
Asn Leu Arg Asn Arg Gly Ile Thr Ala Ile Trp Ile Pro Pro Ala Trp
35 40 45
Lys Gly Thr Ser Gln Asn Asp Val Gly Tyr Gly Ala Tyr Asp Leu Tyr
50 55 60
Asp Leu Gly Glu Phe Asn Gln Lys Gly Thr Val Arg Thr Lys Tyr Gly
65 70 75 80
Thr Arg Ser Gln Leu Glu Ser Ala Ile His Ala Leu Lys Asn Asn Gly
85 90 95
Val Gln Val Tyr Gly Asp Val Val Met Asn His Lys Gly Gly Ala Asp
100 105 110
Ala Thr Glu Asn Val Leu Ala Val Glu Val Asn Pro Asn Asn Arg Asn
115 120 125
Gln Glu Ile Ser Gly Asp Tyr Thr Ile Glu Ala Trp Thr Lys Phe Asp
130 135 140
phe pro Gly Arg Gly Asn Thr Tyr Ser Asp phe Lys Trp Arg Trp Tyr
145 150 155 160
His Phe Asp Gly Val Asp Trp Asp Gln Ser Arg Gln Phe Gln Asn Arg
165 170 175
Ile Tyr Lys Phe Arg Gly Asp Gly Lys Ala Trp Asp Trp Glu Val Asp
180 185 190
Ser Glu Asn Gly Asn Tyr Asp Tyr Leu Met Tyr Ala Asp Val Asp Met
195 200 205
Asp His Pro Glu Val Val Asn Glu Leu Arg Arg Trp Gly Glu Trp Tyr
210 215 220
Thr Asn Thr Leu Asn Leu Asp Gly Phe Arg Ile Asp Ala Val Lys His
225 230 235 240
Ile Lys Tyr Ser Phe Thr Arg Asp Trp Leu Thr His Val Arg Asn Ala
245 250 255
Thr Gly Lys Glu Met Phe Ala Val Ala Glu Phe Trp Lys Asn Asp Leu
260 265 270
Gly Ala Leu Glu Asn Tyr Leu Asn Lys Thr Asn Trp Asn His Ser Val
275 280 285
Phe Asp Val Pro Leu His Tyr Asn Leu Tyr Asn Ala Ser Asn Ser Gly
290 295 300
Gly Asn Tyr Asp Met Ala Lys Leu Leu Asn Gly Thr Val Val Gln Lys
305 310 315 320
His Pro Met His Ala Val Thr Phe Val Asp Asn H1s Asp Ser Gln Pro
325 330 335
Gly Glu Ser Leu Glu Ser Phe Val Gln Glu Trp Phe Lys Pro Leu Ala
340 345 350
Tyr Ala Leu Ile Leu Thr Arg Glu Gln Gly Tyr Pro Ser Val Phe Tyr
355 360 365
Gly Asp Tyr Tyr Gly Ile Pro Thr His Ser Val Pro Ala Met Lys Ala
370 375 380
Lys Ile Asp Pro Ile Leu Glu Ala Arg Gln Asn Phe Ala Tyr Gly Thr
385 390 395 400
Gln His Asp Tyr Phe Asp His His Asn Ile Ile Gly Trp Thr Arg Glu
405 410 415
Gly Asn Thr Thr His Pro Asn Ser Gly Leu Ala Thr Ile Met Ser Asp
420 425 430
Gly Pro Gly Gly Glu Lys Trp Met Tyr Val Gly Gln Asn Lys Ala Gly
435 440 445
Gln Val Trp His Asp Ile Thr Gly Asn Lys Pro Gly Thr Val Thr Ile
450 455 460
Asn Ala Asp Gly Trp Ala Asn Phe Ser Val Asn Gly Gly Ser Val Ser
465 470 475 480
Ile Trp Val Lys Arg
485
(2)SEQ ID NO:9的资料:
(i)序列特征:
(A)长度:1455个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:DNA(基因组)
(xi)序列描述:SEQ ID NO:9:
CATCATAATG GAACAAATGG TACTATGATG CAATATTTCG AATGGTATTT GCCAAATGAC 60
GGGAATCATT GGAACAGGTT GAGGGATGAC GCAGCTAACT TAAAGAGTAA AGGGATAACA 120
GCTGTATGGA TCCCACCTGC ATGGAAGGGG ACTTCCCAGA ATGATGTAGG TTATGGAGCC 180
TATGATTTAT ATGATCTTGG AGAGTTTAAC CAGAAGGGGA CGGTTCGTAC AAAATATGGA 240
ACACGCAACC AGCTACAGGC TGCGGTGACC TCTTTAAAAA ATAACGGCAT TCAGGTATAT 300
GGTGATGTCG TCATGAATCA TAAAGGTGGA GCAGATGGTA CGGAAATTGT AAATGCGGTA 360
GAAGTGAATC GGAGCAACCG AAACCAGGAA ACCTCAGGAG AGTATGCAAT AGAAGCGTGG 420
ACAAAGTTTG ATTTTCCTGG AAGAGGAAAT AACCATTCCA GCTTTAAGTG GCGCTGGTAT 480
CATTTTGATG GGACAGATTG GGATCAGTCA CGCCAGCTTC AAAACAAAAT ATATAAATTC 540
AGGGGAACAG GCAAGGCCTG GGACTGGGAA GTCGATACAG AGAATGGCAA CTATGACTAT 600
CTTATGTATG CAGACGTGGA TATGGATCAC CCAGAAGTAA TACATGAACT TAGAAACTGG 660
GGAGTGTGGT ATACGAATAC ACTGAACCTT GATGGATTTA GAATAGATGC AGTGAAACAT 720
ATAAAATATA GCTTTACGAG AGATTGGCTT ACACATGTGC GTAACACCAC AGGTAAACCA 780
ATGTTTGCAG TGGCTGAGTT TTGGAAAAAT GACCTTGGTG CAATTGAAAA CTATTTGAAT 840
AAAACAAGTT GGAATCACTC GGTGTTTGAT GTTCCTCTCC ACTATAATTT GTACAATGCA 900
TCTAATAGCG GTGGTTATTA TGATATGAGA AATATTTTAA ATGGTTCTGT GGTGCAAAAA 960
CATCCAACAC ATGCCGTTAC TTTTGTTGAT AACCATGATT CTCAGCCCGG GGAAGCATTG 1020
GAATCCTTTG TTCAACAATG GTTTAAACCA CTTGCATATG CATTGGTTCT GACAAGGGAA 1080
CAAGGTTATC CTTCCGTATT TTATGGGGAT TACTACGGTA TCCCAACCCA TGGTGTTCCG 1140
GCTATGAAAT CTAAAATAGA CCCTCTTCTG CAGGCACGTC AAACTTTTGC CTATGGTACG 1200
CAGCATGATT ACTTTGATCA TCATGATATT ATCGGTTGGA CAAGAGAGGG AAATAGCTCC 1260
CATCCAAATT CAGGCCTTGC CACCATTATG TCAGATGGTC CAGGTGGTAA CAAATGGATG 1320
TATGTGGGGA AAAATAAAGC GGGACAAGTT TGGAGAGATA TTACCGGAAA TAGGACAGGC 1380
ACCGTCACAA TTAATGCAGA CGGATGGGGT AATTTCTCTG TTAATGGAGG GTCCGTTTCG 1440
GTTTGGGTGA AGCAA 1455
(2)SEQ ID NO:10的资料:
(i)序列特征:
(A)长度:1455个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:DNA(基因组)
(xi)序列描述:SEQ ID NO:10:
CATCATAATG GGACAAATGG GACGATGATG CAATACTTTG AATGGCACTT GCCTAATGAT 60
GGGAATCACT GGAATAGATT AAGAGATGAT GCTAGTAATC TAAGAAATAG AGGTATAACC 120
GCTATTTGGA TTCCGCCTGC CTGGAAAGGG ACTTCGCAAA ATGATGTGGG GTATGGAGCC 180
TATGATCTTT ATGATTTAGG GGAATTTAAT CAAAAGGGGA CGGTTCGTAC TAAGTATGGG 240
ACACGTAGTC AATTGGAGTC TGCCATCCAT GCTTTAAAGA ATAATGGCGT TCAAGTTTAT 300
GGGGATGTAG TGATGAACCA TAAAGGAGGA GCTGATGCTA CAGAAAACGT TCTTGCTGTC 360
GAGGTGAATC CAAATAACCG GAATCAAGAA ATATCTGGGG ACTACACAAT TGAGGCTTGG 420
ACTAAGTTTG ATTTTCCAGG GAGGGGTAAT ACATACTCAG ACTTTAAATG GCGTTGGTAT 480
CATTTCGATG GTGTAGATTG GGATCAATCA CGACAATTCC AAAATCGTAT CTACAAATTC 540
CGAGGTGATG GTAAGGCATG GGATTGGGAA GTAGATTCGG AAAATGGAAA TTATGATTAT 600
TTAATGTATG CAGATGTAGA TATGGATCAT CCGGAGGTAG TAAATGAGCT TAGAAGATGG 660
GGAGAATGGT ATACAAATAC ATTAAATCTT GATGGATTTA GGATCGATGC GGTGAAGCAT 720
ATTAAATATA GCTTTACACG TGATTGGTTG ACCCATGTAA GAAACGCAAC GGGAAAAGAA 780
ATGTTTGCTG TTGCTGAATT TTGGAAAAAT GATTTAGGTG CCTTGGAGAA CTATTTAAAT 840
AAAACAAACT GGAATCATTC TGTCTTTGAT GTCCCCCTTC ATTATAATCT TTATAACGCG 900
TCAAATAGTG GAGGCAACTA TGACATGGCA AAACTTCTTA ATGGAACGGT TGTTCAAAAG 960
CATCCAATGC ATGCCGTAAC TTTTGTGGAT AATCACGATT CTCAACCTGG GGAATCATTA 1020
GAATCATTTG TACAAGAATG GTTTAAGCCA CTTGCTTATG CGCTTATTTT AACAAGAGAA 1080
CAAGGCTATC CCTCTGTCTT CTATGGTGAC TACTATGGAA TTCCAACACA TAGTGTCCCA 1140
GCAATGAAAG CCAAGATTGA TCCAATCTTA GAGGCGCGTC AAAATTTTGC ATATGGAACA 1200
CAACATGATT ATTTTGACCA TCATAATATA ATCGGATGGA CACGTGAAGG AAATACCACG 1260
CATCCCAATT CAGGACTTGC GACTATCATG TCGGATGGGC CAGGGGGAGA GAAATGGATG 1320
TACGTAGGGC AAAATAAAGC AGGTCAAGTT TGGCATGACA TAACTGGAAA TAAACCAGGA 1380
ACAGTTACGA TCAATGCAGA TGGATGGGCT AATTTTTCAG TAAATGGAGG ATCTGTTTCC 1440
ATTTGGGTGA AACGA 1455
(2)SEQ ID NO:11的资料:
(i)序列特征:
(A)长度:1548个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:DNA(基因组)
(xi)序列描述:SEQ ID NO:11:
GCCGCACCGT TTAACGGCAC CATGATGCAG TATTTTGAAT GGTACTTGCC GGATGATGGC 60
ACGTTATGGA CCAAAGTGGC CAATGAAGCC AACAACTTAT CCAGCCTTGG CATCACCGCT 120
CTTTGGCTGC CGCCCGCTTA CAAAGGAACA AGCCGCAGCG ACGTAGGGTA CGGAGTATAC 180
GACTTGTATG ACCTCGGCGA ATTCAATCAA AAAGGGACCG TCCGCACAAA ATACGGAACA 240
AAAGCTCAAT ATCTTCAAGC CATTCAAGCC GCCCACGCCG CTGGAATGCA AGTGTACGCC 300
GATGTCGTGT TCGACCATAA AGGCGGCGCT GACGGCACGG AATGGGTGGA CGCCGTCGAA 360
GTCAATCCGT CCGACCGCAA CCAAGAAATC TCGGGCACCT ATCAAATCCA AGCATGGACG 420
AAATTTGATT TTCCCGGGCG GGGCAACACC TACTCCAGCT TTAAGTGGCG CTGGTACCAT 480
TTTGACGGCG TTGATTGGGA CGAAAGCCGA AAATTGAGCC GCATTTACAA ATTCCGCGGC 540
ATCGGCAAAG CGTGGGATTG GGAAGTAGAC ACGGAAAACG GAAACTATGA CTACTTAATG 600
TATGCCGACC TTGATATGGA TCATCCCGAA GTCGTGACCG AGCTGAAAAA CTGGGGGAAA 660
TGGTATGTCA ACACAACGAA CATTGATGGG TTCCGGCTTG ATGCCGTCAA GCATATTAAG 720
TTCAGTTTTT TTCCTGATTG GTTGTCGTAT GTGCGTTCTC AGACTGGCAA GCCGCTATTT 780
ACCGTCGGGG AATATTGGAG CTATGACATC AACAAGTTGC ACAATTACAT TACGAAAACA 840
GACGGAACGA TGTCTTTGTT TGATGCCCCG TTACACAACA AATTTTATAC CGCTTCCAAA 900
TCAGGGGGCG CATTTGATAT GCGCACGTTA ATGACCAATA CTCTCATGAA AGATCAACCG 960
ACATTGGCCG TCACCTTCGT TGATAATCAT GACACCGAAC CCGGCCAAGC GCTGCAGTCA 1020
TGGGTCGACC CATGGTTCAA ACCGTTGGCT TACGCCTTTA TTCTAACTCG GCAGGAAGGA 1080
TACCCGTGCG TCTTTTATGG TGACTATTAT GGCATTCCAC AATATAACAT TCCTTCGCTG 1140
AAAAGCAAAA TCGATCCGCT CCTCATCGCG CGCAGGGATT ATGCTTACGG AACGCAACAT 1200
GATTATCTTG ATCACTCCGA CATCATCGGG TGGACAAGGG AAGGGGGCAC TGAAAAACCA 1260
GGATCCGGAC TGGCCGCACT GATCACCGAT GGGCCGGGAG GAAGCAAATG GATGTACGTT 1320
GGCAAACAAC ACGCTGGAAA AGTGTTCTAT GACCTTACCG GCAACCGGAG TGACACCGTC 1380
ACCATCAACA GTGATGGATG GGGGGAATTC AAAGTCAATG GCGGTTCGGT TTCGGTTTGG 1440
GTTCCTAGAA AAACGACCGT TTCTACCATC GCTCGGCCGA TCACAACCCG ACCGTGGACT 1500
GGTGAATTCG TCCGTTGGAC CGAACCACGG TTGGTGGCAT GGCCTTGA 1548
(2)SEQ ID NO:12的资料:
(i)序列特征:
(A)长度:1920个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:DNA(基因组)
(ix)特性:
(A)名称/关键词:CDS
(B)位置:421...1872
(xi)序列描述:SEQ ID NO:12:
CGGAAGATTG GAAGTACAAA AATAAGCAAA AGATTGTCAA TCATGTCATG AGCCATGCGG 60
GAGACGGAAA AATCGTCTTA ATGCACGATA TTTATGCAAC GTTCGCAGAT GCTGCTGAAG 120
AGATTATTAA AAAGCTGAAA GCAAAAGGCT ATCAATTGGT AACTGTATCT CAGCTTGAAG 180
AAGTGAAGAA GCAGAGAGGC TATTGAATAA ATGAGTAGAA GCGCCATATC GGCGCTTTTC 240
TTTTGGAAGA AAATATAGGG AAAATGGTAC TTGTTAAAAA TTCGGAATAT TTATACAACA 300
TCATATGTTT CACATTGAAA GGGGAGGAGA ATCATGAAAC AACAAAAACG GCTTTACGCC 360
CGATTGCTGA CGCTGTTATT TGCGCTCATC TTCTTGCTGC CTCATTCTGC AGCAGCGGCG 420
GCA AAT CTT AAT GGG ACG CTG ATG CAG TAT TTT GAA TGG TAC ATG CCC 468
AAT GAC GGC CAA CAT TGG AGG CGT TTG CAA AAC GAC TCG GCA TAT TTG 516
GCT GAA CAC GGT ATT ACT GCC GTC TGG ATT CCC CCG GCA TAT AAG GGA 564
ACG AGC CAA GCG GAT GTG GGC TAC GGT GCT TAC GAC CTT TAT GAT TTA 612
GGG GAG TTT CAT CAA AAA GGG ACG GTT CGG ACA AAG TAC GGC ACA AAA 660
GGA GAG CTG CAA TCT GCG ATC AAA AGT CTT CAT TCC CGC GAC ATT AAC 708
GTT TAC GGG GAT GTG GTC ATC AAC CAC AAA GGC GGC GCT GAT GCG ACC 756
GAA GAT GTA ACC GCG GTT GAA GTC GAT CCC GCT GAC CGC AAC CGC GTA 804
ATT TCA GGA GAA CAC CTA ATT AAA GCC TGG ACA CAT TTT CAT TTT CCG 852
GGG CGC GGC AGC ACA TAC AGC GAT TTT AAA TGG CAT TGG TAC CAT TTT 900
GAC GGA ACC GAT TGG GAC GAG TCC CGA AAG CTG AAC CGC ATC TAT AAG 948
TTT CAA GGA AAG GCT TGG GAT TGG GAA GTT TCC AAT GAA AAC GGC AAC 996
TAT GAT TAT TTG ATG TAT GCC GAC ATC GAT TAT GAC CAT CCT GAT GTC 1044
GCA GCA GAA ATT AAG AGA TGG GGC ACT TGG TAT GCC AAT GAA CTG CAA 1092
TTG GAC GGT TTC CGT CTT GAT GCT GTC AAA CAC ATT AAA TTT TCT TTT 1140
TTG CGG GAT TGG GTT AAT CAT GTC AGG GAA AAA ACG GGG AAG GAA ATG 1188
TTT ACG GTA GCT GAA TAT TGG CAG AAT GAC TTG GGC GCG CTG GAA AAC 1236
TAT TTG AAC AAA ACA AAT TTT AAT CAT TCA GTG TTT GAC GTG CCG CTT 1284
CAT TAT CAG TTC CAT GCT GCA TCG ACA CAG GGA GGC GGC TAT GAT ATG 1332
AGG AAA TTG CTG AAC GGT ACG GTC GTT TCC AAG CAT CCG TTG AAA TCG 1380
GTT ACA TTT GTC GAT AAC CAT GAT ACA CAG CCG GGG CAA TCG CTT GAG 1428
TCG ACT GTC CAA ACA TGG TTT AAG CCG CTT GCT TAC GCT TTT ATT CTC 1476
ACA AGG GAA TCT GGA TAC CCT CAG GTT TTC TAC GGG GAT ATG TAC GGG 1524
ACG AAA GGA GAC TCC CAG CGC GAA ATT CCT GCC TTG AAA CAC AAA ATT 1572
GAA CCG ATC TTA AAA GCG AGA AAA CAG TAT GCG TAC GGA GCA CAG CAT 1620
GAT TAT TTC GAC CAC CAT GAC ATT GTC GGC TGG ACA AGG GAA GGC GAC 1668
AGC TCG GTT GCA AAT TCA GGT TTG GCG GCA TTA ATA ACA GAC GGA CCC 1716
GGT GGG GCA AAG CGA ATG TAT GTC GGC CGG CAA AAC GCC GGT GAG ACA 1764
TGG CAT GAC ATT ACC GGA AAC CGT TCG GAG CCG GTT GTC ATC AAT TCG 1812
GAA GGC TGG GGA GAG TTT CAC GTA AAC GGC GGG TCG GTT TCA ATT TAT 1860
GTT CAA AGA TAG AAGAGCAGAG AGGACGGATT TCCTGAAGGA AATCCGTTTT 1912
TTTATTTT 1920
(2)SEQ ID NO:12的资料:
(i)序列特征:
(A)长度:2084个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:DNA(基因组)
(ix)特性:
(A)名称/关键词:CDS
(B)位置:343...1794
(xi)序列描述:SEQ ID NO:12:
GCCCCGCACA TACGAAAAGA CTGGCTGAAA ACATTGAGCC TTTGATGACT GATGATTTGG 60
CTGAAGAAGT GGATCGATTG TTTGAGAAAA GAAGAAGACC ATAAAAATAC CTTGTCTGTC 120
ATCAGACAGG GTATTTTTTA TGCTGTCCAG ACTGTCCGCT GTGTAAAAAT AAGGAATAAA 180
GGGGGGTTGT TATTATTTTA CTGATATGTA AAATATAATT TGTATAAGAA AATGAGAGGG 240
AGAGGAAACA TGATTCAAAA ACGAAAGCGG ACAGTTTCGT TCAGACTTGT GCTTATGTGC 300
ACGCTGTTAT TTGTCAGTTT GCCGATTACA AAAACATCAG CC GTA AAT GGC ACG 354
CTG ATG CAG TAT TTT GAA TGG TAT ACG CCG AAC GAC GGC CAG CAT TGG 402
AAA CGA TTG CAG AAT GAT GCG GAA CAT TTA TCG GAT ATC GGA ATC ACT 450
GCC GTC TGG ATT CCT CCC GCA TAC AAA GGA TTG AGC CAA TCC GAT AAC 498
GGA TAC GGA CCT TAT GAT TTG TAT GAT TTA GGA GAA TTC CAG CAA AAA 546
GGG ACG GTC AGA ACG AAA TAC GGC ACA AAA TCA GAG CTT CAA GAT GCG 594
ATC GGC TCA CTG CAT TCC CGG AAC GTC CAA GTA TAC GGA GAT GTG GTT 642
TTG AAT CAT AAG GCT GGT GCT GAT GCA ACA GAA GAT GTA ACT GCC GTC 690
GAA GTC AAT CCG GCC AAT AGA AAT CAG GAA ACT TCG GAG GAA TAT CAA 738
ATC AAA GCG TGG ACG GAT TTT CGT TTT CCG GGC CGT GGA AAC ACG TAC 786
AGT GAT TTT AAA TGG CAT TGG TAT CAT TTC GAC GGA GCG GAC TGG GAT 834
GAA TCC CGG AAG ATC AGC CGC ATC TTT AAG TTT CGT GGG GAA GGA AAA 882
GCG TGG GAT TGG GAA GTA TCA AGT GAA AAC GGC AAC TAT GAC TAT TTA 930
ATG TAT GCT GAT GTT GAC TAC GAC CAC CCT GAT GTC GTG GCA GAG ACA 978
AAA AAA TGG GGT ATC TGG TAT GCG AAT GAA CTG TCA TTA GAC GGC TTC 1026
CGT ATT GAT GCC GCC AAA CAT ATT AAA TTT TCA TTT CTG CGT GAT TGG 1074
GTT CAG GCG GTC AGA CAG GCG ACG GGA AAA GAA ATG TTT ACG GTT GCG 1122
GAG TAT TGG CAG AAT AAT GCC GGG AAA CTC GAA AAC TAC TTG AAT AAA 1170
ACA AGC TTT AAT CAA TCC GTG TTT GAT GTT CCG CTT CAT TTC AAT TTA 1218
CAG GCG GCT TCC TCA CAA GGA GGC GGA TAT GAT ATG AGG CGT TTG CTG 1266
GAC GGT ACC GTT GTG TCC AGG CAT CCG GAA AAG GCG GTT ACA TTT GTT 1314
GAA AAT CAT GAC ACA CAG CCG GGA CAG TCA TTG GAA TCG ACA GTC CAA 1362
ACT TGG TTT AAA CCG CTT GCA TAC GCC TTT ATT TTG ACA AGA GAA TCC 1410
GGT TAT CCT CAG GTG TTC TAT GGG GAT ATG TAC GGG ACA AAA GGG ACA 1458
TCG CCA AAG GAA ATT CCC TCA CTG AAA GAT AAT ATA GAG CCG ATT TTA 1506
AAA GCG CGT AAG GAG TAC GCA TAC GGG CCC CAG CAC GAT TAT ATT GAC 1554
CAC CCG GAT GTG ATC GGA TGG ACG AGG GAA GGT GAC AGC TCC GCC GCC 1602
AAA TCA GGT TTG GCC GCT TTA ATC ACG GAC GGA CCC GGC GGA TCA AAG 1650
CGG ATG TAT GCC GGC CTG AAA AAT GCC GGC GAG ACA TGG TAT GAC ATA 1698
ACG GGC AAC CGT TCA GAT ACT GTA AAA ATC GGA TCT GAC GGC TGG GGA 1746
GAG TTT CAT GTA AAC GAT GGG TCC GTC TCC ATT TAT GTT CAG AAA TAA 1794
GGTAATAAAA AAACACCTCC AAGCTGAGTG CGGGTATCAG CTTGGAGGTG CGTTTATTTT 1854
TTCAGCCGTA TGACAAGGTC GGCATCAGGT GTGACAAATA CGGTATGCTG GCTGTCATAG 1914
GTGACAAATC CGGGTTTTGC GCCGTTTGGC TTTTTCACAT GTCTGATTTT TGTATAATCA 1974
ACAGGCACGG AGCCGGAATC TTTCGCCTTG GAAAAATAAG CGGCGATCGT AGCTGCTTCC 2034
AATATGGATT GTTCATCGGG ATCGCTGCTT TTAATCACAA CGTGGGATCC 2084
(2)SEQ ID NO:13的资料:
(i)序列特征:
(A)长度:1455个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:DNA(基因组)
(xi)序列描述:SEQ ID NO:13:
CATCATAATG GAACAAATGG TACTATGATG CAATATTTCG AATGGTATTT GCCAAATGAC 60
GGGAATCATT GGAACAGGTT GAGGGATGAC GCAGCTAACT TAAAGAGTAA AGGGATAACA 120
GCTGTATGGA TCCCACCTGC ATGGAAGGGG ACTTCCCAGA ATGATGTAGG TTATGGAGCC 180
TATGATTTAT ATGATCTTGG AGAGTTTAAC CAGAAGGGGA CGGTTCGTAC AAAATATGGA 240
ACACGCAACC AGCTACAGGC TGCGGTGACC TCTTTAAAAA ATAACGGCAT TCAGGTATAT 300
GGTGATGTCG TCATGAATCA TAAAGGTGGA GCAGATGGTA CGGAAATTGT AAATGCGGTA 360
GAAGTGAATC GGAGCAACCG AAACCAGGAA ACCTCAGGAG AGTATGCAAT AGAAGCGTGG 420
ACAAAGTTTG ATTTTCCTGG AAGAGGAAAT AACCATTCCA GCTTTAAGTG GCGCTGGTAT 480
CATTTTGATG GGACAGATTG GGATCAGTCA CGCCAGCTTC AAAACAAAAT ATATAAATTC 540
AGGGGAACAG GCAAGGCCTG GGACTGGGAA GTCGATACAG AGAATGGCAA CTATGACTAT 600
CTTATGTATG CAGACGTGGA TATGGATCAC CCAGAAGTAA TACATGAACT TAGAAACTGG 660
GGAGTGTGGT ATACGAATAC ACTGAACCTT GATGGATTTA GAATAGATGC AGTGAAACAT 720
ATAAAATATA GCTTTACGAG AGATTGGCTT ACACATGTGC GTAACACCAC AGGTAAACCA 780
ATGTTTGCAG TGGCTGAGTT TTGGAAAAAT GACCTTGGTG CAATTGAAAA CTATTTGAAT 840
AAAACAAGTT GGAATCACTC GGTGTTTGAT GTTCCTCTCC ACTATAATTT GTACAATGCA 900
TCTAATAGCG GTGGTTATTA TGATATGAGA AATATTTTAA ATGGTTCTGT GGTGCAAAAA 960
CATCCAACAC ATGCCGTTAC TTTTGTTGAT AACCATGATT CTCAGCCCGG GGAAGCATTG 1020
GAATCCTTTG TTCAACAATG GTTTAAACCA CTTGCATATG CATTGGTTCT GACAAGGGAA 1080
CAAGGTTATC CTTCCGTATT TTATGGGGAT TACTACGGTA TCCCAACCCA TGGTGTTCCG 1140
GCTATGAAAT CTAAAATAGA CCCTCTTCTG CAGGCACGTC AAACTTTTGC CTATGGTACG 1200
CAGCATGATT ACTTTGATCA TCATGATATT ATCGGTTGGA CAAGAGAGGG AAATAGCTCC 1260
CATCCAAATT CAGGCCTTGC CACCATTATG TCAGATGGTC CAGGTGGTAA CAAATGGATG 1320
TATGTGGGGA AAAATAAAGC GGGACAAGTT TGGAGAGATA TTACCGGAAA TAGGACAGGC 1380
ACCGTCACAA TTAATGCAGA CGGATGGGGT AATTTCTCTG TTAATGGAGG GTCCGTTTCG 1440
GTTTGGGTGA AGCAA 1455
(2)SEQ ID NO:14的资料:
(i)序列特征:
(A)长度:1455个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:DNA(基因组)
(xi)序列描述:SEQ ID NO:14:
CATCATAATG GGACAAATGG GACGATGATG CAATACTTTG AATGGCACTT GCCTAATGAT 60
GGGAATCACT GGAATAGATT AAGAGATGAT GCTAGTAATC TAAGAAATAG AGGTATAACC 120
GCTATTTGGA TTCCGCCTGC CTGGAAAGGG ACTTCGCAAA ATGATGTGGG GTATGGAGCC 180
TATGATCTTT ATGATTTAGG GGAATTTAAT CAAAAGGGGA CGGTTCGTAC TAAGTATGGG 240
ACACGTAGTC AATTGGAGTC TGCCATCCAT GCTTTAAAGA ATAATGGCGT TCAAGTTTAT 300
GGGGATGTAG TGATGAACCA TAAAGGAGGA GCTGATGCTA CAGAAAACGT TCTTGCTGTC 360
GAGGTGAATC CAAATAACCG GAATCAAGAA ATATCTGGGG ACTACACAAT TGAGGCTTGG 420
ACTAAGTTTG ATTTTCCAGG GAGGGGTAAT ACATACTCAG ACTTTAAATG GCGTTGGTAT 480
CATTTCGATG GTGTAGATTG GGATCAATCA CGACAATTCC AAAATCGTAT CTACAAATTC 540
CGAGGTGATG GTAAGGCATG GGATTGGGAA GTAGATTCGG AAAATGGAAA TTATGATTAT 600
TTAATGTATG CAGATGTAGA TATGGATCAT CCGGAGGTAG TAAATGAGCT TAGAAGATGG 660
GGAGAATGGT ATACAAATAC ATTAAATCTT GATGGATTTA GGATCGATGC GGTGAAGCAT 720
ATTAAATATA GCTTTACACG TGATTGGTTG ACCCATGTAA GAAACGCAAC GGGAAAAGAA 780
ATGTTTGCTG TTGCTGAATT TTGGAAAAAT GATTTAGGTG CCTTGGAGAA CTATTTAAAT 840
AAAACAAACT GGAATCATTC TGTCTTTGAT GTCCCCCTTC ATTATAATCT TTATAACGCG 900
TCAAATAGTG GAGGCAACTA TGACATGGCA AAACTTCTTA ATGGAACGGT TGTTCAAAAG 960
CATCCAATGC ATGCCGTAAC TTTTGTGGAT AATCACGATT CTCAACCTGG GGAATCATTA 1020
GAATCATTTG TACAAGAATG GTTTAAGCCA CTTGCTTATG CGCTTATTTT AACAAGAGAA 1080
CAAGGCTATC CCTCTGTCTT CTATGGTGAC TACTATGGAA TTCCAACACA TAGTGTCCCA 1140
GCAATGAAAG CCAAGATTGA TCCAATCTTA GAGGCGCGTC AAAATTTTGC ATATGGAACA 1200
CAACATGATT ATTTTGACCA TCATAATATA ATCGGATGGA CACGTGAAGG AAATACCACG 1260
CATCCCAATT CAGGACTTGC GACTATCATG TCGGATGGGC CAGGGGGAGA GAAATGGATG 1320
TACGTAGGGC AAAATAAAGC AGGTCAAGTT TGGCATGACA TAACTGGAAA TAAACCAGGA 1380
ACAGTTACGA TCAATGCAGA TGGATGGGCT AATTTTTCAG TAAATGGAGG ATCTGTTTCC 1440
ATTTGGGTGA AACGA 1455
(2)SEQ ID NO:15的资料:
(i)序列特征:
(A)长度:60个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=正向引物FSA
(ix)特性:
(A)名称/关键词:misc-feature
(B)位置:22-27、29、31-33、41
(C)其他资料:/Note=1:35%A,65%C
2:83%G,17%A
3:63%G,37%T
4:86%G,14%A
5:85%G,15%C
6:50%T,50%C
7:95%A,5%G
8:58%G,37%A,5%T
9:86%C,13%A,1%G
10:83%T,17%G
11:92%G,8%C
(xi)序列描述:SEQ ID NO:15:
caaaatcgta tctacaaatt c123456a7g 8910tgggatt
11ggaagtaga ttcggaaaat
60
(2)SEQ ID NO:16的资料:
(i)序列特征:
(A)长度:21个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=反向引物RSA
(xi)序列描述:SEQ ID NO:16:
gaatttgtag atacgatttt g
21
(2)SEQ ID NO:17的资料:
(i)序列特征:
(A)长度:24个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物B1
(xi)序列描述:SEQ ID NO:17:
CGATTGCTGA CGCTGTTATT TGCG 24
(2)SEQ ID NO:18的资料:
(i)序列特征:
(A)长度:24个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物Y2
(xi)序列描述:SEQ ID NO:18:
CTTGTTCCCT TGTCAGAACC AATG 24
(2)SEQ ID NO:19的资料:
(i)序列特征:
(A)长度:30个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物101458
(xi)序列描述:SEQ ID NO:19:
GTCATAGTTG CCGAAATCTG TATCGACTTC 30
(2)SEQ ID NO:20的资料:
(i)序列特征:
(A)长度:35个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物101638
(xi)序列描述:SEQ ID NO:20:
CCCAGTCCCA CGTACGTCCC CTGAATTTATATA TTTTG 35
(2)SEQ ID NO:21的资料:
(i)序列特征:
(A)长度:21个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=Oligo 1
(A)名称/关键词:misc-feature
(B)位置:12
(D)其他资料:/Note=N=25%A、25%C、25%G、25%T
(xi)序列描述:SEQ ID NO:21:
CCCAGTCCCA GNTCTTTCCC CTGAATTTAT ATATTTTG 38
(2)SEQ ID NO:22的资料:
(i)序列特征:
(A)长度:25个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物X2
(xi)序列描述:SEQ ID NO:22:
GCGTGGACAA AGTTTGATTT TCCTG 25
(2)SEQ ID NO:23的资料:
(i)序列特征:
(A)长度:21个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA01
(xi)序列描述:SEQ ID NO:23:
(2)SEQ ID NO:24的资料:
(i)序列特征:
(A)长度:24个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA03
(xi)序列描述:SEQ ID NO:24:
GCATTGGATG CTTTTGAACA ACCG 24
(2)SEQ ID NO:25的资料:
(i)序列特征:
(A)长度:26个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA07
(xi)序列描述:SEQ ID NO:25:
CGCAAAATGA TATCGGGTAT GGAGCC 26
(2)SEQ ID NO:26的资料:
(i)序列特征:
(A)长度:29个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/dese=引物DA20
(ix)特性:
(A)名称/关键词:misc-feature
(B)位置:13、14
(D)其他资料:/Note:S=C和G的混合物
W=A和T的混合物
(xi)序列描述:SEQ ID NO:26:
GTGATGAACC ACSWAGGTGG AGCTGATGC 29
(2)SEQ ID NO:27的资料:
(i)序列特征:
(A)长度:30个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA14
(ix)特性:
(A)名称/关键词:misc-feature
(B)位置:13、14
(D)其他资料:/Note:R=A和G的混合物
Y=C和T的混合物
(xi)序列描述:SEQ ID NO:27:
GATGGTGTAT GGRYCAATCA CGACAATTCC 30
(2)SEQ ID NO:28的资料:
(i)序列特征:
(A)长度:28个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA15
(xi)序列描述:SEQ ID NO:28:
GGTGTATGGG ATAACTCACG ACAATTCC 28
(2)SEQ ID NO:29的资料:
(i)序列特征:
(A)长度:28个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA16
(xi)序列描述:SEQ ID NO:29:
GGTGTATGGG ATCTCTCACG ACAATTCC 28
(2)SEQ ID NO:30的资料:
(i)序列特征:
(A)长度:32个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA17
(xi)序列描述:SEQ ID NO:30:
GGGATCAATC ACGAAATTTC CAAAATCGTA TC 32
(2)SEQ ID NO:31的资料:
(i)序列特征:
(A)长度:32个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA18
(xi)序列描述:SEQ ID NO:31:
GGGATCAATC ACGACTCTTC CAAAATCGTA TC 32
(2)SEQ ID NO:32的资料:
(i)序列特征:
(A)长度:34个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA06
(xi)序列描述:SEQ ID NO:32:
GGAAATTATG ATTATATCAT GTATGCAGAT GTAG 34
(2)SEQ ID NO:33的资料:
(i)序列特征:
(A)长度:30个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA09
(xi)序列描述:SEQ ID NO:33:
GCTGAATTTT GGTCGAATGA TTTAGGTGCC 30
(2)SEQ ID NO:34的资料:
(i)序列特征:
(A)长度:30个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA11
(xi)序列描述:SEQ ID NO:34:
GCTGAATTTT GGTCGAATGA TTTAGGTGCC 30
(2)SEQ ID NO:35的资料:
(i)序列特征:
(A)长度:27个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA21
(xi)序列描述:SEQ ID NO:35:
GAATTTTGGA AGTACGATTT AGGTCGG 27
(2)SEQ ID NO:36的资料:
(i)序列特征:
(A)长度:29个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA12
(ix)特性:
(A)名称/关键词:misc-feature
(B)位置:12、13
(D)其他资料:/Note:R=A和G的混合物
Y=C和T的混合物
(xi)序列描述:SEQ ID NO:36:
GGAAAAACGA TRYCGGTGCC TTGGAGAAC 29
(2)SEQ ID NO:37的资料:
(i)序列特征:
(A)长度:27个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA13
(ix)特性:
(A)名称/关键词:misc-feature
(B)位置:14,15
(D)其他资料:/Note:R=A和G的混合物
Y=C和T的混合物
(xi)序列描述:SEQ ID NO:37:
GATTTAGGTG CCTRYCAGAA CTATTTA 27
(2)SEQ ID NO:38的资料:
(i)序列特征:
(A)长度:26个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA08
(xi)序列描述:SEQ ID NO:38:
CCCCCTTCAT GAGAATCTTT ATAACG 26
(2)SEQ ID NO:39的资料:
(i)序列特征:
(A)长度:25个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA04
(xi)序列描述:SEQ ID NO:39:
GAATCCGAAC CTCATTACAC ATTCG 25
(2)SEQ ID NO:40的资料:
(i)序列特征:
(A)长度:38个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA05
(xi)序列描述:SEQ ID NO:40:
CGGATGGACT CGAGAAGGAA ATACCACG 38
(2)SEQ ID NO:41的资料:
(i)序列特征:
(A)长度:31个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA10
(xi)序列描述:SEQ ID NO:41:
CGTAGGGCAA AATCAGGCCG GTCAAGTTTG G 31
(2)SEQ ID NO:42的资料:
(i)序列特征:
(A)长度:31个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA22
(xi)序列描述:SEQ ID NO:42:
CATAACTGGA AATCGCCCGG GAACAGTTAC G 31
(2)SEQ ID NO:43的资料:
(i)序列特征:
(A)长度:29个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA19
(ix)特性:
(A)名称/关键词:misc-feature
(B)位置:12
(D)其他资料:/Note:W=A和T的混合物
(xi)序列描述:SEQ ID NO:43:
CTGGAAATAA AWCCGGAACA GTTACG 36
(2)SEQ ID NO:44的资料:
(i)序列特征:
(A)长度:32个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA23
(xi)序列描述:SEQ ID NO:44:
GGAAATAAAC CAGGACCCGT TACGATCAAT GC 32
(2)SEQ ID NO:45的资料:
(i)序列特征:
(A)长度:28个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA32
(xi)序列描述:SEQ ID NO:45:
GAGGCTTGGA CTAGGTTTGA TTTTCCAG 28
(2)SEQ ID NO:46的资料:
(i)序列特征:
(A)长度:30个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物DA31
(xi)序列描述:SEQ ID NO:46:
GCTGAATTTT GGCGCAATGA TTTAGGTGCC 30
(2)SEQ ID NO:47的资料:
(i)序列特征:
(A)长度:34个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物bm4
(xi)序列描述:SEQ ID NO:47:
GTGTTTGACG TCCCGCTTCA TGAGAATTTA CAGG 34
(2)SEQ ID NO:48的资料:
(i)序列特征:
(A)长度:34个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物bm5
(xi)序列描述:SEQ ID NO:48:
GTGTTTGACG TCCCGCTTCA TAAGAATTTA CAGG 34
(2)SEQ ID NO:49的资料:
(i)序列特征:
(A)长度:34个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物bm6
(xi)序列描述:SEQ ID NO:49:
GTGTTTGACG TCCCGCTTCA TGCCAATTTA CAGG 34
(2)SEQ ID NO:50的资料:
(i)序列特征:
(A)长度:32个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物bm8
(xi)序列描述:SEQ ID NO:50:
AGGGAATCCG GATACCCTGA GGTTTTCTAC GG 32
(2)SEQ ID NO:51的资料:
(i)序列特征:
(A)长度:34个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物bm11
(xi)序列描述:SEQ ID NO:51:
GATGTGGTTT TGGATCATAA GGCCGGCGCT GATG 34
(2)SEQ ID NO:52的资料:
(i)序列特征:
(A)长度:22个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物p1
(xi)序列描述:SEQ ID NO:52:
CTGTTATTAA TGCCGCCAAA CC 22
(2)SEQ ID NO:53的资料:
(i)序列特征:
(A)长度:24个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物p2
(xi)序列描述:SEQ ID NO:53:
GGAAAAGAAA TGTTTACGGT TGCG 24
(2)SEQ ID NO:54的资料:
(i)序列特征:
(A)长度:25个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物p3
(xi)序列描述:SEQ ID NO:54:
GAAATGAAGC GGAACATCAA ACACG 25
(2)SEQ ID NO:55的资料:
(i)序列特征:
(A)长度:30个碱基对
(B)类型:核酸
(C)链型:单链
(D)拓扑结构:线性
(ii)分子类型:其他核酸
(ix)特性:
(A)名称/关键词:misc-feature
(B)其他资料:/desc=引物p4
(xi)序列描述:SEQ ID NO:55:
GTATGATTTA GGAGAATTCC 20
Claims (5)
1.一种亲本类透阿米尔α-淀粉酶的变体,该变体具有α-淀粉酶活性,所述变体包含1或多个突变,其对应于下列SEQ ID NO:2所示氨基酸序列中的突变:
T141,K142,F143,D144,F145,P146,G147,R148,G149,Q174,R181,G182,D183,G184,K185,A186,W189,S193,N195,H107,K108,G109,D166,W167,D168,Q169,S170,R171,Q172,F173,F267,W268,K269,N270,D271,L272,G273,A274,L275,K311,E346,K385,G456,N457,K458,P459,G460,T461,V462,T463。
2.权利要求1的变体,所述变体有1或多个下列取代或缺失:
T141A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
K142A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
F143A,D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
D144A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F145A,D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
P146A,D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
G147A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
R148A,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G149A,O,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
R181*,A,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G182*,A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
D183*,A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
G184*,A,R,D,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
K185A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
A186D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
W189A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
S193A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,T,W,Y,V;
N195A,D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
H107A,D,R,N,C,E,Q,G,I,L,K,M,F,P,S,T,W,Y,V ;
K108A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
G109A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
D166A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
W167A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
D168A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
Q169A,D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
S170A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,T,W,Y,V;
R171A,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
Q172A,D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F173A,D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
Q174*,A,D,R,N,C,E,G,H,I,L,K,M,F,P,S,T,W,Y,V;
F267A,D,R,N,C,E,Q,G,H,I,L,K,M,P,S,T,W,Y,V;
W268A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,Y,V;
K269A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
N270A,D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
D271A,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
L272A,D,R,N,C,E,Q,G,H,I,K,M,F,P,S,T,W,Y,V;
G273A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
A274D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
L275A,D,R,N,C,E,Q,G,H,I,K,M,F,P,S,T,W,Y,V;
K311A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
E346A,D,R,N,C,Q,G,H,I,K,L,M,F,P,S,T,W,Y,V;
K385A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
G456A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
N457A,D,R,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
K458A,D,R,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
P459A,D,R,N,C,E,Q,G,H,I,L,K,M,F,S,T,W,Y,V;
G460A,D,R,N,C,E,Q,H,I,L,K,M,F,P,S,T,W,Y,V;
T461A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V;
V462A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y;
T463A,D,R,N,C,E,Q,G,H,I,L,K,M,F,P,S,W,Y,V。
3.权利要求2的变体,其中所述变体有1或多个下列取代或缺失:K142R;S193P;N195F;K269R,Q;N270Y,R,D;K311R;E346Q;K385R;K458R;P459T;T461P;Q174*;R181Q,N,S;G182T,S,N;D183*;G184*;K185A,R,D,C,E,Q,G,H,I,L,M,N,F,P,S,T,W,Y,V;A186T,S,N,I,V,R;W189T,S,N,Q。
4.权利要求1-3的变体,其中所述变体在D183+G184位点缺失,还有1或多个下列取代或缺失:K142R;S193P;N195F;K269R,Q;N270Y,R,D;K311R;E346Q;K385R;K458R;P459T;T461P;Q174*;R181Q,N,S;G182T,S,N;D183*;G184*;K185A,R,D,C,E,Q,G,H,I,L,M,N,F,P,S,T,W,Y,V;A186T,S,N,I,V,R;W189T,S,N,Q。
5.权利要求1-4任何一项的变体,其中相对亲本α-淀粉酶所述变体至少下列性能之一发生改变:
i)在pH8到10.5的pH稳定性提高;和/或
ii)在pH8到10.5的Ca2+稳定性提高,和/或
iii)在温度为10到60℃,优选20-50℃,特别是30-40℃特异活性增强。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK124097 | 1997-10-30 | ||
| DK1240/97 | 1997-10-30 | ||
| DK1240/1997 | 1997-10-30 | ||
| DKPA199800936 | 1998-07-14 | ||
| DKPA199800936 | 1998-07-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB988108712A Division CN1163597C (zh) | 1997-10-30 | 1998-10-30 | α-淀粉酶突变体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1550549A true CN1550549A (zh) | 2004-12-01 |
| CN100593034C CN100593034C (zh) | 2010-03-03 |
Family
ID=55701615
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB988108712A Ceased CN1163597C (zh) | 1997-10-30 | 1998-10-30 | α-淀粉酶突变体 |
| CN200410061736A Expired - Lifetime CN100593034C (zh) | 1997-10-30 | 1998-10-30 | α-淀粉酶突变体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB988108712A Ceased CN1163597C (zh) | 1997-10-30 | 1998-10-30 | α-淀粉酶突变体 |
Country Status (11)
| Country | Link |
|---|---|
| US (8) | US6204232B1 (zh) |
| EP (4) | EP1027428B1 (zh) |
| JP (1) | JP4426094B2 (zh) |
| CN (2) | CN1163597C (zh) |
| AT (1) | ATE490311T1 (zh) |
| AU (1) | AU9737398A (zh) |
| BR (2) | BRPI9816290B1 (zh) |
| CA (2) | CA2845178A1 (zh) |
| DE (1) | DE69842027D1 (zh) |
| ES (1) | ES2515218T3 (zh) |
| WO (1) | WO1999023211A1 (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103649307A (zh) * | 2011-06-30 | 2014-03-19 | 诺维信公司 | α-淀粉酶变体 |
| CN112458069A (zh) * | 2013-01-03 | 2021-03-09 | 诺维信公司 | α-淀粉酶变体以及对其进行编码的多核苷酸 |
| CN113186178A (zh) * | 2010-02-10 | 2021-07-30 | 诺维信公司 | 在螯合剂存在下具有高稳定性的变体和包含变体的组合物 |
| CN115975990A (zh) * | 2022-07-18 | 2023-04-18 | 青岛蔚蓝生物集团有限公司 | 一种高比活中温淀粉酶突变体 |
Families Citing this family (386)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440716B1 (en) * | 1995-02-03 | 2002-08-27 | Novozymes A/S | α-amylase mutants |
| EP2206768B1 (en) * | 1997-10-13 | 2015-04-01 | Novozymes A/S | Alpha-amylase mutants |
| US6361989B1 (en) * | 1997-10-13 | 2002-03-26 | Novozymes A/S | α-amylase and α-amylase variants |
| US6410295B1 (en) | 1999-03-30 | 2002-06-25 | Novozymes A/S | Alpha-amylase variants |
| US6623948B1 (en) * | 1999-03-31 | 2003-09-23 | Novozymes A/S | Nucleic acid sequences encoding alkaline alpha-amylases |
| ES2532606T3 (es) * | 1999-03-31 | 2015-03-30 | Novozymes A/S | Polipéptidos con actividad de alfa-amilasa alcalina y ácidos nucleicos que los codifican |
| CN100523182C (zh) | 1999-06-10 | 2009-08-05 | 花王株式会社 | 突变α-淀粉酶 |
| CN1390252A (zh) * | 1999-11-10 | 2003-01-08 | 诺维信公司 | Fungamyl样α-淀粉酶变体 |
| US7005288B1 (en) | 1999-11-10 | 2006-02-28 | Novozymes A/S | Fungamyl-like alpha-amylase variants |
| US6350599B1 (en) | 2000-01-12 | 2002-02-26 | Novozymes A/S | Pullulanase variants and methods for preparing such variants with predetermined properties |
| WO2001064852A1 (en) * | 2000-03-03 | 2001-09-07 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| JP5571274B2 (ja) | 2000-03-08 | 2014-08-13 | ノボザイムス アクティーゼルスカブ | 改変された特性を有する変異体 |
| DE10036752C2 (de) * | 2000-07-28 | 2003-02-20 | Henkel Kgaa | Wasch- und Reinigungsmittel mit einem neuen amylolytischen Enzym aus Bacillus sp. A 7-7(DSM 12368) |
| PL366249A1 (en) * | 2000-07-28 | 2005-01-24 | Henkel Kommanditgesellschaft Auf Aktien | Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| US20020155574A1 (en) * | 2000-08-01 | 2002-10-24 | Novozymes A/S | Alpha-amylase mutants with altered properties |
| JP4426716B2 (ja) * | 2000-10-11 | 2010-03-03 | 花王株式会社 | 高生産性α−アミラーゼ |
| EP1337648B1 (de) | 2000-11-28 | 2007-09-19 | Henkel Kommanditgesellschaft auf Aktien | Cyclodextrin -glucanotransferase(cg tase) aus bacillus agaradherens(dsm 9948)sowie wasch-und reinigungsmittel mit dieser neuen cyclodextrin-glucanotransferase |
| CA2438205C (en) * | 2001-02-21 | 2015-11-03 | Diversa Corporation | Enzymes having alpha amylase activity and methods of use thereof |
| EP2159279A3 (en) | 2001-05-15 | 2010-05-12 | Novozymes A/S | Alpha-amylase variant with altered properties |
| DE10138753B4 (de) * | 2001-08-07 | 2017-07-20 | Henkel Ag & Co. Kgaa | Wasch- und Reinigungsmittel mit Hybrid-Alpha-Amylasen |
| JP4897186B2 (ja) * | 2002-03-27 | 2012-03-14 | 花王株式会社 | 変異アルカリセルラーゼ |
| US7226771B2 (en) | 2002-04-19 | 2007-06-05 | Diversa Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
| JP2005523019A (ja) | 2002-04-19 | 2005-08-04 | ダイヴァーサ コーポレイション | ホスホリパーゼ、それらをコードする核酸、ならびに、それらの作製方法および使用方法 |
| KR20080045764A (ko) | 2002-06-14 | 2008-05-23 | 신젠타 파티서페이션즈 아게 | 자일라나제, 이를 암호화하는 핵산, 및 이의 제조 및 사용방법 |
| US7642079B2 (en) * | 2002-10-10 | 2010-01-05 | Michelle Cayouette | Proteases, nucleic acids encoding them and methods for making and using them |
| DE10362172B4 (de) * | 2003-03-05 | 2009-04-02 | Henkel Ag & Co. Kgaa | Wasch-und Reinigungsmittel mit Alpha-Amylase-Varianten mit verbesserter Alkaliaktivität |
| DK2194133T3 (en) | 2003-03-06 | 2016-02-29 | Basf Enzymes Llc | Amylases, nucleic acids encoding them, and methods of making and using the same |
| EP1601332A4 (en) | 2003-03-07 | 2012-05-02 | Verenium Corp | HYDROLASES, NUCLEIC ACIDS ENCODING THEM, AND METHODS OF MAKING AND USING SAME |
| AU2004223394A1 (en) * | 2003-03-20 | 2004-10-07 | Verenium Corporation | Glucosidases, nucleic acids encoding them and methods for making and using them |
| DK2341136T3 (en) | 2003-04-04 | 2016-09-12 | Basf Enzymes Llc | Pectate lyases, nucleic acids encoding them, and methods of making and using them |
| EP1654355B1 (en) | 2003-06-13 | 2010-04-21 | Danisco A/S | Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products |
| MXPA06000067A (es) | 2003-07-02 | 2007-01-25 | Diversa Corp | Glucanasas, acidos nucleicos que las codifican y metodos para hacerlas y usarlas. |
| EP2292744A1 (en) | 2003-07-07 | 2011-03-09 | Genencor International, Inc. | Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| US8143048B2 (en) | 2003-07-07 | 2012-03-27 | Danisco A/S | Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| CA2891101A1 (en) | 2003-08-11 | 2005-03-10 | Basf Enzymes Llc | Laccases, nucleic acids encoding them and methods for making and using them |
| CA2854912A1 (en) * | 2004-07-05 | 2006-01-12 | Novozymes A/S | Alpha-amylase variants with altered properties |
| EP2295557B1 (en) | 2004-07-07 | 2017-09-06 | DuPont Nutrition Biosciences ApS | Exoamylase variants |
| DE102004047777B4 (de) | 2004-10-01 | 2018-05-09 | Basf Se | Alpha-Amylase-Varianten mit erhöhter Lösungsmittelstabilität, Verfahren zu deren Herstellung sowie deren Verwendung |
| NZ583532A (en) | 2005-03-15 | 2011-09-30 | Verenium Corp | Cellulases, nucleic acids encoding them and methods for making and using them |
| US8030050B2 (en) | 2005-07-07 | 2011-10-04 | Danisco A/S | Modified amylases from Pseudomonas species |
| DE102006038448A1 (de) | 2005-12-28 | 2008-02-21 | Henkel Kgaa | Enzym-haltiges Reinigungsmittel |
| EP2216403A3 (en) | 2006-02-02 | 2010-11-24 | Verenium Corporation | Esterases and related nucleic acids and methods |
| WO2007094852A2 (en) | 2006-02-10 | 2007-08-23 | Verenium Corporation | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
| PL1989302T3 (pl) | 2006-02-14 | 2019-03-29 | Bp Corp North America Inc | Ksylanazy, kodujące je kwasy nukleinowe i sposoby ich wytwarzania i stosowania |
| CA2656313C (en) | 2006-06-19 | 2018-07-03 | Danisco A/S | Ps4 exoamylase h307k/r variant |
| CN106222185B (zh) | 2006-08-04 | 2021-12-03 | 维莱尼姆公司 | 葡聚糖酶、编码它们的核酸及制备和使用它们的方法 |
| MX2009003034A (es) | 2006-09-21 | 2009-11-18 | Verenium Corp | Fosfolipasas, acidos nucleicos que las codifican, y metodos de hacerlas y usarlas. |
| HUE033455T2 (en) | 2006-12-21 | 2017-12-28 | Basf Enzymes Llc | Amylases and glucoamylases, nucleic acids encoding them, and methods for their preparation and use |
| NZ610301A (en) | 2007-01-30 | 2015-03-27 | Bp Corp North America Inc | Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| EP2428572A3 (en) | 2007-03-09 | 2012-12-12 | Danisco US, Inc., Genencor Division | Alkaliphilic Bacillus species alpha-amylase variants, compositions comprising alpha-amylase variants, and methods of use |
| US9133425B2 (en) | 2007-06-06 | 2015-09-15 | Danisco Us Inc. | Methods for improving multiple protein properties |
| CN101952437B (zh) | 2007-10-03 | 2014-04-09 | 维莱尼姆公司 | 木聚糖酶、编码它们的核酸以及其制备和应用方法 |
| US8066818B2 (en) | 2008-02-08 | 2011-11-29 | The Procter & Gamble Company | Water-soluble pouch |
| US20090209447A1 (en) | 2008-02-15 | 2009-08-20 | Michelle Meek | Cleaning compositions |
| EP2100947A1 (en) | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
| US20090233830A1 (en) | 2008-03-14 | 2009-09-17 | Penny Sue Dirr | Automatic detergent dishwashing composition |
| US8357503B2 (en) | 2008-08-29 | 2013-01-22 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
| US8153391B2 (en) | 2008-08-29 | 2012-04-10 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
| US8198062B2 (en) * | 2008-08-29 | 2012-06-12 | Dsm Ip Assets B.V. | Hydrolases, nucleic acids encoding them and methods for making and using them |
| EP2166092A1 (en) | 2008-09-18 | 2010-03-24 | The Procter and Gamble Company | Detergent composition |
| EP2166076A1 (en) | 2008-09-23 | 2010-03-24 | The Procter & Gamble Company | Cleaning composition |
| EP2166073A1 (en) | 2008-09-23 | 2010-03-24 | The Procter & Gamble Company | Cleaning composition |
| EP2166075A1 (en) * | 2008-09-23 | 2010-03-24 | The Procter and Gamble Company | Cleaning composition |
| US20100125046A1 (en) | 2008-11-20 | 2010-05-20 | Denome Frank William | Cleaning products |
| EP3998328A1 (en) | 2009-02-09 | 2022-05-18 | The Procter & Gamble Company | Detergent composition |
| WO2010097436A1 (en) | 2009-02-27 | 2010-09-02 | Novozymes A/S | Mutant cells having reduced expression of metallopeptidase, suitable for recombinant polypeptide production |
| WO2011005730A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | A catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte |
| WO2011005913A1 (en) | 2009-07-09 | 2011-01-13 | The Procter & Gamble Company | A catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte |
| HUE029942T2 (en) | 2009-08-13 | 2017-04-28 | Procter & Gamble | Method for washing low temperature fabrics |
| UA109884C2 (uk) | 2009-10-16 | 2015-10-26 | Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування | |
| UA111708C2 (uk) | 2009-10-16 | 2016-06-10 | Бандж Ойлз, Інк. | Спосіб рафінування олії |
| EP3434764A3 (en) | 2009-12-09 | 2019-04-03 | The Procter & Gamble Company | Fabric and home care products |
| ES2422593T3 (es) | 2009-12-10 | 2013-09-12 | Procter & Gamble | Método y uso de una composición para lavavajillas |
| ES2423580T5 (es) | 2009-12-10 | 2021-06-17 | Procter & Gamble | Método y uso de una composición para lavado de vajillas |
| EP2333040B2 (en) | 2009-12-10 | 2019-11-13 | The Procter & Gamble Company | Detergent composition |
| EP2333042B1 (en) | 2009-12-10 | 2015-07-01 | The Procter and Gamble Company | Automatic dishwashing product and use thereof |
| US20120329090A1 (en) | 2009-12-21 | 2012-12-27 | Novozymes A/S | Methods for Producing Heterologous Polypeptides in Thiol-Disulfide Oxidoreductase-Deficient Bacterial Mutant Cells |
| EP3101127B1 (en) | 2010-01-04 | 2019-03-20 | Novozymes A/S | Alpha-amylase variants with improved stability |
| EP2357220A1 (en) * | 2010-02-10 | 2011-08-17 | The Procter & Gamble Company | Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent |
| PL2361964T3 (pl) | 2010-02-25 | 2013-05-31 | Procter & Gamble | Kompozycja detergentu |
| EP2380481B1 (en) | 2010-04-23 | 2014-12-31 | The Procter and Gamble Company | Automatic dishwashing product |
| ES2579217T3 (es) | 2010-04-23 | 2016-08-08 | The Procter & Gamble Company | Partícula |
| EP2383329A1 (en) | 2010-04-23 | 2011-11-02 | The Procter & Gamble Company | Particle |
| EP2380478A1 (en) | 2010-04-23 | 2011-10-26 | The Procter & Gamble Company | Automatic dishwashing product |
| ES2565192T3 (es) | 2010-04-23 | 2016-04-01 | The Procter & Gamble Company | Método para perfumar |
| PL2380961T3 (pl) | 2010-04-23 | 2018-10-31 | The Procter & Gamble Company | Kompozycja detergentu |
| ES2694398T3 (es) | 2010-05-06 | 2018-12-20 | Danisco Us Inc. | Composiciones y métodos que comprenden variantes de subtilisina |
| ES2643613T3 (es) | 2010-08-17 | 2017-11-23 | The Procter & Gamble Company | Detergentes para el lavado de vajillas a mano sostenibles y estables |
| PL2606111T3 (pl) | 2010-08-17 | 2018-05-30 | The Procter And Gamble Company | Sposób ręcznego zmywania naczyń zapewniający długotrwałą pianę |
| AR083354A1 (es) | 2010-10-06 | 2013-02-21 | Bp Corp North America Inc | Polipeptidos variantes cbh i (celobiohidrolasas i) con reducida inhibicion de producto |
| DK2705146T3 (en) | 2011-05-05 | 2019-03-04 | Danisco Us Inc | COMPOSITIONS AND PROCEDURES INCLUDING SERINE PROTEASE VARIABLES |
| RU2663114C2 (ru) | 2011-05-05 | 2018-08-01 | Дзе Проктер Энд Гэмбл Компани | Способы и композиции, содержащие варианты сериновой протеазы |
| US20140371435A9 (en) | 2011-06-03 | 2014-12-18 | Eduardo Torres | Laundry Care Compositions Containing Thiophene Azo Dyes |
| EP2537918A1 (en) | 2011-06-20 | 2012-12-26 | The Procter & Gamble Company | Consumer products with lipase comprising coated particles |
| EP2540824A1 (en) * | 2011-06-30 | 2013-01-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
| EP4026901B1 (en) * | 2011-06-30 | 2025-01-22 | Novozymes A/S | Method for screening alpha-amylases |
| EP2551335A1 (en) | 2011-07-25 | 2013-01-30 | The Procter & Gamble Company | Enzyme stabilized liquid detergent composition |
| EP2584028B1 (en) | 2011-10-19 | 2017-05-10 | The Procter & Gamble Company | Particle |
| HK1201559A1 (zh) | 2011-10-28 | 2015-09-04 | Danisco Us Inc. | 变体成麦芽六糖α-淀粉酶变体 |
| KR101882182B1 (ko) * | 2011-11-22 | 2018-07-27 | 삼성전자주식회사 | 식기 세척기 및 그 제어 방법 |
| BR112014019142A2 (pt) | 2012-02-03 | 2017-06-27 | Procter & Gamble | composições e métodos para tratamento de superfícies com lipases |
| BR112014023153B1 (pt) | 2012-03-19 | 2021-02-23 | Milliken & Company | corantes de carboxilato |
| US9909109B2 (en) | 2012-04-02 | 2018-03-06 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
| PL2662436T3 (pl) | 2012-05-11 | 2018-02-28 | The Procter And Gamble Company | Kompozycja detergentu |
| EP2674475A1 (en) | 2012-06-11 | 2013-12-18 | The Procter & Gamble Company | Detergent composition |
| CN104471048B (zh) | 2012-07-12 | 2018-11-16 | 诺维信公司 | 具有脂肪酶活性的多肽及编码它的多核苷酸 |
| EP2700703B1 (en) | 2012-08-24 | 2018-05-02 | The Procter and Gamble Company | Dishwashing method |
| ES2678543T3 (es) | 2012-08-24 | 2018-08-13 | The Procter & Gamble Company | Método de lavado de vajillas |
| JP2016506442A (ja) | 2012-12-20 | 2016-03-03 | ザ プロクター アンド ギャンブルカンパニー | ケイ酸塩でコーティングされた漂白剤を含む洗剤組成物 |
| EP2746381A1 (en) | 2012-12-21 | 2014-06-25 | The Procter & Gamble Company | Cleaning pack |
| ES2652301T3 (es) | 2013-03-05 | 2018-02-01 | The Procter & Gamble Company | Composiciones tensioactivas mixtas de amida de base azucarada |
| ES2676895T5 (es) * | 2013-03-11 | 2022-04-27 | Danisco Us Inc | Variantes combinatorias de alfa-amilasa |
| WO2014147127A1 (en) | 2013-03-21 | 2014-09-25 | Novozymes A/S | Polypeptides with lipase activity and polynucleotides encoding same |
| AU2014241193B2 (en) | 2013-03-28 | 2016-10-20 | The Procter And Gamble Company | Cleaning compositions containing a polyetheramine |
| EP2997142A1 (en) * | 2013-05-17 | 2016-03-23 | Novozymes A/S | Polypeptides having alpha amylase activity |
| MX2015016438A (es) | 2013-05-28 | 2016-03-01 | Procter & Gamble | Composiciones que comprenden tintes fotocromicos para el tratamiento de superficies. |
| WO2014194054A1 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
| CN105492603B (zh) | 2013-05-29 | 2022-06-03 | 丹尼斯科美国公司 | 新型金属蛋白酶 |
| EP3004314B1 (en) | 2013-05-29 | 2018-06-20 | Danisco US Inc. | Novel metalloproteases |
| JP6367930B2 (ja) | 2013-05-29 | 2018-08-01 | ダニスコ・ユーエス・インク | 新規メタロプロテアーゼ |
| EP3011021A1 (en) * | 2013-06-21 | 2016-04-27 | Novozymes A/S | Polypeptides having amylase activity and polynucleotides encoding same |
| WO2015042087A1 (en) | 2013-09-18 | 2015-03-26 | The Procter & Gamble Company | Laundry care composition comprising carboxylate dye |
| US9834682B2 (en) | 2013-09-18 | 2017-12-05 | Milliken & Company | Laundry care composition comprising carboxylate dye |
| WO2015042086A1 (en) | 2013-09-18 | 2015-03-26 | The Procter & Gamble Company | Laundry care composition comprising carboxylate dye |
| MX2016003538A (es) | 2013-09-18 | 2016-06-28 | Procter & Gamble | Composiciones para el cuidado de la ropa que contienen colorantes azoicos de tiofeno y carboxilato. |
| EP2857487A1 (en) | 2013-10-07 | 2015-04-08 | WeylChem Switzerland AG | Multi-compartment pouch comprising cleaning compositions, washing process and use for washing and cleaning of textiles and dishes |
| EP2857485A1 (en) | 2013-10-07 | 2015-04-08 | WeylChem Switzerland AG | Multi-compartment pouch comprising alkanolamine-free cleaning compositions, washing process and use for washing and cleaning of textiles and dishes |
| EP2857486A1 (en) | 2013-10-07 | 2015-04-08 | WeylChem Switzerland AG | Multi-compartment pouch comprising cleaning compositions, washing process and use for washing and cleaning of textiles and dishes |
| DK3080263T3 (da) | 2013-12-13 | 2019-10-07 | Danisco Us Inc | Serinproteaser af bacillus gibsonii-clade |
| TR201906371T4 (tr) | 2013-12-13 | 2019-05-21 | Danisco Inc | Bacillus türlerinin serin proteazları. |
| KR20160099629A (ko) | 2013-12-16 | 2016-08-22 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 점도 조절제로서의 폴리 알파-1,3-글루칸 에테르의 사용 |
| MX381013B (es) | 2013-12-18 | 2025-03-12 | Nutrition & Biosciences Usa 4 Inc | Éteres de poli-alfa-1,3-glucano catiónicos. |
| WO2015112339A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
| WO2015112340A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
| EP3097172A1 (en) | 2014-01-22 | 2016-11-30 | The Procter & Gamble Company | Method of treating textile fabrics |
| EP3097175B1 (en) | 2014-01-22 | 2018-10-17 | The Procter and Gamble Company | Fabric treatment composition |
| CA2841024C (en) | 2014-01-30 | 2017-03-07 | The Procter & Gamble Company | Unit dose article |
| WO2015123323A1 (en) | 2014-02-14 | 2015-08-20 | E. I. Du Pont De Nemours And Company | Poly-alpha-1,3-1,6-glucans for viscosity modification |
| US10752562B2 (en) | 2014-02-25 | 2020-08-25 | The Procter & Gamble Company | Process for making renewable surfactant intermediates and surfactants from fats and oils and products thereof |
| WO2015130669A1 (en) | 2014-02-25 | 2015-09-03 | The Procter & Gamble Company | A process for making renewable surfactant intermediates and surfactants from fats and oils and products thereof |
| EP2915872A1 (en) | 2014-03-06 | 2015-09-09 | The Procter and Gamble Company | Dishwashing composition |
| EP2915873A1 (en) | 2014-03-06 | 2015-09-09 | The Procter and Gamble Company | Dishwashing composition |
| US9695253B2 (en) | 2014-03-11 | 2017-07-04 | E I Du Pont De Nemours And Company | Oxidized poly alpha-1,3-glucan |
| DK3119884T3 (da) | 2014-03-21 | 2019-10-14 | Danisco Us Inc | Serinproteaser af bacillus-arter |
| EP3122850A1 (en) | 2014-03-27 | 2017-02-01 | The Procter & Gamble Company | Cleaning compositions containing a polyetheramine |
| JP6262365B2 (ja) | 2014-03-27 | 2018-01-17 | ザ プロクター アンド ギャンブル カンパニー | ポリエーテルアミンを含有する洗浄組成物 |
| EP3122849B1 (en) | 2014-03-27 | 2021-07-21 | The Procter & Gamble Company | Cleaning compositions containing a polyetheramine |
| EP2924105A1 (en) | 2014-03-28 | 2015-09-30 | The Procter and Gamble Company | Water soluble unit dose article |
| EP2924107A1 (en) | 2014-03-28 | 2015-09-30 | The Procter and Gamble Company | Water soluble unit dose article |
| EP2940116B1 (en) | 2014-04-30 | 2018-10-17 | The Procter and Gamble Company | Detergent |
| WO2015171592A1 (en) | 2014-05-06 | 2015-11-12 | Milliken & Company | Laundry care compositions |
| WO2015187757A1 (en) | 2014-06-06 | 2015-12-10 | The Procter & Gamble Company | Detergent composition comprising polyalkyleneimine polymers |
| CN106661563A (zh) * | 2014-06-12 | 2017-05-10 | 诺维信公司 | 氧化稳定的α‑淀粉酶变体 |
| US9714403B2 (en) | 2014-06-19 | 2017-07-25 | E I Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
| WO2015195777A1 (en) | 2014-06-19 | 2015-12-23 | E. I. Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
| US9617502B2 (en) | 2014-09-15 | 2017-04-11 | The Procter & Gamble Company | Detergent compositions containing salts of polyetheramines and polymeric acid |
| EP3197988B1 (en) | 2014-09-25 | 2018-08-01 | The Procter & Gamble Company | Cleaning compositions containing a polyetheramine |
| US20160090552A1 (en) | 2014-09-25 | 2016-03-31 | The Procter & Gamble Company | Detergent compositions containing a polyetheramine and an anionic soil release polymer |
| US9388368B2 (en) | 2014-09-26 | 2016-07-12 | The Procter & Gamble Company | Cleaning compositions containing a polyetheramine |
| US20170233710A1 (en) | 2014-10-17 | 2017-08-17 | Danisco Us Inc. | Serine proteases of bacillus species |
| WO2016069544A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
| EP3212662B1 (en) | 2014-10-27 | 2020-04-08 | Danisco US Inc. | Serine proteases |
| WO2016069557A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases of bacillus species |
| EP3957729A1 (en) | 2014-10-27 | 2022-02-23 | Danisco US Inc. | Serine proteases |
| WO2016069548A2 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
| US20160137956A1 (en) | 2014-11-17 | 2016-05-19 | The Procter & Gamble Company | Benefit agent delivery compositions |
| PL3026102T3 (pl) | 2014-11-26 | 2019-06-28 | The Procter & Gamble Company | Saszetka czyszcząca |
| EP3026103B1 (en) | 2014-11-26 | 2018-07-25 | The Procter and Gamble Company | Cleaning pouch |
| EP3026099B1 (en) | 2014-11-26 | 2021-02-17 | The Procter and Gamble Company | Cleaning pouch |
| EP3026100B1 (en) | 2014-11-26 | 2018-07-25 | The Procter and Gamble Company | Cleaning pouch |
| EP3034597A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Detergent composition |
| PL3034588T3 (pl) | 2014-12-17 | 2019-09-30 | The Procter And Gamble Company | Kompozycja detergentu |
| EP3034596B2 (en) | 2014-12-17 | 2021-11-10 | The Procter & Gamble Company | Detergent composition |
| EP3034590A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Method of automatic dishwashing |
| EP3034592A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Method of automatic dishwashing |
| EP3034589A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Detergent composition |
| EP3034591A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Method of automatic dishwashing |
| ES2668504T3 (es) | 2014-12-22 | 2018-05-18 | The Procter & Gamble Company | Proceso para reciclar bolsas de detergente |
| US10131929B2 (en) | 2014-12-23 | 2018-11-20 | E. I. Du Pont De Nemours And Company | Enzymatically produced cellulose |
| EP3050952A1 (en) | 2015-02-02 | 2016-08-03 | The Procter and Gamble Company | Method of dishwashing |
| EP3050950B1 (en) | 2015-02-02 | 2018-09-19 | The Procter and Gamble Company | New use of sulfonated polymers |
| ES2714130T3 (es) | 2015-02-02 | 2019-05-27 | Procter & Gamble | Composición detergente |
| EP3050948B1 (en) | 2015-02-02 | 2018-09-19 | The Procter and Gamble Company | New use of complexing agent |
| EP3050951A1 (en) | 2015-02-02 | 2016-08-03 | The Procter and Gamble Company | Method of dishwashing |
| EP3050954A1 (en) | 2015-02-02 | 2016-08-03 | The Procter and Gamble Company | New use of sulfonated polymers |
| EP3050947A1 (en) | 2015-02-02 | 2016-08-03 | The Procter and Gamble Company | Detergent pack |
| EP3050955B2 (en) | 2015-02-02 | 2023-11-08 | The Procter & Gamble Company | Detergent pack |
| EP3088503B1 (en) | 2015-04-29 | 2018-05-23 | The Procter and Gamble Company | Method of treating a fabric |
| PL3088502T3 (pl) | 2015-04-29 | 2018-10-31 | The Procter & Gamble Company | Sposób obróbki tkaniny |
| CN107548415A (zh) | 2015-04-29 | 2018-01-05 | 宝洁公司 | 洗涤织物的方法 |
| WO2016176240A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of treating a fabric |
| CN107820515A (zh) | 2015-04-29 | 2018-03-20 | 宝洁公司 | 洗涤剂组合物 |
| JP6866302B2 (ja) | 2015-05-04 | 2021-04-28 | ミリケン・アンド・カンパニーMilliken & Company | ランドリーケア組成物中の青味剤としてのロイコトリフェニルメタン色素 |
| CN107750275A (zh) | 2015-05-08 | 2018-03-02 | 诺维信公司 | α‑淀粉酶变体以及编码它们的多核苷酸 |
| EP3294881B1 (en) | 2015-05-08 | 2022-12-28 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
| US20180112204A1 (en) | 2015-05-13 | 2018-04-26 | Danisco Us Inc. | AprL-CLADE PROTEASE VARIANTS AND USES THEREOF |
| EP3101103B1 (en) | 2015-06-05 | 2019-04-24 | The Procter and Gamble Company | Compacted liquid laundry detergent composition |
| EP3101100B1 (en) | 2015-06-05 | 2018-02-07 | The Procter and Gamble Company | Compacted liquid laundry detergent composition |
| EP3101107B1 (en) | 2015-06-05 | 2019-04-24 | The Procter and Gamble Company | Compacted liquid laundry detergent composition |
| EP3101102B2 (en) | 2015-06-05 | 2023-12-13 | The Procter & Gamble Company | Compacted liquid laundry detergent composition |
| WO2016201040A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc. | Water-triggered enzyme suspension |
| WO2016201069A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc | Low-density enzyme-containing particles |
| US20180134997A1 (en) | 2015-06-09 | 2018-05-17 | Danisco Us Inc. | Osmotic burst encapsulates |
| EP3310911B1 (en) | 2015-06-17 | 2023-03-15 | Danisco US Inc. | Bacillus gibsonii-clade serine proteases |
| PL3124587T3 (pl) | 2015-07-29 | 2019-08-30 | The Procter And Gamble Company | Wielofazowy produkt czyszczący w postaci dawki jednostkowej |
| EP3124586A1 (en) | 2015-07-29 | 2017-02-01 | The Procter and Gamble Company | Process for reducing malodour in a pack |
| JP7364331B2 (ja) | 2015-11-05 | 2023-10-18 | ダニスコ・ユーエス・インク | パエニバチルス(Paenibacillus)属種マンナナーゼ |
| JP7364330B2 (ja) | 2015-11-05 | 2023-10-18 | ダニスコ・ユーエス・インク | パエニバチルス(Paenibacillus)属種及びバチルス(Bacillus)属種のマンナナーゼ |
| EP3374400B1 (en) | 2015-11-13 | 2022-04-13 | Nutrition & Biosciences USA 4, Inc. | Glucan fiber compositions for use in laundry care and fabric care |
| JP2019504932A (ja) | 2015-11-13 | 2019-02-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company | 洗濯ケアおよび織物ケアにおいて使用するためのグルカン繊維組成物 |
| WO2017083226A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
| JP2019502779A (ja) | 2015-11-26 | 2019-01-31 | ザ プロクター アンド ギャンブル カンパニー | プロテアーゼを含む液体洗剤組成物及び封入リパーゼ |
| EP3178917A1 (en) | 2015-12-08 | 2017-06-14 | The Procter and Gamble Company | Cleaning pouch |
| WO2017100720A1 (en) | 2015-12-09 | 2017-06-15 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
| US20180362946A1 (en) | 2015-12-18 | 2018-12-20 | Danisco Us Inc. | Polypeptides with endoglucanase activity and uses thereof |
| CA3006607A1 (en) * | 2015-12-30 | 2017-07-06 | Novozymes A/S | Enzyme variants and polynucleotides encoding the same |
| ES2802454T3 (es) | 2016-04-08 | 2021-01-19 | Procter & Gamble | Composición de limpieza para lavavajillas |
| EP3228687B1 (en) | 2016-04-08 | 2019-05-22 | The Procter and Gamble Company | Dishwashing cleaning composition |
| EP3228686B1 (en) | 2016-04-08 | 2021-10-27 | The Procter & Gamble Company | Automatic dishwashing |
| WO2017176501A1 (en) | 2016-04-08 | 2017-10-12 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
| DK179660B1 (en) * | 2016-04-08 | 2019-03-13 | Novozymes A/S | Stabilized Alpha-Amylase Variants and use of the same |
| CN105802940B (zh) * | 2016-04-18 | 2019-04-16 | 广西大学 | 一种地衣芽胞杆菌高温α-淀粉酶突变体及其应用 |
| EP3241889B1 (en) | 2016-05-03 | 2019-03-20 | The Procter and Gamble Company | Cleaning composition |
| CN109715791B (zh) | 2016-05-03 | 2023-07-14 | 丹尼斯科美国公司 | 蛋白酶变体及其用途 |
| EP3452569A1 (en) | 2016-05-03 | 2019-03-13 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
| EP3241891B1 (en) | 2016-05-03 | 2019-04-03 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
| EP3241890B1 (en) | 2016-05-03 | 2019-06-26 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
| BR112018072586A2 (pt) | 2016-05-05 | 2019-02-19 | Danisco Us Inc | variantes de protease e usos das mesmas |
| US11661567B2 (en) | 2016-05-31 | 2023-05-30 | Danisco Us Inc. | Protease variants and uses thereof |
| EP3257931A1 (en) | 2016-06-17 | 2017-12-20 | The Procter and Gamble Company | Detergent composition |
| MX2018015559A (es) | 2016-06-17 | 2019-06-06 | Danisco Us Inc | Variantes de proteasa y sus usos. |
| EP3266860B1 (en) | 2016-07-08 | 2020-04-08 | The Procter and Gamble Company | Process for making a particle |
| EP3275989A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
| EP3275987A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
| EP3275988B1 (en) | 2016-07-26 | 2020-07-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
| EP3275986B1 (en) | 2016-07-26 | 2020-07-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
| EP3275985A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
| EP3290503A3 (en) | 2016-09-01 | 2018-05-30 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
| EP3312265A1 (en) | 2016-10-18 | 2018-04-25 | The Procter and Gamble Company | Detergent composition |
| BR112019006576A2 (pt) | 2016-11-01 | 2019-07-02 | Milliken & Co | corantes leuco como agentes de azulamento em composições de cuidados de lavanderia |
| CA3038855A1 (en) | 2016-11-01 | 2018-05-11 | The Procter & Gamble Company | Leuco colorants as bluing agents in laundry care compositions |
| EP3535362A1 (en) | 2016-11-01 | 2019-09-11 | The Procter and Gamble Company | Leuco colorants as bluing agents in laundry care compositions, packaging, kits and methods thereof |
| US20180119056A1 (en) | 2016-11-03 | 2018-05-03 | Milliken & Company | Leuco Triphenylmethane Colorants As Bluing Agents in Laundry Care Compositions |
| EP3535365A2 (en) | 2016-11-07 | 2019-09-11 | Danisco US Inc. | Laundry detergent composition |
| DK3330349T3 (da) | 2016-12-02 | 2024-07-15 | Procter & Gamble | Rengøringssammensætninger, der indbefatter enzymer |
| CN110088261B (zh) | 2016-12-02 | 2022-05-06 | 宝洁公司 | 包含酶的清洁组合物 |
| US10550443B2 (en) | 2016-12-02 | 2020-02-04 | The Procter & Gamble Company | Cleaning compositions including enzymes |
| CN110312795B (zh) | 2016-12-21 | 2024-07-23 | 丹尼斯科美国公司 | 蛋白酶变体及其用途 |
| CN110312794B (zh) | 2016-12-21 | 2024-04-12 | 丹尼斯科美国公司 | 吉氏芽孢杆菌进化枝丝氨酸蛋白酶 |
| EP3339423A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
| EP3339410A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Automatic dishwashing composition |
| US20180216039A1 (en) | 2017-02-01 | 2018-08-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
| US11453871B2 (en) | 2017-03-15 | 2022-09-27 | Danisco Us Inc. | Trypsin-like serine proteases and uses thereof |
| EP3601515A1 (en) | 2017-03-31 | 2020-02-05 | Danisco US Inc. | Delayed release enzyme formulations for bleach-containing detergents |
| EP3601553B1 (en) | 2017-03-31 | 2025-12-03 | Danisco US Inc. | Alpha-amylase combinatorial variants |
| EP3415592A1 (en) | 2017-06-15 | 2018-12-19 | The Procter & Gamble Company | Water-soluble unit dose article comprising a solid laundry detergent composition |
| EP3418364A1 (en) | 2017-06-19 | 2018-12-26 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
| EP3418365A1 (en) | 2017-06-19 | 2018-12-26 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
| EP3418366A1 (en) | 2017-06-19 | 2018-12-26 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
| CA3067837A1 (en) | 2017-06-30 | 2019-01-03 | Danisco Us Inc | Low-agglomeration, enzyme-containing particles |
| EP3441450A1 (en) | 2017-08-11 | 2019-02-13 | The Procter & Gamble Company | Automatic dishwashing composition |
| EP3668973A2 (en) | 2017-08-18 | 2020-06-24 | Danisco US Inc. | Alpha-amylase variants |
| EP3456808A1 (en) | 2017-09-13 | 2019-03-20 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
| EP3467085A1 (en) | 2017-10-05 | 2019-04-10 | The Procter & Gamble Company | Dishwashing cleaning composition |
| ES2874024T3 (es) | 2017-10-05 | 2021-11-04 | Procter & Gamble | Composición de limpieza para el lavado de vajillas |
| WO2019075144A1 (en) | 2017-10-12 | 2019-04-18 | The Procter & Gamble Company | LEUCO COLORANTS IN COMBINATION WITH A SECOND BLEACHING AGENT AS AZURING AGENTS IN LAUNDRY CARE COMPOSITIONS |
| TWI715878B (zh) | 2017-10-12 | 2021-01-11 | 美商美力肯及公司 | 隱色著色劑及組成物 |
| CA3074938A1 (en) | 2017-10-12 | 2019-04-18 | The Procter & Gamble Company | Leuco colorants as bluing agents in laundry care composition |
| WO2019075148A1 (en) | 2017-10-12 | 2019-04-18 | The Procter & Gamble Company | LEUCO-COLORANTS AS AZURING AGENTS IN LAUNDRY CARE COMPOSITIONS |
| BR112020008476B1 (pt) | 2017-11-01 | 2023-11-21 | Milliken & Company | Composto leuco |
| CN111373039A (zh) | 2017-11-29 | 2020-07-03 | 丹尼斯科美国公司 | 具有改善的稳定性的枯草杆菌蛋白酶变体 |
| CN111742041B (zh) | 2017-12-21 | 2023-06-06 | 丹尼斯科美国公司 | 包含耐热干燥剂的含酶的热熔细粒 |
| BR112020016068A2 (pt) | 2018-02-08 | 2020-12-08 | Danisco Us Inc. | Partículas cera termicamente resistente matriz para encapsulamento de enzima |
| EP3530723B1 (en) | 2018-02-21 | 2023-03-29 | The Procter & Gamble Company | Automatic dishwashing composition |
| US12415996B2 (en) | 2018-06-19 | 2025-09-16 | Danisco Us Inc. | Subtilisin variants |
| US20210363470A1 (en) | 2018-06-19 | 2021-11-25 | Danisco Us Inc | Subtilisin variants |
| US20230174962A1 (en) | 2018-07-31 | 2023-06-08 | Danisco Us Inc | Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid |
| EP3844255A1 (en) | 2018-08-30 | 2021-07-07 | Danisco US Inc. | Enzyme-containing granules |
| EP3856882A1 (en) | 2018-09-27 | 2021-08-04 | Danisco US Inc. | Compositions for medical instrument cleaning |
| WO2020077331A2 (en) | 2018-10-12 | 2020-04-16 | Danisco Us Inc | Alpha-amylases with mutations that improve stability in the presence of chelants |
| EP3887515A1 (en) | 2018-11-28 | 2021-10-06 | Danisco US Inc. | Subtilisin variants having improved stability |
| JP7275297B2 (ja) | 2019-03-14 | 2023-05-17 | ザ プロクター アンド ギャンブル カンパニー | 酵素を含むクリーニング組成物 |
| US11248194B2 (en) | 2019-03-14 | 2022-02-15 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
| JP7275299B2 (ja) | 2019-03-14 | 2023-05-17 | ザ プロクター アンド ギャンブル カンパニー | 綿の処理方法 |
| ES3028186T3 (en) | 2019-05-22 | 2025-06-18 | Procter & Gamble | Automatic dishwashing method |
| CN114174504A (zh) | 2019-05-24 | 2022-03-11 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体和使用方法 |
| CN114174486A (zh) | 2019-06-06 | 2022-03-11 | 丹尼斯科美国公司 | 用于清洁的方法和组合物 |
| EP3760699A1 (en) | 2019-07-02 | 2021-01-06 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
| BR112022007697A2 (pt) | 2019-10-24 | 2022-07-12 | Danisco Us Inc | Alfa-amilase variante que forma maltopentaose/maltohexaose |
| EP3835396B1 (en) | 2019-12-09 | 2025-12-03 | The Procter & Gamble Company | A detergent composition comprising a polymer |
| CN111471668B (zh) * | 2020-02-28 | 2022-05-24 | 浙江工业大学 | 一种腈水解酶突变体及其在制备1-氰基环己基乙酸中的应用 |
| DE102020205400A1 (de) | 2020-04-29 | 2021-11-04 | Henkel Ag & Co. Kgaa | Hochalkalisches Textilwaschmittel mit Protease |
| DE102020205381A1 (de) | 2020-04-29 | 2021-11-04 | Henkel Ag & Co. Kgaa | Hochalkalisches Textilwaschmittel mit Protease |
| CA3173147A1 (en) | 2020-06-05 | 2021-12-09 | Phillip Kyle Vinson | Detergent compositions containing a branched surfactant |
| WO2022047149A1 (en) | 2020-08-27 | 2022-03-03 | Danisco Us Inc | Enzymes and enzyme compositions for cleaning |
| EP3974504B1 (en) | 2020-09-29 | 2023-07-26 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
| WO2022074037A2 (en) * | 2020-10-07 | 2022-04-14 | Novozymes A/S | Alpha-amylase variants |
| EP4237498A1 (en) | 2020-10-27 | 2023-09-06 | Milliken & Company | Compositions comprising leuco compounds and colorants |
| EP4237530A1 (en) | 2020-10-29 | 2023-09-06 | The Procter & Gamble Company | Cleaning compositions containing alginate lyase enzymes |
| US11840679B2 (en) | 2020-11-17 | 2023-12-12 | The Procter & Gamble Company | Automatic dishwashing composition |
| EP4006131A1 (en) | 2020-11-30 | 2022-06-01 | The Procter & Gamble Company | Method of laundering fabric |
| EP4011256A1 (de) | 2020-12-14 | 2022-06-15 | Henkel AG & Co. KGaA | Verfahren zur reinigung einer elektromotorisch betriebenen küchenmaschine |
| WO2022128620A1 (de) | 2020-12-14 | 2022-06-23 | Henkel Ag & Co. Kgaa | Verfahren zur reinigung einer elektromotorisch betriebenen küchenmaschine |
| EP4012011A1 (de) | 2020-12-14 | 2022-06-15 | Henkel AG & Co. KGaA | Reinigungsmittel insbesondere für eine küchenmaschine |
| DE102021213462A1 (de) | 2021-11-30 | 2023-06-01 | Henkel Ag & Co. Kgaa | Verfahren zur Reinigung einer elektromotorisch betriebenen Küchenmaschine |
| WO2022129166A1 (en) | 2020-12-15 | 2022-06-23 | Novozymes A/S | Mutated host cells with reduced cell motility |
| EP4267654A1 (en) | 2020-12-23 | 2023-11-01 | Basf Se | Amphiphilic alkoxylated polyamines and their uses |
| WO2022165107A1 (en) | 2021-01-29 | 2022-08-04 | Danisco Us Inc | Compositions for cleaning and methods related thereto |
| MX2023005793A (es) | 2021-03-15 | 2023-05-29 | Procter & Gamble | Composiciones de limpieza que contienen variantes de polipeptido. |
| WO2022199418A1 (en) | 2021-03-26 | 2022-09-29 | Novozymes A/S | Detergent composition with reduced polymer content |
| CA3211422A1 (en) | 2021-05-05 | 2022-11-10 | Neil Joseph Lant | Methods for making cleaning compositions and detecting soils |
| EP4086330A1 (en) | 2021-05-06 | 2022-11-09 | The Procter & Gamble Company | Surface treatment |
| EP4108150B1 (en) | 2021-06-22 | 2024-10-16 | The Procter & Gamble Company | A method of treating dishware in a domestic automatic dishwashing machine |
| EP4108767A1 (en) | 2021-06-22 | 2022-12-28 | The Procter & Gamble Company | Cleaning or treatment compositions containing nuclease enzymes |
| WO2023278297A1 (en) | 2021-06-30 | 2023-01-05 | Danisco Us Inc | Variant lipases and uses thereof |
| EP4123007A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Fabric treatment using bacterial spores |
| EP4123006A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Composition comprising spores and pro-perfume materials |
| EP4386035A4 (en) | 2021-08-10 | 2025-07-30 | Nippon Catalytic Chem Ind | POLYALKYLENE OXIDE-CONTAINING COMPOUND |
| EP4396320A2 (en) | 2021-09-03 | 2024-07-10 | Danisco US Inc. | Laundry compositions for cleaning |
| CN117957318A (zh) | 2021-09-13 | 2024-04-30 | 丹尼斯科美国公司 | 含有生物活性物质的颗粒 |
| WO2023064749A1 (en) | 2021-10-14 | 2023-04-20 | The Procter & Gamble Company | A fabric and home care product comprising cationic soil release polymer and lipase enzyme |
| EP4194536A1 (en) | 2021-12-08 | 2023-06-14 | The Procter & Gamble Company | Laundry treatment cartridge |
| EP4194537A1 (en) | 2021-12-08 | 2023-06-14 | The Procter & Gamble Company | Laundry treatment cartridge |
| US20250034535A1 (en) | 2021-12-10 | 2025-01-30 | Novozymes A/S | Improved protein production in recombinant bacteria |
| EP4448749A2 (en) | 2021-12-16 | 2024-10-23 | Danisco US Inc. | Subtilisin variants and methods of use |
| WO2023114988A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Variant maltopentaose/maltohexaose-forming alpha-amylases |
| CN118679251A (zh) | 2021-12-16 | 2024-09-20 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体和使用方法 |
| EP4448750A2 (en) | 2021-12-16 | 2024-10-23 | Danisco US Inc. | Subtilisin variants and uses thereof |
| WO2023168234A1 (en) | 2022-03-01 | 2023-09-07 | Danisco Us Inc. | Enzymes and enzyme compositions for cleaning |
| EP4273210A1 (en) | 2022-05-04 | 2023-11-08 | The Procter & Gamble Company | Detergent compositions containing enzymes |
| EP4273209A1 (en) | 2022-05-04 | 2023-11-08 | The Procter & Gamble Company | Machine-cleaning compositions containing enzymes |
| EP4525615A2 (en) | 2022-05-14 | 2025-03-26 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
| EP4279571A1 (en) | 2022-05-19 | 2023-11-22 | The Procter & Gamble Company | Laundry composition comprising spores |
| EP4286500A1 (en) | 2022-06-01 | 2023-12-06 | The Procter & Gamble Company | Use of xylanase in a dishwashing process |
| EP4286501B1 (en) | 2022-06-01 | 2025-01-08 | The Procter & Gamble Company | Dishwashing detergent composition comprising xylanase and block co-polymer |
| DE102022205588A1 (de) | 2022-06-01 | 2023-12-07 | Henkel Ag & Co. Kgaa | Wasch- und reinigungsmittel mit verbesserter enzymstabilität |
| DE102022205593A1 (de) | 2022-06-01 | 2023-12-07 | Henkel Ag & Co. Kgaa | Wasch- und reinigungsmittel mit verbesserter enzymstabilität |
| DE102022205591A1 (de) | 2022-06-01 | 2023-12-07 | Henkel Ag & Co. Kgaa | Wasch- und reinigungsmittel mit verbesserter enzymstabilität |
| DE102022205594A1 (de) | 2022-06-01 | 2023-12-07 | Henkel Ag & Co. Kgaa | Leistungsverbesserte und lagerstabile protease-varianten |
| EP4286499A1 (en) | 2022-06-01 | 2023-12-06 | The Procter & Gamble Company | Dishwashing detergent composition comprising xylanase and sulphonated carboxylate polymer |
| CN119487167A (zh) | 2022-06-21 | 2025-02-18 | 丹尼斯科美国公司 | 用于清洁的包含具有嗜热菌蛋白酶活性的多肽的组合物和方法 |
| EP4321604A1 (en) | 2022-08-08 | 2024-02-14 | The Procter & Gamble Company | A fabric and home care composition comprising surfactant and a polyester |
| EP4324900A1 (en) | 2022-08-17 | 2024-02-21 | Henkel AG & Co. KGaA | Detergent composition comprising enzymes |
| CA3265943A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | DETERGENT COMPOSITIONS AND ASSOCIATED PROCESSES |
| WO2024050339A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Mannanase variants and methods of use |
| CN120112635A (zh) | 2022-09-02 | 2025-06-06 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体及其相关方法 |
| EP4339268B1 (en) | 2022-09-16 | 2025-09-03 | The Procter & Gamble Company | Cartridge for automatic dishwashing chemical distribution |
| EP4361061A1 (en) | 2022-10-26 | 2024-05-01 | The Procter & Gamble Company | Detergent product |
| WO2024094778A1 (en) | 2022-11-04 | 2024-05-10 | Clariant International Ltd | Polyesters |
| EP4612211A1 (en) | 2022-11-04 | 2025-09-10 | The Procter & Gamble Company | Fabric and home care composition |
| WO2024094790A1 (en) | 2022-11-04 | 2024-05-10 | Clariant International Ltd | Polyesters |
| WO2024102698A1 (en) | 2022-11-09 | 2024-05-16 | Danisco Us Inc. | Subtilisin variants and methods of use |
| DE102022131732A1 (de) | 2022-11-30 | 2024-06-06 | Henkel Ag & Co. Kgaa | Verbesserte Waschleistung durch den Einsatz einer Protease fusioniert mit speziellem Adhäsionsvermittlerpeptid |
| WO2024120767A1 (en) | 2022-12-05 | 2024-06-13 | Novozymes A/S | Modified rna polymerase activities |
| EP4630526A1 (en) | 2022-12-05 | 2025-10-15 | The Procter & Gamble Company | Fabric and home care composition comprising a polyalkylenecarbonate compound |
| CN120303384A (zh) | 2022-12-12 | 2025-07-11 | 宝洁公司 | 织物和家庭护理组合物 |
| EP4386074B1 (en) | 2022-12-16 | 2025-12-03 | The Procter & Gamble Company | Fabric and home care composition |
| JP2026500823A (ja) | 2023-01-09 | 2026-01-08 | ザ プロクター アンド ギャンブル カンパニー | 重ね合わされた多区分の水溶性単位用量自動食器洗浄洗剤パウチ |
| EP4658776A1 (en) | 2023-02-01 | 2025-12-10 | Danisco US Inc. | Subtilisin variants and methods of use |
| US20240263162A1 (en) | 2023-02-01 | 2024-08-08 | The Procter & Gamble Company | Detergent compositions containing enzymes |
| WO2024186819A1 (en) | 2023-03-06 | 2024-09-12 | Danisco Us Inc. | Subtilisin variants and methods of use |
| EP4680013A1 (en) | 2023-03-16 | 2026-01-21 | Nutrition & Biosciences USA 4, Inc. | Brevibacillus fermentate extracts for cleaning and malodor control and use thereof |
| EP4458932A1 (en) | 2023-05-04 | 2024-11-06 | The Procter & Gamble Company | A fabric and home care composition |
| EP4458933A1 (en) | 2023-05-05 | 2024-11-06 | The Procter & Gamble Company | A fabric and home care composition comprising a propoxylated polyol |
| EP4481027A1 (en) | 2023-06-19 | 2024-12-25 | The Procter & Gamble Company | Cleaning compositions containing enzymes |
| EP4484536A1 (en) | 2023-06-26 | 2025-01-01 | The Procter & Gamble Company | Fabric and home care composition |
| EP4488351A1 (en) | 2023-07-03 | 2025-01-08 | The Procter & Gamble Company | Compositions containing a porphyrin binding protein |
| WO2025071996A1 (en) | 2023-09-28 | 2025-04-03 | Danisco Us Inc. | Variant cutinase enzymes with improved solubility and uses thereof |
| WO2025085351A1 (en) | 2023-10-20 | 2025-04-24 | Danisco Us Inc. | Subtilisin variants and methods of use |
| EP4549541A1 (en) | 2023-11-02 | 2025-05-07 | The Procter & Gamble Company | Fabric and home care composition |
| EP4549540A1 (en) | 2023-11-02 | 2025-05-07 | The Procter & Gamble Company | Fabric and home care composition |
| EP4553137A1 (en) | 2023-11-08 | 2025-05-14 | The Procter & Gamble Company | A fabric and home care composition comprising a polyester |
| EP4559998A1 (en) | 2023-11-22 | 2025-05-28 | The Procter & Gamble Company | Composition comprising microcapsules comprising spores |
| EP4570893A1 (en) | 2023-12-15 | 2025-06-18 | The Procter & Gamble Company | Fabric and home care composition |
| EP4570892A1 (en) | 2023-12-15 | 2025-06-18 | The Procter & Gamble Company | A laundry detergent composition |
| EP4610340A1 (en) | 2024-03-01 | 2025-09-03 | The Procter & Gamble Company | A laundry detergent composition comprising a polyester |
| EP4624555A1 (en) | 2024-03-26 | 2025-10-01 | The Procter & Gamble Company | Fabric and home care compositions |
| EP4624554A1 (en) | 2024-03-26 | 2025-10-01 | The Procter & Gamble Company | Fabric care compositions |
| WO2025213357A1 (en) | 2024-04-09 | 2025-10-16 | The Procter & Gamble Company | Particulate fabric care composition |
| EP4636063A1 (en) | 2024-04-19 | 2025-10-22 | The Procter & Gamble Company | A unit dose laundry detergent product |
| WO2025217909A1 (en) | 2024-04-19 | 2025-10-23 | The Procter & Gamble Company | Particulate fabric care product |
| EP4644515A1 (en) | 2024-05-02 | 2025-11-05 | The Procter & Gamble Company | Composition comprising spores and cationic glucan |
| EP4660287A1 (en) | 2024-06-06 | 2025-12-10 | The Procter & Gamble Company | Use of a polysaccharide ester in a laundry detergent composition |
| EP4663732A1 (en) | 2024-06-10 | 2025-12-17 | The Procter & Gamble Company | Use of graft polymer in a laundry detergent composition |
| EP4663733A1 (en) | 2024-06-10 | 2025-12-17 | The Procter & Gamble Company | Use of a graft polymer in a laundering process |
| WO2026024922A1 (en) | 2024-07-25 | 2026-01-29 | Danisco Us Inc. | Subtilisin variants and methods of use |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3912590A (en) | 1973-01-03 | 1975-10-14 | Novo Industri As | Procedure for liquefying starch |
| JPS57174089A (en) | 1981-04-20 | 1982-10-26 | Novo Industri As | Chain dividing enzyme product |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| DK122686D0 (da) | 1986-03-17 | 1986-03-17 | Novo Industri As | Fremstilling af proteiner |
| DK311186D0 (da) | 1986-06-30 | 1986-06-30 | Novo Industri As | Enzymer |
| KR960006119B1 (ko) | 1986-07-09 | 1996-05-09 | 노보 노르디스크 아크티에 셀스카브 | 전분 액화용 알파-아밀라아제 혼합물 |
| DE3909096A1 (de) | 1989-03-20 | 1990-09-27 | Garabed Antranikian | Alpha-amylase |
| DE69032360T2 (de) | 1989-06-29 | 1998-12-03 | Genencor International, Inc., Rochester, N.Y. | Mutierte mikrobielle alpha-Amylasen mit erhöhter thermischer, saurer und/oder alkylischer Stabilität |
| AU639570B2 (en) | 1990-05-09 | 1993-07-29 | Novozymes A/S | A cellulase preparation comprising an endoglucanase enzyme |
| ATE175235T1 (de) | 1993-02-11 | 1999-01-15 | Genencor Int | Oxidativ stabile alpha-amylase |
| JPH09503916A (ja) | 1993-10-08 | 1997-04-22 | ノボ ノルディスク アクティーゼルスカブ | アミラーゼ変異体 |
| DE69534464T2 (de) * | 1994-03-29 | 2006-09-28 | Novozymes A/S | Alkalische amylase aus bacellus |
| CA2194571C (en) * | 1994-06-17 | 2009-02-24 | Jan Metske Van Der Laan | Novel amylolytic enzymes derived from the b. licheniformis .alpha.-amylase, having improved characteristics |
| AU4483496A (en) * | 1995-02-03 | 1996-08-21 | Novo Nordisk A/S | A method of designing alpha-amylase mutants with predetermined properties |
| AR000862A1 (es) | 1995-02-03 | 1997-08-06 | Novozymes As | Variantes de una ó-amilasa madre, un metodo para producir la misma, una estructura de adn y un vector de expresion, una celula transformada por dichaestructura de adn y vector, un aditivo para detergente, composicion detergente, una composicion para lavado de ropa y una composicion para la eliminacion del |
| US6440716B1 (en) * | 1995-02-03 | 2002-08-27 | Novozymes A/S | α-amylase mutants |
| US6093562A (en) * | 1996-02-05 | 2000-07-25 | Novo Nordisk A/S | Amylase variants |
| DE19503621A1 (de) | 1995-02-03 | 1996-08-08 | Bosch Gmbh Robert | Hubkolbenpumpe |
| US5736499A (en) * | 1995-06-06 | 1998-04-07 | Genencor International, Inc. | Mutant A-amylase |
| WO1997007202A1 (en) | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Novel lipolytic enzymes |
| CN1246455C (zh) * | 1996-04-30 | 2006-03-22 | 诺沃奇梅兹有限公司 | α-淀粉酶变体 |
| MY119088A (en) * | 1996-11-26 | 2005-03-31 | Sony Corp | Information input method, information input sheet, and information input apparatus |
| EP2206768B1 (en) * | 1997-10-13 | 2015-04-01 | Novozymes A/S | Alpha-amylase mutants |
| KR19990059284A (ko) * | 1997-12-30 | 1999-07-26 | 서평원 | 디지탈 트렁크 접속부에서 톤 감시 및 에뮬레이션시스템 |
-
1998
- 1998-10-30 JP JP2000519071A patent/JP4426094B2/ja not_active Expired - Lifetime
- 1998-10-30 EP EP98951291A patent/EP1027428B1/en not_active Expired - Lifetime
- 1998-10-30 CN CNB988108712A patent/CN1163597C/zh not_active Ceased
- 1998-10-30 AU AU97373/98A patent/AU9737398A/en not_active Abandoned
- 1998-10-30 EP EP10180215.5A patent/EP2386569B1/en not_active Expired - Lifetime
- 1998-10-30 ES ES10180200.7T patent/ES2515218T3/es not_active Expired - Lifetime
- 1998-10-30 BR BRPI9816290A patent/BRPI9816290B1/pt not_active IP Right Cessation
- 1998-10-30 AT AT98951291T patent/ATE490311T1/de not_active IP Right Cessation
- 1998-10-30 WO PCT/DK1998/000471 patent/WO1999023211A1/en not_active Ceased
- 1998-10-30 EP EP10180224A patent/EP2388267A1/en not_active Withdrawn
- 1998-10-30 DE DE69842027T patent/DE69842027D1/de not_active Expired - Lifetime
- 1998-10-30 EP EP10180200.7A patent/EP2386568B1/en not_active Expired - Lifetime
- 1998-10-30 CN CN200410061736A patent/CN100593034C/zh not_active Expired - Lifetime
- 1998-10-30 US US09/183,412 patent/US6204232B1/en not_active Expired - Lifetime
- 1998-10-30 BR BRPI9813328A patent/BRPI9813328B1/pt active IP Right Grant
- 1998-10-30 CA CA2845178A patent/CA2845178A1/en not_active Abandoned
- 1998-10-30 CA CA2308119A patent/CA2308119C/en not_active Expired - Lifetime
-
2001
- 2001-01-25 US US09/769,864 patent/US6673589B2/en not_active Expired - Lifetime
-
2003
- 2003-09-19 US US10/665,667 patent/US20040038368A1/en not_active Abandoned
-
2004
- 2004-11-04 US US10/980,923 patent/US20050084937A1/en not_active Abandoned
-
2007
- 2007-12-10 US US11/953,532 patent/US20090263881A1/en not_active Abandoned
-
2013
- 2013-03-05 US US13/785,190 patent/US20140017715A1/en not_active Abandoned
-
2014
- 2014-01-24 US US14/163,585 patent/US20140248685A1/en not_active Abandoned
-
2016
- 2016-02-01 US US15/012,229 patent/US20160222365A1/en not_active Abandoned
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113186178A (zh) * | 2010-02-10 | 2021-07-30 | 诺维信公司 | 在螯合剂存在下具有高稳定性的变体和包含变体的组合物 |
| US12473541B2 (en) | 2010-02-10 | 2025-11-18 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
| CN103649307A (zh) * | 2011-06-30 | 2014-03-19 | 诺维信公司 | α-淀粉酶变体 |
| CN103649307B (zh) * | 2011-06-30 | 2020-03-27 | 诺维信公司 | α-淀粉酶变体 |
| CN112458069A (zh) * | 2013-01-03 | 2021-03-09 | 诺维信公司 | α-淀粉酶变体以及对其进行编码的多核苷酸 |
| CN115975990A (zh) * | 2022-07-18 | 2023-04-18 | 青岛蔚蓝生物集团有限公司 | 一种高比活中温淀粉酶突变体 |
| CN115975990B (zh) * | 2022-07-18 | 2024-04-30 | 青岛润博特生物科技有限公司 | 一种高比活中温淀粉酶突变体 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001521739A (ja) | 2001-11-13 |
| US20040038368A1 (en) | 2004-02-26 |
| EP1027428B1 (en) | 2010-12-01 |
| CN1278298A (zh) | 2000-12-27 |
| WO1999023211A1 (en) | 1999-05-14 |
| US20050084937A1 (en) | 2005-04-21 |
| US20140017715A1 (en) | 2014-01-16 |
| CA2308119C (en) | 2014-06-03 |
| JP4426094B2 (ja) | 2010-03-03 |
| CN100593034C (zh) | 2010-03-03 |
| BRPI9813328B1 (pt) | 2016-04-12 |
| EP2386569B1 (en) | 2014-08-06 |
| EP2386568A1 (en) | 2011-11-16 |
| DE69842027D1 (de) | 2011-01-13 |
| EP2386569A1 (en) | 2011-11-16 |
| US20090263881A1 (en) | 2009-10-22 |
| US6204232B1 (en) | 2001-03-20 |
| EP1027428A1 (en) | 2000-08-16 |
| US20140248685A1 (en) | 2014-09-04 |
| CA2845178A1 (en) | 1999-05-14 |
| CA2308119A1 (en) | 1999-05-14 |
| US20160222365A1 (en) | 2016-08-04 |
| US6673589B2 (en) | 2004-01-06 |
| BRPI9816290B1 (pt) | 2016-10-11 |
| ATE490311T1 (de) | 2010-12-15 |
| AU9737398A (en) | 1999-05-24 |
| EP2386568B1 (en) | 2014-08-06 |
| EP2388267A1 (en) | 2011-11-23 |
| ES2515218T3 (es) | 2014-10-29 |
| US20010039253A1 (en) | 2001-11-08 |
| BR9813328A (pt) | 2000-08-22 |
| CN1163597C (zh) | 2004-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1163597C (zh) | α-淀粉酶突变体 | |
| CN1234854C (zh) | 具有碱性α-淀粉酶活性的多肽以及编码该多肽的核酸 | |
| CN1189558C (zh) | 淀粉酶变体 | |
| CN1436232A (zh) | 具有改变的特性的变体 | |
| CN1252256C (zh) | α-淀粉酶变体 | |
| CN1246455C (zh) | α-淀粉酶变体 | |
| CN1244695C (zh) | 新的果胶酸裂解酶 | |
| CN1529752A (zh) | 具有改变特性的α-淀粉酶突变体 | |
| CN1172501A (zh) | 设计具有预定特性的α-淀粉酶突变体的方法 | |
| CN1351657A (zh) | 具有碱性α-淀粉酶活性的多肽及其编码核酸 | |
| CN1104499C (zh) | 氧化作用稳定的α-淀粉酶 | |
| CN1158637A (zh) | 改进的清洁组合物 | |
| CN1172500A (zh) | 淀粉酶变体 | |
| CN1333821A (zh) | α-淀粉酶变体 | |
| CN1871344A (zh) | 在洗涤剂中具有改善稳定性的蛋白酶 | |
| CN1509330A (zh) | 具有纤维二糖酶活性的多肽和编码其的多核苷酸 | |
| CN1729287A (zh) | 具有纤维二糖水解酶ⅱ活性的多肽及编码它的多核苷酸 | |
| CN1443236A (zh) | 从芽孢杆菌a7-7(dsm12368)中提取的新型淀粉分解酶以及含有该新型淀粉分解酶的洗涤剂和清洗剂 | |
| CN1292028A (zh) | 麦芽α淀粉酶变体 | |
| CN1536089A (zh) | 用于在真菌细胞中表达基因的启动子 | |
| CN1246153A (zh) | 包括相应于地衣芽孢杆菌A210、H405和/或、T412的残基的修饰的突变α-淀粉酶 | |
| CN1620501A (zh) | 具有纤维二糖水解酶i活性的多肽和编码多肽的多核苷酸 | |
| CN1784490A (zh) | 变体枯草杆菌蛋白酶(枯草杆菌酶) | |
| CN1902310A (zh) | 具有β-葡糖苷酶活性的多肽和编码所述多肽的多核苷酸 | |
| CN1252258C (zh) | 具有改进的卵污渍洗涤性能的新枯草杆菌酶 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20100303 |